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 There are two overarching themes of this dissertation. The first is to evaluate the 
robustness of unique relationships between nonacute cannabis use occurring across 
adolescence and young adulthood and young adult cognitive outcomes. The second is to 
explore possible alternative explanations for associations found and separate the potential 
causal influences of nonacute cannabis on cognition from pre-existing shared familial or 
environmental factors. 
Research in this area has predominantly relied upon cross-sectional studies, and 
critics have raised concerns regarding the impact of extraneous factors insufficiently 
addressed within prior research, leaving the true relationship between cannabis and 
cognition uncertain. To address this and other limitations in the literature, this dissertation 
was designed to examine the relationship between nonacute cannabis use across 
adolescence and young adulthood and young adult cognitive outcomes. We used a large 
population-based twin sample (N = 801) with longitudinal tracking of cannabis use at 
multiple time points along with extensive neuropsychological assessment and 
interviewing and a quasi-experimental research design (cotwin control design) to draw 
stronger causal inferences regarding the relationship between nonacute cannabis use and 
cognition.  
Across the two studies, consistent with prior research, nonacute cannabis use was 
associated with deficits in neurocognitive outcomes. Study 1 highlighted the importance 
of controlling for confounding as many of the associations did not survive covariate 
analyses, such that cannabis did not uniquely predict cognitive outcomes. However, 




domains, such as decision-making, processing speed, visuospatial attention, and general 
cognitive abilities. A pattern of sex-specific effects emerged such that males performed 
more poorly than females on decision-making and processing speed tasks with cannabis 
use. Converging on conclusions from Study 1 to explore the etiology of the most robust 
relationships, Study 2 found evidence that deficits in neurocognitive performance 
indexed pre-existing familial or environmental liability toward cannabis use but may also 
in turn be adversely impacted by heavy and early cannabis use, specifically for IQ and, in 
males, decision-making performance.  
Collectively, this work suggests a complex relationship between nonacute 
cannabis use and cognition, with differences in cognition reflecting a mixture of 
premorbid familial risk factors and possible adverse consequences of cannabis exposure. 
This information has implications for shaping policy decisions and targeting preventative 
and intervention efforts to reduce negative consequences of cannabis exposure in 
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The overarching theme of this dissertation is to examine the relationship between 
nonacute cannabis use and neurocognitive outcomes during the sensitive 
neurodevelopmental period of adolescence and young adulthood. Cross-sectional 
research has consistently found an association between nonacute cannabis use and 
cognition. This relationship is often assumed to represent a neurotoxic consequence of 
cannabis on the brain, but the relationship between cognition and cannabis is complex. 
Several avenues may account for associations demonstrated between cannabis use and 
cognition, including a) cannabis exposure has a direct adverse impact on cognition, b) 
unmeasured variables explain cannabis use and cognitive deficits, and c) cognitive 
deficits predate cannabis initiation and index shared familial or environmental risk 
toward later cannabis use. Indeed, it may be a combination of one, two, or all of these 
factors. 
Understanding the nature of the relationship between cannabis and cognition is 
imperative to inform policy decisions regarding the legalization of cannabis and targeting 
prevention or harm reduction efforts. However, the extant literature has not yet come to a 
clear consensus on the exact nature of this association. To address this open question, the 
studies presented here used a large, population-based twin sample to assess the 
association between cannabis and neurocognitive performance, capitalizing on the robust, 
multi-assessment longitudinal study design and the causally informative nature of twins 
using the cotwin control analysis. Cotwin control designs allow for more stringent control 
of shared familial and environmental factors through the genetic and environmental 




As reiterated in studies 1 and 2, adolescence and young adulthood are critical 
periods for neuromaturation and neuronal restructuring but are also periods of peak 
substance use. During these time frames, exposure to substances, such as cannabis, may 
disrupt brain developmental processes and produce harmful and potentially lasting effects 
that would otherwise not be seen if maturation was complete, pointing to youth as a time 
of possible vulnerability for neurocognitive insults. There are also numerous 
neurobiological reasons that sex-specific effects would be expected in the relationship 
between cannabis exposure and neurocognitive outcomes due to differences in the 
pharmacologic effects of Δ9-tetrahydrocannabinol (THC), the primary psychoactive 
ingredient in cannabis, in males and females. Cannabis exposure during adolescence or 
young adulthood, in particular, may result in sex-specific effects as brain maturational 
trajectories vary, such that males undergo a protracted neurodevelopmental course 
compared to females. Maturational restructuring of the brain during adolescence and 
young adulthood might provide the necessary environment for sex-specific effects to 
emerge.  
The two studies presented in this dissertation share several strengths that address 
gaps in the literature (described in more detail in Study 1). First, we used a large, 
population-based longitudinal sample of males and females with multiple, comprehensive 
follow-up assessments over the critical neurodevelopmental period of adolescence to 
young adulthood and peak substance use. We also used several dimensional measures to 
characterize cannabis use across adolescence and young adulthood, which are more 
reliable and valid than discrete group comparisons typically used in the cannabis 




cognitive domains, including those often under-represented in the longitudinal and twin 
literature and measured pre-exposure cognitive ability to address questions regarding 
temporal sequencing of the association. More exhaustive interviewing regarding 
psychosocial, environmental, and participant-specific factors allowed us to better address 
possible confounding variables, increasing confidence in findings and causal inferences.  
Study 1 examined the phenotypic link between dimensional measures of nonacute 
cannabis use across adolescence to young adulthood and an extensive battery of young 
adult cognitive outcomes. We focused on the evaluation of cannabis-related associations, 
independent of common confounding variables (e.g., pre-exposure cognitive ability, 
socioeconomic status, alcohol/nicotine use, education, recent cannabis use), along with 
more nuanced factors, such as sex-specific effects, implications of recency of last 
cannabis use, and exploratory analyses of effects unique to cannabis users. The 
conclusions drawn from Study 1 were used to hone the focus of Study 2 to the most 
relevant and robust nonacute cannabis use and cognitive associations. Study 2 built on the 
results of Study 1 by assessing the causal association between nonacute cannabis use and 
cognitive performance, disentangling pre-existing liability, and exposure-related 
consequences of cannabis use across adolescence.  
General Study Characteristics 
Sample 
Participants for both studies comprised monozygotic and same-sex dizygotic 
twins drawn from the Enrichment Study (ES), a component of the Minnesota Twin 
Family Study (MTFS) at the Minnesota Center for Twin and Family Research (MCTFR). 




twins conducted at the MCTFR (Keyes et al., 2009; Wilson et al., 2019). The ES twins 
were recruited and assessed at age 11 and were followed at ages 14, 17, and 24. A small 
subset of ES twins (n=265) were assessed at age 20; however, this follow-up was 
discontinued early and was not included in the current studies due to its comparatively 
small size to the larger sample. Years for intake recruitment and follow-ups included: 
1999-2001 (age-11), 2003-2010 (age-14), 2006-2012 (age-17), 2013-2018 (age-24).  
Of the original 998 twins recruited for the ES sample at the age-11 intake, 81% (n 
= 809) participated in the most recent age-24 follow-up in some capacity. Twin 
participation at the age-24 assessment was not uniform across all neurocognitive 
assessments due to logistic factors, such as time constraints during interviewing or 
impractical travel distances to participate in-person that necessitated phone interviews (n 
= 111). Eight individuals were excluded as they reported cannabis exposure before their 
intake assessment. Sample sizes for initial analyses will be reported in tables provided for 
each study, and the possible impact of attrition was examined in study 1.  
For participants included in this project, mean age (SD) for each assessment wave 
were as follows: 11.86 (0.43), 15.04 (0.55), 17.89 (0.47), 24.43 (0.90). Age at the most 
recent follow-up (age-24) break down included: 22 (22), 23 (229), 24 (351), 25 (150), 26 
(40), 27 (7), 28 (2). Given age dispersion at the most recent assessment, age was included 
as a covariate in all models. Racial and ethnic backgrounds mimicked that of the general 
population in Minnesota at the time of recruitment; as such, the ES sample was 
predominantly white (93%). Cannabis use data was pulled from all four assessment 
waves. Neurocognitive outcomes were obtained from the age-24 assessment wave and 




Cannabis use measures 
Cannabis use was assessed at ages 11, 14, 17, and 24. Six variables were used to 
characterize cannabis use. Variables included frequency of use (past 12 months), number 
of uses (since last assessment), heaviest frequency (lifetime), age of initiation, recent use 
(past 24-hour), and length of abstinence (time since last use from age-24 assessment). 
Two of these variables (frequency of cannabis (past 12 months) and the number of uses 
(since last assessment)) were combined at each follow-up assessment wave (i.e., 14, 17, 
and 24) and then averaged to form a single cumulative measure of cannabis exposure 
across adolescence to young adulthood (cannabis index). A similar approach has been 
used in several other studies from our group that have examined the impact of cannabis 
use on cognition (Malone et al., 2021; Schaefer et al., 2021). The other four variables 
(lifetime heaviest frequency, age of initiation, recent cannabis use, length of abstinence) 
were examined individually. Our primary variables of interest were the cannabis index, 
lifetime heaviest frequency, and age of initiation. Recent use and length of abstinence 
were utilized as covariates and are detailed in each study's method section. 
Cannabis was assessed using the Computerized Substance Use (CSU; McGue et 
al., 2014) questionnaire and a revised version of the drug supplement from the Diagnostic 
Interview for Children and Adolescents – Revised (DICA-R; Reich, 2000; Welner et al., 
1987). A modified version of the Substance Abuse Module (SAM; Robins et al., 1987) 
from the Composite International Diagnostic Interview (CIDI; Robins et al., 1988) was 
used to assess substance use at ages 17 and 24. Assessments were administered by 
interviewers with at least a bachelor-level degree in psychology or a related discipline 




SAM assess Diagnostic and Statistical Manual of Mental Disorders (DSM) diagnostic 
criteria for cannabis use disorder (CUD). The number of uses was obtained from the 
DICA-R (age 11, 14) and the SAM (age 17, 24). Frequency of use (past 12 months) was 
obtained from the CSU (age 11, 14) and the SAM (age 17, 24). Heaviest frequency was 
only asked on the SAM and was asked for lifetime (age 17) and since the last assessment 
(age 24) to cover the entirety of the lifespan (i.e., birth to age 24). Age of initiation was 
pulled from the DICA-R (age 11, 14) and the SAM (age 17, 24). Length of abstinence 
(time since last use) was asked on the SAM (age 24). 
Cannabis index. To obtain our cannabis index, which characterized cumulative 
cannabis exposure from adolescence to young adulthood, separate cannabis indices were 
first calculated for each follow-up wave (i.e., 14, 17, and 24) by averaging two items: (1) 
frequency of use in the past 12 months, and (2) number of times used since last 
assessment. Due to skew and spareness, we transformed responses of frequency and 
number of uses into ordinal measures before averaging these two items, with six 
categories per item. For frequency of use in the past 12 months, categories included: 0 
(no use), 1 (<1x/month), 2 (1-3x/month), 3 (1-4x/week), 4 (every day or nearly every 
day), or 5 (>1x/day). For number of uses since last assessment, categories included: 0 (no 
use), 1 (1-4 uses), 2 (5-30 uses), 3 (31-100 uses), 4 (101-400 uses), or 5 (>400 uses or 
“too many to count”). After we obtained individual indices for each follow-up assessment 
wave, we computed our cannabis index by averaging each of the separate indices into a 
single composite measure to summarize overall exposure from adolescence to young 
adulthood. Consistent with prior research using similar composite measures (Malone et 




had purposefully excluded individuals who had used cannabis before their intake 
assessment and, as such, age-11 cannabis use was zero for all participants.  
Lifetime heaviest frequency.  Participants were asked to think about the period 
when they were using cannabis the most, either in their lifetime (asked at age 17) or since 
their last assessment (asked at age 24), and then asked to report the frequency of their 
cannabis use during that time. We used the max value reported at either their age-17 or 
age-24 evaluation to assess for heaviest frequency in the participant’s lifetime (i.e., birth 
to age 24). Mimicking procedures used to develop the cannabis index, we transformed 
lifetime heaviest frequency into an ordinal measure containing six categories to reduce 
skew and spareness of responses. Categories included: 0 (no use), 1 (<1/year), 2 
(>1x/year to 2 to 3x/month), 3 (1 to 2x/week to nearly every day), 4 (1 to 2x/day), 5 
(3x/day). 
Age of initiation. Age of initiation was defined as the first exposure to cannabis 
regardless of the amount used. We asked participants how old they were when they first 
tried cannabis at each assessment wave to obtain this value. The age reported at the 
earliest assessment was used, as this was the report most proximal to when use occurred, 
likely reducing measurement error due to retrospective reporting over more extended 
periods. 
To illustrate the variation in normative cannabis use behaviors, descriptive 
statistics for our cannabis use variables are presented in Table. 1 with distributions 
presented for our three cannabis variables in Figure 1. Of the 801 participants used in our 
studies, 162 (20%) qualified for a cannabis use disorder (CUD) at some point in the 




24 assessment as DSM criteria for CUD were only asked since the last assessment (e.g., 
past seven years). However, this is generally commensurate with national prevalence 
rates (Waddell, 2021). At the age-24 assessment, 293 participants reported never using 
cannabis in their lifetime. Sixty-four individuals reported using cannabis within the 24-
hours preceding their age 24 assessment. Consistent with national data (Johnston et al., 














A comprehensive neuropsychological battery was administered at the age-24 
follow-up, assessing various cognitive domains, including verbal learning and memory, 
processing speed, verbal attention and working memory, visuospatial attention and 
working memory, decision-making, cognitive inhibition, and general cognitive abilities 
(see Table 2 for descriptive statistics of cognitive variables). Tests were selected given 
their strong psychometric properties, frequent use within research and/or clinical settings, 
and previous use within the cannabis use literature specifically. Scores derived from the 
completed neurocognitive battery are used to evaluate for possible implications of 
cannabis exposure on cognitive functioning.  
Verbal learning and memory  
Rey Auditory Verbal Learning Test (RAVLT; Schmidt, 1996). The RAVLT 
measures an individual’s ability to acquire, consolidate, and retrieve verbal information. 
In past research, cannabis users were found to learn (Lamers et al., 2006; Solowij et al., 
2011) and recall (Becker et al., 2014; Lamers et al., 2006; Pujol et al., 2014) fewer words 
on the RAVLT compared to controls. The test began with an initial learning phase, in 
which the participants were read a list containing 15 words five times (Trial 1-5) at a pace 
of approximately one word per second. After each list presentation, they were asked to 
repeat as many words as possible from the list. Next, as part of an interference trial (Trial 
B), individuals were read a new list of 15 words a single time and asked to recall as many 
words as possible from this new list. After this, there was an immediate recall trial (Trial 
6), during which the participants were asked to recall as many words as possible from the 




delayed recall trial was undertaken (Trial 7), and the participants were again asked to 
recall as many words as possible from the first word list without prior warning. Three 
scores are derived from this task to assess verbal learning and memory, including: (1) a 
total learning score calculated as the summation of the number of words an individual 
was able to repeat back across all five learning trials (total learning), (2) a measure of 
retention over a short delay adjusted for overall learning represented by the difference 
between the number of words repeated on Trial 5 and the number of words recalled on 
Trial 6 (short-delay recall), and (3) a measure of retention over a long delay adjusted for 
overall learning represented by the difference between the number of words repeated on 
Trial 5 and the number of words recalled on Trial 7 (long-delay recall).  
Processing speed  
Digit Symbol-Coding (Wechsler Adult Intelligence Scale-III (WAIS-III) Digit 
Symbol-Coding; Wechsler, 1997a). Digit symbol-coding assesses processing speed and 
psychomotor functioning. Performance on this measure has been shown to be lower in 
cannabis users compared to controls (Winward et al., 2014), and earlier-onset users have 
shown more significant deficits compared to late-onset cannabis users in a prior 
longitudinal study (Jacobus et al., 2015). For this task, a subject was shown a key that 
displays a set of symbols that are matched with numbers. Using the key, the subject was 
asked to subsequently fill in as many empty boxes with the appropriate symbol under its 
corresponding number as quickly and accurately as possible in a 120-second time frame. 
A participant's raw score represented the number of accurately documented symbols in 
the designated timeframe. Raw scores were then converted to scaled scores following 




Symbol Search (WAIS-III Symbol Search; Wechsler, 1997a). This test is also 
primarily a measure of mental processing speed and visual scanning. Subjects were asked 
to visually scan a row of symbols (search group) and compare these symbols to a set of 
two additional symbols (target group). They are then asked to mark as rapidly and 
accurately as possible whether or not a symbol in the search group was identical to one of 
the symbols in the target group. If no symbols in the search group were identical to the 
target group, they were instructed to mark the "no" box at the end of the row. Participants 
were given 120 seconds to complete as many items as possible. A participant's raw score 
represented the number of accurately marked symbols or "no" boxes less any errors 
executed in the designated time period. Like digit symbol-coding, raw scores were then 
converted to scaled scores following WAIS-III instructions utilizing age-corrected 
normative data.   
Processing Speed Index (WAIS-III Symbol Search; Wechsler, 1997a). The 
processing speed index is a summary measure of an individual’s overall speed of 
information processing. Both chronic and occasional adolescent cannabis users have been 
found to have deficits in processing speed index scores compared to non-consumers 
(Frolli et al., 2021). In prior longitudinal studies, current heavy cannabis users 
demonstrated lower mean scores on the processing speed index when compared to 
controls (Fried et al., 2005). An index score was derived from administering the digit 
symbol-coding and symbol search subtests described above using WAIS-III instructions 
and scoring procedures to obtain a standard score.   




Digit Span Forward and Backward (WAIS-III Digit Span; Wechsler, 1997a). 
Digit span forward is a measure of basic verbal attention abilities and maintenance 
component of working memory. Prior research demonstrated deficits on both digit span 
forward (Croft et al., 2001) and digit span backward (Croft et al., 2001; Jacobus et al., 
2015) task in cannabis users compared to controls and found associations between an 
earlier age of onset and poorer performance on digit span backward (Gouzoulis-
Mayfrank et al., 2000). For this task, participants were orally presented a string of digits 
at a pace of approximately one digit per second and then asked to immediately verbally 
repeat back the digits in the same order previously listed. Digit span backward reflects an 
individual's ability to maintain verbal information online and manipulate that information 
based on the task demands. The presentation was the same as the forward condition; 
however, after the presentation, participants were instead asked to repeat the number 
string in the reverse order than they were initially presented. In both the forward and 
backward conditions, digit strings became progressively longer as the participant 
continued to correctly repeat digit strings, with the max length being nine digits. Two 
variables were derived from the digit span subtest, including: (1) longest digit span 
forward, or the max number of digits that a participant was able to repeat back in the 
original order, and (2) longest digit span backward, or the max number of digits a 
participant was able to repeat back in reverse order. 
RAVLT Trail 1 (RAVLT; Schmidt, 1996). Trial 1 of the RAVLT is a measure of 
attention span for a list of words. Several studies have found impairments in cannabis 
users’ performance on the first list learning trial of the RAVLT when contrasted with 




RAVLT test administration, a score was obtained based on the number of words repeated 
back on the first trial presentation of the 15-word list (Trial 1; see above for further 
details on RAVLT administration). 
Visuospatial attention and working memory 
Spatial Span Forward and Backward (Spatial Span; Wechsler, 1997b). The 
spatial span test is a measure of basic visuospatial attention, information maintenance, 
and mental manipulation. Spatial span forward and backward have both been associated 
with cannabis dependence and frequency of cannabis use in prior research (Meier et al., 
2018). It is considered the visuospatial analog to the digit span test. Participant's spatial 
span was measured using an irregular array of ten blocks similar to the Weschler Memory 
Scale-3rd edition spatial span task and modified for display on a PC monitor utilizing E-
prime task presentation software (version 2.0; Schneider et al., 2002). Before beginning 
the forward and backward conditions, participants were given a practice trial. During 
both the spatial span forward and backward condition, the computer lit up a series of 
blue-colored squares one by one placed in various locations on a white background 
screen at a pace of approximately one square per second. When the computer stopped, 
during the spatial span forward condition, participants were instructed to use the mouse to 
click on the squares in the same order they lit up on the screen. During the spatial span 
backward condition, participants were instructed to click on the squares in reverse order. 
Two variables were derived from the spatial span task, including: (1) longest spatial span 
forward, or the max number of correctly identified squares selected in the original 
presentation order, and (2) longest spatial span backward, or the max number of correctly 





Iowa Gambling Task (IGT; Bechara et al., 1994). The Iowa Gambling Task was 
originally developed to quantify poor judgment and impulsive decision-making. Several 
studies have found poorer performance on the IGT when compared to controls (Becker et 
al., 2014; Gonzalez et al., 2012; Solowij et al., 2012; Verdejo-García et al., 2013). 
Participants completed a computerized version of the IGT using E-prime task software 
(version 2.0; Schneider et al., 2002). There were 100 total trials across five blocks. This 
computer task presents four decks of cards face down on the screen (Decks 1, 2, 3, and 
4). The participant was instructed to choose one card at a time from one of the four card 
decks. Each time they chose, they were given feedback about winning and/or losing some 
money. There was no limit to how often a participant could select from each deck. For 
each selection from Decks 1 and 4 ("advantageous decks"), participants would win either 
$0.10 or $0.15. Decks 1 and 4 differed in that with Deck 1, participants had a 50% 
chance of losses that varied from $0.05 to $0.20, whereas with Deck 4, there was a 10% 
chance of losses that varied from $0.60 to $0.65. Decks 1 and 4 were considered 
"advantageous" as losses were organized so that participants would accrue a net gain of 
$1.25 over 20 selections from these decks. For each selection from Decks 2 and 3 
("disadvantageous decks"), participants would win $0.25; however, losses were 
structured so that participants would incur a net loss of $1.25 over 20 selections from 
these decks, hence their label of "disadvantageous decks." Decks 2 and 3 differed in that 
with Deck 2, participants had a 50% chance of losses that varied from $0.35 to $0.90, 
whereas with Deck 3, there was a 10% chance of losses that varied from $3.00 to $3.25. 




money at the end of the task. Participants were paid their winnings in cash at the end of 
the day. Three measures were derived to evaluate IGT performance, including (1) overall 
performance, which was computed by subtracting the number of deck selections from the 
disadvantageous decks (2 and 3) from those from the advantageous decks (1 and 4) 
across all 100 trials (DM overall; Tolpak et al., 2010), (2) decision-making under 
ambiguity, characterized by the difference between advantageous and disadvantageous 
selections over the first two blocks (DM ambiguity; i.e., first 40 trials), and (3) decision-
making under risk, defined as the difference between advantageous and disadvantageous 
sections across the remaining three blocks (i.e., last 60 trials) (DM risk; Almy et al., 
2018).  
Cognitive inhibition  
Go/No-Go Task (Go/No-Go Task; Roche, Garavan, Foxe, & O’Mara, 2005). The 
1-back go/no-go task was used to assess inhibitory control, or the ability to rapidly cancel 
a behavior or action even after it was initiated. Prior research has found trends for poorer 
performance on Go/No-go tasks with an earlier age of onset of cannabis use and that 
cannabis users make a greater number of errors (Hester et al., 2009; Tamm et al., 2013). 
This computerized task encompassed three blocks of 144 pseudorandomized trials. 
During this task, two white letters were alternately presented over a black background for 
300ms. Letter combinations (X-Y, D-U, O-P) were different across each of the three 
blocks. Participants were instructed to press a button when the stimulus presented 
followed a different stimulus ("go" trials) but were asked to withhold their response when 
the stimulus was preceded by an identical stimulus ("no-go" trials). Participants were 




each trial following the response window. Participants were also given twenty practice 
trials before beginning the full task. Within each block, 25% of trials were no-go trials. 
Two variables were derived from task performance, including: (1) false alarm rate (No-
go Error Rate), or frequency of responding to no-go trials, which is conceptualized as a 
measure of response inhibition specifically, and (2) d-prime, which refers to the z-
transformed hit rate minus the z-transformed false-alarm rate and is considered the most 
comprehensive measure of overall task performance (Wickens, 2002).  
General cognitive ability 
Block Design (Wechsler Adult Intelligence Scale-Revised (WAIS-R) Block Design; 
Wechsler, 1981). Block design is broadly utilized as a measure of an individual's 
perceptual reasoning and problem-solving abilities. Worse block design performance has 
been found to be associated with greater mean levels of percent days of cannabis use 
across time (Infanted et al., 2019) and cannabis use predicted poorer block design 
performance in a sample of school age children (Morin et al., 2019).  For this task, 
participants were presented with either two, four, or nine identical blocks with all white, 
all red, or half red and half white surfaces. Using the blocks provided, the subject was 
asked to duplicate a pattern as quickly as possible that the administrator presented. As the 
individual progressed, the patterns would require more blocks and become increasingly 
more difficult. Raw scores were then converted to an age-correct scaled score following 
WAIS-R scoring guidelines. 
Vocabulary (WAIS-R Vocabulary; Wechsler, 1981). This test is a measure of 
verbal knowledge and concept formation. Phenotypic associations were found in a recent 




a vocabulary task (Schaefer et al., 2021). For this task, participants were presented a word 
both orally and visually. The participant was then asked to define the word. The test 
includes 66 words that increased in difficulty as items were successfully completed. Raw 
scores were then converted to an age-correct scaled score following WAIS-R scoring 
guidelines. 
Prorated Full Scale Intelligence Quotient (WAIS-R Prorated FSIQ; Wechsler, 
1981). FSIQ is a measure of an individual’s general cognitive and intellectual 
functioning. A recent meta-analysis of longitudinal studies found declines in intelligence 
quotient (IQ) scores were associated with cannabis use (Power et al., 2021). An estimate 
of the FSIQ summary score was derived from the administration of the block design and 















Study 1. Young Adult Neuropsychological Outcomes Associated with Cannabis Use 
from Adolescence to Young Adulthood 
 
Abstract 
Background. The perceived risks of cannabis use have been steadily declining, 
particularly among adolescents and young adults. However, the potency of cannabis 
products has increased over recent decades, raising concerns regarding the consequences 
of cannabis exposure. Research suggests nonacute cannabis exposure is associated with 
impairments in cognition and highlights adolescence to young adulthood as a vulnerable 
period for adverse consequences. However, the robustness and strength of the 
connections between nonacute cannabis and cognition, including how well these 
connections hold after accounting for relevant variables, remains to be fully elucidated 
given methodologic limitations within the literature. Limitations comprised inconsistent 
control of confounders, over reliance on discrete group comparisons (e.g., "user" vs. 
"non-users") despite dimensional nature of data without a consistent definition of groups 
between studies, and narrow representation of cannabis behaviors (e.g., focus on user 
status or frequency of use) within a primarily cross-sectional literature base. Additionally, 
less focus has been placed on understanding nuances of the relationship between cannabis 
use and cognition that may confer additional risk for adverse cognitive outcomes (e.g., 
sex-specific effects). We sought to characterize the relationship between cannabis use 
occurring across adolescence into young adulthood and young adult cognitive outcomes 
and examine alternative explanations, confounding factors, and nuances, such as the 




Method. Dimensional measures of cannabis and other substance use were 
obtained across four assessment waves from age 11 to 24 in a population-based sample of 
801 twins (55% female). Primary variables of interest were a summary measure of 
cumulative cannabis exposure across all assessment waves (cannabis index), lifetime 
heaviest frequency, and age of cannabis initiation. Participants completed a battery of 
cognitive assessments at age 24, and pre-exposure IQ was assessed at age 11. Linear 
mixed models (LMMs) were used to explore the relationships between cannabis use 
variables of interest and cognitive outcomes. Covariates of interest included pre-exposure 
IQ, parental socioeconomic status, alcohol and nicotine use, years of education, recent 
cannabis use, and length of abstinence from cannabis. All models include covariates for 
age, sex, and zygosity. 
Results. Several significant associations were found in initial analyses between 
cannabis use and cognition; however, many of these were attenuated once relevant 
confounding factors were covaried. Independent of covariates, significant effects 
remained between an earlier age of cannabis initiation and lower prorated FSIQ scores 
and weaker visuospatial attention performance. Sex-specific effects emerged on a 
processing speed and decision-making task, such that males demonstrated greater 
processing speed deficits with an earlier age of cannabis initiation and greater decision-
making impairments with higher lifetime heaviest frequencies than females. Impairments 
on a block design task appeared to be most strongly related to cumulative cannabis use, 
but no other significant effects were found with our cumulative cannabis use measure. 
Findings for age of initiation rose above a composite measure of frequency and quantity 




scores were also evidenced with higher lifetime heaviest frequencies when assessing for 
deficits in cannabis users only. Differences in performance did not emerge when 
comparing cannabis users with less than a month of abstinence to those that had not used 
in at least a year, and abstinence length did not predict performance on our cognitive 
measures  
Conclusions. Results from this longitudinal study suggest that individuals who 
use cannabis earlier during adolescence and have heavier peak frequencies of use are 
more vulnerable to persistent deficits in cognition even with prolonged abstinence, 
particularly males. Results suggest that more diffuse moderate levels of cannabis use, 


















Cannabis is currently the most used illicit substance in the United States. High 
rates of use are unsurprising given the steady decline since the mid-2000s in the public’s 
perceived risk associated with cannabis use and, as is often the case with a downward 
shift in perceived risk, personal disapproval rates have also been falling over the last 
decade (Johnston et al., 2021). These changes in perception surrounding cannabis have 
been accompanied by shifts in policy and cannabis potency as well. For instance, at the 
time of writing this paper, 37 states have legalized cannabis use at the medicinal level, 
and 18 states, plus the District of Columbia, have legalized it at the recreational level 
(Berke et al., 2021). Alongside legalization, the cannabis products produced within the 
recreational and medicinal markets have seen a significant increase in delta-9-
tetrahydrocannabinol (THC), the primary psychoactive ingredient in cannabis, with some 
products containing up to +80% THC content (Chandra et al., 2019; Russo, 2016). This 
increase has raised concerns given that THC exposure has been linked with several 
adverse outcomes, including interference with normal neurophysiological processes 
(Bossong & Niesink, 2010; Mizrahi et al., 2017). The changes in potency and push for 
legalization have placed additional expediency on the need for research on the enduring 
impacts of cannabis exposure on the brain to better inform policy. 
Risk conferred within youth 
There is a particular urgency for research focusing on the ramifications of 
cannabis use in youth. The necessity to understand the consequences of cannabis 
exposure on the adolescent and young adult brain is salient for two reasons. First, 




characterized by behavioral changes, such as increased risk-taking (Dayan et al., 2010). 
The 2020 Monitoring the Future survey conducted on youth substance use found that 
daily marijuana use levels in 8th to 12th graders were at or near the highest level recorded 
since 1991, with 6.9% of 12th graders reporting smoking cannabis daily (Johnston et al., 
2021).  
Second, these periods of peak substance use occur during a time of substantial 
neuroanatomical development, with changes in both gray and white matter occurring well 
into early adulthood (Andersen et al., 2000; Lenroot et al., 2007; Sowell et al., 2002). It is 
hypothesized that, due to this ongoing neuroanatomical restructuring, adolescents and 
young adults, relative to older cohorts, are more vulnerable to potential cannabis 
exposure-related insults to brain structure and function. Interruption to developmental 
processes may result in lasting impairments in critical mechanisms, particularly those 
involved with the pharmacological effects of cannabis (Ellgren et al., 2008; Lubman et 
al., 2015).  
Animal studies have supported this hypothesis. Rodent studies have found lasting 
alterations in glutamatergic functioning following adolescent THC exposure (Gleason et 
al., 2012). Other rodent studies have noted that adult rats, exposed to THC during 
adolescence or young adulthood, demonstrated diminished social interaction and 
recognition (O'Shea et al., 2006; Leweke & Schneider, 2011) and altered motivational 
processes (Rubino et al., 2008). Research has highlighted deficits in working memory in 
adolescent, but not adult, rats with the same amount of THC exposure (Quinn et al., 
2008). Impairments were also found in sensorimotor gating and recognition memory in 




exposed to chronic doses of THC during adolescence demonstrated lasting deficits in 
learning (Harte and Dow-Edwards, 2010).  
The human literature generally converges on similar findings. For instance, a 
large longitudinal study found that cannabis use during adolescence was associated with 
altered cerebral cortical development, particularly in brain regions rich in cannabinoid 
receptors, and was associated with greater attentional impulsiveness (Albaugh et al., 
2021). Decreasing resting functional connectivity with dorsolateral prefrontal and 
orbitofrontal cortices, as well as a lack of increase of resting functional connectivity with 
the superior frontal gyrus, have also been demonstrated in adolescence with a cannabis 
use disorder compared to those without, which overlapped with deficits in executive 
functioning performance (Camchong et al., 2017). An earlier age of initial cannabis 
exposure has been associated with protracted verbal learning and memory (Barthelemy et 
al., 2020; Jacobus et al., 2015), processing speed (Ehrenreich et al., 1999; Jacobus et al., 
2015), cognitive disinhibition (Gruber et al., 2011; Solowij et al., 2012), poor working 
memory (Becker et al., 2010), and deficits in decision-making task performance 
(Castellanos-Ryan et al., 2017); however, other studies have not replicated these results 
(Ross et al., 2020; Scott et al., 2018). Exploration of risk conferred by the age of cannabis 
exposure warrants further exploration.  
Existing literature 
Cross-sectional literature 
Given concerns that adolescence and young adulthood may represent periods of 




substantial cross-sectional literature base focused on the implications of nonacute 
cannabis use and cognitive function during these developmental time points.  
 Within cross-sectional studies, evidence has emerged that adolescent and young 
adult cannabis users demonstrate a relatively consistent pattern of deficits in verbal 
learning and memory (Becker et al., 2014; Hanson et al., 2010; Lamers et al., 2006; 
Solowij et al., 2011), processing speed (King et al., 2011; Medina et al., 2007; Tapert et 
al., 2007; Winward et al., 2014), and decision-making performance (Becker et al., 2014; 
Clark et al., 2009; Grant et al., 2012; Gonzalez et al., 2012; Hanson et al., 2014; Lamers 
et al., 2006; Solowij et al., 2012; Tamm et al., 2013; Verdejo-García et al., 2007; 
Verdejo-García et al., 2013). Significant effects typically occurred in heavy, frequent 
cannabis users (Scott et al., 2018), with some evidence for persistent deficits despite 
abstinence (Bolla et al., 2002; Medina et al., 2007; Winward et al., 2014; Wallace et al., 
2020) and more pronounced impairments seen in early-onset cannabis users (Ehrenreich 
et al., 1999; Pope et al., 2003; Schweinsburg et al., 2008; Solowij et al., 2011). Less 
consistent evidence has emerged for deficits in attention (Becker et al., 2014; Lisdahl & 
Price 2012; Medina et al., 2007; Petker et al., 2019;), working memory (Becker et al., 
2010; Hanson et al., 2014; Parlar et al., 2021; Petker et al., 2019), and cognitive 
inhibition (Dougherty et al., 2013; Gonzalez et al., 2012; Takagi et al., 2011) within 
adolescents and young adults.  
Meta-analyses have attempted to address some of the inconsistencies. In an early 
meta-analysis of 11 studies, Grant and colleagues (2003) demonstrated small but 
discernable deficits in the domains of learning and memory but not attention, executive 




abstinence did not moderate the effects. Schreiner and Dunn (2012) similarly found small 
but significant effects sizes for poorer learning and memory performance in cannabis 
users compared to controls; however, unlike Grant et al. (2013), they also found deficits 
in attention and executive functioning domains. Differences in results could be 
attributable to sample size as Schreiner and Dunn included 33 studies and effect sizes 
were characterized as small, suggesting that the earlier meta-analysis may have been 
underpowered to decern effects.  
Scott et al. (2018) reaffirmed this in a large meta-analysis of 69 studies focusing 
on adolescents and young adults, documenting small effect sizes for reduced cognitive 
functioning with frequent, heavy cannabis use in learning and memory, processing speed, 
inhibition, working memory, and attention. However, they noted that effect sizes were no 
longer significant when analyses were constrained to studies with at least 72-hour 
abstinence periods, which the author interpreted as evidence that deficits seen in cannabis 
users may be due to residual effects of recent use or withdrawal rather than persistent 
effects. There was no association with age of onset of cannabis use, although definitions 
within individual studies for "early-onset" ranged from use before age 15 to age 18 when 
looking at discrete groups. A meta-analysis examining the impact of abstinence on the 
association between nonacute cannabis use and verbal learning and memory also noted 
some amelioration of deficits related to cannabis, with deficits appearing to resolve 
between 7 and 28 days of abstinence (Krzyzanowski & Pudon, 2019).  
Lovell et al. (2020) analyzed 30 young adult and adult studies, comparing 849 
cannabis users to 764 controls, and found cannabis use was associated with small-




moderate deficits for decision-making and, unlike Schreiner and Dunn (2012) and Scott 
et al., (2018), prolonged abstinence ( 25 days) did not influence outcomes, except for 
executive functioning. No significant group differences were noted for simple reaction 
speed, working memory, or attention, nor did age of onset (defined as <16 years of age) 
influence outcomes. Consistent with this, in a meta-analysis of adolescents and adults, 
Ganzer and colleagues (2016) assessed the role of sustained abstinence of at least 14 
days. Even with abstinence, they found moderate deficits in learning and memory and 
executive functioning (e.g., inhibitory control/decision-making) in cannabis users 
compared to controls (Ganzer et al., 2016). A meta-analysis of 13 studies of young adult 
chronic cannabis users partially affirmed these results, noting an association between 
chronic cannabis use and short- and long-delay memory, decision-making, and attention 
tasks, but not inhibition (Figueiredo et al. 2020). 
Altogether, meta-analyses consistently report neurocognitive deficits in cannabis 
users, particularly with heavy, frequent cannabis use. Reviews indicate that learning and 
memory impairments appear to be the most consistent findings (Broyd et al., 2016; 
Duperrouzel et al., 2020). More moderate evidence is seen for deficits in processing 
speed and attention. Aspects of executive functioning, such as decision-making, also have 
support, but comparatively fewer cross-sectional studies have examined decision-making 
specifically, and most of those studies focus on young adulthood. Results for other 
cognitive domains continue to be characterized as mixed (Broyd et al., 2016; Ajmer et al., 
2021), nor is it clear whether deficits resolve with abstinence.  
Scott et al. (2018) cites limitations due to heterogeneity in the characterization of 




substance use and the possibility of reverse causation. Duperrouzel et al. (2020) noted 
that because meta-analyses are based on cross-sectional research, they are limited in their 
ability to conclude causality and may also have trouble speaking to the impact of age of 
onset. Retrospective reports of the age of onset may be particularly susceptible to 
measurement error with cross-sectional cohorts as participants may be reporting on 
events occurring over decades prior. Other identified limitations included the small 
sample sizes of included studies (n < 100; Duperrouzel et al., 2020), variability in 
neurocognitive tasks used (Figueiredo et al., 2019; Lovell et al., 2020), and over-reliance 
on group comparisons (e.g., "user" vs. "non-user," "heavy" vs. "light") despite the 
dimensional nature of the data (Infante et al., 2020). Large longitudinal studies should 
focus on addressing these limitations.   
Longitudinal and twin studies  
In longitudinal cohort studies following adolescents and young adults post-
initiation of cannabis use, cannabis users demonstrated worse learning and delayed recall 
for list-learning and story memory tasks compared to controls (Becker et al., 2018), with 
evidence of persistent deficits through three weeks of abstinence (Jacobus et al., 2015) 
but possible amelioration of impairments after 12 months of abstinence (Tait et al., 2011). 
More significant deficits were also noted in early-onset cannabis users (defined < age 16; 
Jacobus et al., 2015) and with greater cannabis use frequencies (Pacheco-Colón et al., 
2021). These are partially consistent with a longitudinal study with pre-and post-initiation 
cognitive measures, such that current, heavy users had lower mean scores on immediate 
and delayed recall tasks in a sample of 113 adolescents followed over eight years 




months abstinence) regardless of frequency of use (Fried et al., 2005). In another project 
from our group, Malone et al. (2021) found that propensity to use alcohol (e.g., academic 
problems and family occupation) accounted for the relationship between cumulative 
cannabis use and verbal learning in a large sample of twins, and no relationship was 
found between cannabis and memory performance, which was replicated in a more 
modest sample of 175 adolescents followed into adulthood (Infante et al., 2019). 
However, in a sample of African American youth, early-onset cannabis users evidenced 
declines in story-memory performance across adolescence (Barthelemy et al., 2019), and 
another study found familial effects in sibling pairs, not alcohol use, accounted for the 
relationship between cannabis use and delayed recall (Ellingson et al., 2021). 
 Despite three weeks of abstinence, early-onset cannabis users performed more 
poorly on a speeded coding task than controls (Jacobus et al.,2015). But this was not 
replicated in other post-cannabis initiation longitudinal studies (Becker et al., 2018). A 
longitudinal study with pre-and post-initiation cognitive measures suggested that 
processing speed deficits associated with current, heavy cannabis use resolved after three 
months of abstinence as former users performed similarly to controls (Fried et al., 2005). 
Infante and colleagues (2019), who confirmed 24-hour abstinence from cannabis with 
drug screening before cognitive assessment, did not find a relationship between 
processing speed and cannabis use. As suggested by Scott et al. (2018), effect sizes for 
processing speed may diminish when accounting for abstinence length. 
  When verbal attention was assessed with a list-learn task, evidence was found for 
deficits in a cannabis and alcohol using group and early-onset cannabis users with three 




evidence for an association between initial learning on a list-learning task, but this 
relationship was attenuated when accounting for propensity to use alcohol (e.g., risk 
factors for later substance use; Malone et al., 2021). Conversely, longitudinal studies 
using a digit-span task found no evidence of deficits in cannabis users (Becker et al., 
2018; Fried et al., 2005; Jacobus et al., 2015) or associations with the age of initiation 
(Castellanos-Ryan et al., 2017), frequency of use in the last year (Castellanos-Ryan et al., 
2017; Infante et al., 2019), or cumulative use (Schaefer et al., 2021). In a younger, more 
moderately using sample of twins, Meier et al. (2018) found pre-exposure IQ accounted 
for the relationship between cannabis dependence and a sustained attention task using 
digit sequences.  
Verbal working memory deficits were evidenced in a group of alcohol and 
marijuana users, followed post-initiation of cannabis use, compared to controls (Jacobus 
et al., 2015). However, pre-initiation performance accounted for differences between 
cannabis users and control subjects in another study (Fried et al., 2005). In line with this, 
no associations were found between frequency of use or cumulative use and verbal 
working memory performance (Castellanos-Ryan et al., 2017; Schaefer et al., 2021); 
however, early-onset, regular cannabis users (typically with use before age 15) 
demonstrated deficits compared to never-users in a large longitudinal study (Mahedy et 
al., 2021), but the covariate for alcohol use may have under-represented alcohol exposure 
levels as it characterized alcohol use as whether or not an individual had a “whole drink” 
prior to age 13.  
Relatively few longitudinal studies have focused on visuospatial attention. When 




demonstrated between cannabis users and controls (Wendel et al., 2021), consistent with 
a previous investigation (Fried et al., 2005). In a longitudinal study with more follow-ups, 
poorer performance on a spatial span task was related to both cannabis dependence and 
frequency of cannabis use in the past year. However, differences in performance were not 
demonstrated between twins discordant for cannabis use, which was not consistent with a 
causal effect of cannabis use on visuospatial attention (Meier et al., 2018).  
Mixed findings emerged for visuospatial working memory. In post-cannabis 
initiation cohort studies, young adult cannabis users demonstrated poorer efficiency on a 
visuospatial working memory task compared to controls (Becker et al., 2018), and in a 
sample of school-age children, cannabis use predicted impairment on a working memory 
task assessed one year later (Morin et al., 2019). However, worse visuospatial working 
memory performance at earlier time points also conferred risk for greater substance use 
in subsequent follow-up years. In their twin analyses, Meier et al. (2018) found 
differences in performance on a spatial span working memory task between twins 
discordant for frequency of cannabis use in the previous year, but twins discordant for 
cannabis dependence did not evidence differences in working memory performance. It 
may be that visuospatial working memory performance both confers risk for later 
substance use behaviors and could be adversely impacted by cannabis exposure, although 
other longitudinal studies found no association between visuospatial working memory 
and cannabis user status, frequency of use in the past six months, or age of initiation 
(Wendel et al., 2021; Ross et al., 2020).   
Longitudinal investigations of decision-making tended to cover tighter age ranges 




post-cannabis initiation, cannabis users demonstrated deficits in risky decision-making at 
their baseline assessment compared to controls, but not at their 2-year follow-up 
assessment, which the authors attributed to possible recovery of function with reduced 
use or behavioral tolerance with regular use (Becker et al., 2018). In a sample of 
adolescent males followed for a longer period from age 13 to 20, past-year cannabis use 
frequency reported at age 14 predicted declines in performance on a reward-based 
decision-making task, which appeared to persist even with a year of abstinence 
(Castellanos-Ryan et al., 2017). Other studies with shorter follow-up periods (e.g., two 
years and five years, respectively) found no relationship between decision-making and 
cannabis use (Pacheco-Colón et al., 2021; Wendel et al., 2021). Longer follow-up periods 
may be needed to assess the full extent of the association between cannabis use and 
decision-making in adolescents and young adults.  
In school-aged children, individuals more likely to use cannabis showed worse 
inhibitory control performance; however, greater cannabis use in a given year was also 
associated with poor inhibitory control one year later (Morin et al., 2019), suggesting at 
least some impact of cannabis exposure on cognitive inhibition. Consistent with this, 
greater mean levels of cannabis use were associated with poorer inhibitory control 
(Infante et al., 2019), and early-onset, regular cannabis users had a lower mean 
performance on a response inhibition task (Mahedy et al., 2021). In their twin study, Ross 
and colleagues (2020) found potential evidence for an exposure-related effect of 
frequency of cannabis use in the past six months reported at age 17 and worse scores on a 
summary score of executive functioning, which accounted for cognitive inhibition; 




Conversely in a recent sibling study, Ellingson and colleagues’ (2021) results suggested 
that familial factors associated with greater cannabis use were associated with poorer 
inhibitory. 
 In an often-cited study, Meier and colleagues (2012) examined the association 
between cannabis dependence and intelligence scores in a large longitudinal study 
following individuals from early adolescence and well into adulthood. Results revealed 
that cannabis dependence was associated with a decline in intelligence scores from age 
13 to 38. Impairments were concentrated in adolescent-onset cannabis users (weekly use 
or cannabis dependence before age 18), with more persistent use associated with greater 
decline. Other studies have demonstrated similar declines in intelligence scores in 
adolescent and young adult cannabis users (Boccio & Beaver, 2017) and poorer 
performance on a perceptual reasoning task with greater mean levels of percent days of 
cannabis use (Infante et al., 2019). Prior investigations also suggest deficits in 
intelligence and perceptual reasoning scores with heavier frequencies of cannabis use or 
early-onset cannabis use but note that deficits appeared transient and may resolve with 
abstinence (Fried et al., 2005; Infante et al., 2019). However, the causal nature of these 
associations has been questioned. 
Regarding Meier et al.'s (2012) study, critics have suggested that the associations 
seen were better accounted for by confounding factors such as socioeconomic status 
(Rogeberg, 2013) or personality factors (Daly, 2013). In response, several twin studies 
have investigated the relationship between cannabis and general cognitive ability. Twin 
studies found evidence to suggest that deficits in general cognitive ability scores of 




effects of cannabis use (Jackson et al., 2016; Meier et al., 2018; Schaefer et al., 2021). 
Similarly, Castellanos-Ryan et al. (2017) found that the association between cannabis use 
and decline in verbal IQ was accounted for by high school graduation status and Mokrysz 
and colleagues (2016) found that after covarying for group differences in cigarette 
smoking, cannabis users no longer differed from non-users on IQ scores. A recent meta-
analytic review of longitudinal studies of intelligence found significant associations 
between frequent or dependent cannabis use in youth and IQ change (Power et al., 2021). 
The author cited concerns regarding possible confounding; however, they felt that the 
hypothesis that family-level vulnerability predisposing to IQ decline, while possible, 
seemed less likely to be fully explanatory (Ellingson et al., 2020; Power et al., 2021). 
 As demonstrated in the above summary, longitudinal and twin studies to date do 
not necessarily converge on a single conclusion regarding the relationship between 
nonacute cannabis use and neurocognitive functioning in youth. However, they concur 
with the importance of examining the role of confounders, such as pre-exposure IQ, 
education, socioeconomic status, and other substance use (Castellanos-Ryan et al., 2017; 
Malone et al., 2021; Meier et al., 2018; Mokrysz et al., 2016). Prior research also 
highlights the need to use large, longitudinal investigations with multiple follow-ups 
across both adolescence and young adulthood to better assess nuances of the association 
between cannabis use and cognition along with abstinence from cannabis (Castellanos-
Ryan et al., 2017; Infante et al., 2019; Jacobus et al., 2015; Pacheco-Colón et al., 2019). 
Evidence can be seen for possible task-dependent effects (Jacobus et al., 2015; Becker et 
al., 2018; Schaefer et al., 2021), as well as continued reliance on group comparisons 




use within a constrained period of six months to a year. It will be imperative that future 
studies consider these factors. 
Influence of sex on vulnerability to adverse cannabis consequences  
An often under-considered factor within the context of cannabis' impact on the 
brain, developmental processes, and cognition has been the role of sex. Accumulating 
evidence suggests sex-specific effects of cannabis exposure, including differences in 
pharmacokinetics and behavioral effects of cannabis compounds (Cooper & Craft, 2018; 
Ruiz et al., 2021). Animal studies have demonstrated that female rats metabolize THC to 
its most highly active metabolite, whereas male rats metabolize into multiple compounds 
(Narimatsu et al., 1991). Cannabinoid receptor type 1 (CB1) density also varies by sex, 
such that CB1 density, where THC binds in the brain, was greater for males than females 
(Burston et al., 2010; Mateos et al., 2011). Further, adolescent female rats evidenced 
greater CB1 desensitization than male rats following THC exposure in brain regions such 
as the prefrontal cortex and hippocampus (Burston et al., 2010). Different behavioral 
pictures have emerged within the animal literature as well, such that male rats presented 
with greater anhedonia while female rats presented with significant behavioral despair 
(Rubio et al., 2008). Females rats also showed increased locomotor activity after acute 
THC exposure compared to male rats (Wiley, 2003). 
Human studies converge on sex-related differences in the implications of cannabis 
use as well. For instance, females have been shown to develop less tachycardia than 
males after smoking (Cocchetto et al., 1981) and may experience greater reinforcement 
from cannabis use than males (Fattore et al., 2007). Additionally, a telescoping effect has 




more rapidly than men and enter treatment for cannabis use disorder sooner and after less 
cannabis use compared to males (Greenfield et al., 2010; Hernandez-Avila et al., 2004). 
Within the cross-sectional literature on nonacute cannabis use, heavy cannabis-using 
females performed worse than light cannabis using females on a visuospatial task, but no 
differences were found between heavy and light cannabis using males (Pope et al., 1997). 
Other studies of adolescents and young adults have found greater deficits in male 
cannabis users on measures of memory, processing speed, cognitive flexibility, and 
decision-making compared to their female counterparts (Crane, Schuster, & Gonzalez, 
2013; King et al., 2011; Lisdahl & Price, 2012; Petker et al., 2019; Pope and Yurgelun-
Todd, 1996). A recent cross-sectional study in adolescents and young adults found 
domain-specific sex effects such that females performed worse with an earlier age of 
initiated use on attention and cognitive switching tasks than males, but more cannabis use 
was associated with worse memory in males than females (Savulich et al., 2021). 
However, other studies report no sex-specific effects (Solowij et al., 2011). Few 
longitudinal studies reported examining sex-specific effects of cannabis on cognition in 
adolescents and young adults but did not find evidence for an interaction between sex and 
cannabis use (Fried et al., 2005; Meier et al., 2018; Tait et al., 2011). 
Neurodevelopmental considerations need to be made when understanding the 
implications of sex-specific effects of cannabis exposure. Trajectories of 
neurodevelopment vary by sex in that females typically undergo earlier neuromaturation 
than males (Lenroot et al., 2007; Giedd et al., 1999). In females, total brain size typically 
peaks between 10 and 11 years of age, whereas total brain size peaks somewhat later at 




et al., 2007). Additionally, gray matter volume in the prefrontal cortex has been found to 
peak one to two years earlier in females than males, while males demonstrated greater 
age-related increases in white matter (Giedd et al., 1999). The endocannabinoid system 
plays a critical role in normal neurodevelopment and mediates processes, such as 
synaptogenesis, immune processes, and memory formation, and may be sensitive to 
alterations caused by exogenous cannabinoids, such as THC (Atkinson & Abbott, 2018).  
As such, sex differences in neuromaturation may create a variable environment 
for THC exposure to occur and thus, depending on the timing of exposure, could result in 
further differentiation of cannabis consequences. Preliminary evidence within humans 
supports this assertion. Specifically, a cross-sectional study of young adult regular 
cannabis users found that an earlier age of regular initiated use was related to poorer 
episodic memory in females but not in males (Crane et al., 2015). Taken together, 
research suggests a unique relationship regarding the sex-specific effects of cannabis use 
on cognitive functioning and biological mechanisms. This area warrants further 
consideration, particularly in longitudinal studies, given the paucity of research.  
Purpose and strengths of the current study 
  The aim of the current project was to assess the robustness of the relationship 
between nonacute cannabis use during adolescence and young adulthood and young adult 
neurocognitive function and examine nuances that may confer additional risk for adverse 
outcomes.  Focus was placed on addressing the aforementioned gaps in the literature, 
including third variable confounding and over-reliance on discrete group comparisons 
with a narrow focus of cannabis use behaviors, sex-specific effects, and persistence of 




We were well situated to address these gaps for several reasons: a) we used a 
large, population-based longitudinal sample of males and females with multiple, 
comprehensive follow-up assessments over the critical neurodevelopmental period of 
adolescence to young adulthood and peak substance use (Johnston et al., 2021); b) using 
this longitudinal dataset, we computed continuous measures of cumulative cannabis use 
(cannabis index), lifetime heaviest frequency, and age of cannabis initiation, using 
information from multiple timepoints, likely reducing measurement error of retrospective 
reporting; c) in addition to an extensive neurocognitive battery assessed at the most 
recent follow-up (age 24), intelligence was assessed at intake prior to exposure to 
cannabis, establishing baseline cognitive abilities; d) assessment waves included 
comprehensive interviewing regarding psychosocial, environmental, and participant 
specific factors that have been identified in the literature as relating to nonacute cannabis 
use and cognition, which included socioeconomic status (Mills et al., 2019; Peters et al., 
2018), education (Esch et al., 2014; Silins et al., 2015), alcohol and nicotine use (Agrawal 
et al., 2004; Malone et al., 2021), recent cannabis use (Curran et al., 2020; Kroon et al., 
2021) and time since last use of cannabis (Fried et al., 2005; Scott et al., 2018; Schreiner 
& Dunn, 2012). 
 We included measures for cognitive domains previously shown to be associated 
with cannabis use in either the cross-sectional or longitudinal literature as noted above, 
including verbal learning and memory, processing speed, decision-making, verbal 
attention and working memory, visuospatial attention and working memory, cognitive 
inhibition, and general cognitive abilities. The extensive neurocognitive battery was 




literature with pre-exposure measures of cognitive ability (e.g., visuospatial attention, 
processing speed, decision-making, cognitive inhibition). 
 Differential risk for poor neurocognitive outcomes related to cannabis exposure 
may be conferred based on an individual’s sex. Age of cannabis onset, in particular, may 
interact with sex producing differential effects depending on the timing of use given 
discrepant neurodevelopmental trajectories of males and females (Crane, Schuster, Fusar-
Poli, & Gonzalez, 2013). To the best of our knowledge, sex-specific effects have not yet 
been explored for cumulative cannabis use across both adolescence and young adulthood 
or age of initiation on cognitive outcomes within the adolescent or young adult 
longitudinal literature. Prior literature identified sex and its association with cannabis use 
as an area for further consideration given the limited research (Crane, Schuster, Fusar-
Poli, & Gonzalez, 2013; Figueiredo et al., 2020; Greaves, 2020), which we investigated 
within this project.  
Given our goal of understanding nuances of the association between cannabis use 
and cognition, as an exploratory analysis, we assessed for unique effects of lifetime 
heaviest frequency ever used within cannabis users, excluding non-users. There may be 
factors specific to cannabis users that could influence cognitive outcomes or patterns of 
cannabis use (Harvey et al., 2007; Pope et al., 1997); however, this has yet to be explored 
in the longitudinal literature using dimensional measures of cannabis use. 
Hypotheses given the current state of the literature 
Based on the above-summarized literature, we hypothesized that greater overall 
cannabis exposure, higher lifetime heaviest frequencies, and an earlier age of cannabis 




sectional and longitudinal literature of adolescent and young adult research, deficits most 
consistently arose in the domain of verbal learning and memory with more modest 
evidence for impaired decision-making, processing speed, and cognitive inhibition. There 
is mixed evidence or uncertainty regarding temporal sequencing of deficits, suggesting 
possible reverse causation, for the domains of verbal attention and working memory, 
visuospatial attention and working memory, and general cognitive abilities.  
While the importance of covarying for relevant factors is evident, the exact role 
that our confounding variables of pre-exposure IQ, socioeconomic status, alcohol and 
nicotine use, education, and recent cannabis use will play in the relationship between our 
cannabis variables and each of our cognitive outcomes. However, broadly, we 
hypothesized that our confounders would likely attenuate effect sizes, if not wholly 
moderate, some of the effects between cannabis use and cognitive outcomes.  
Several neurobiological differences suggest sex-specific effects may emerge with 
cannabis use, which is broadly supported within the human and animal literature. The 
exact pattern of such effects is unclear given the paucity of research for cannabis use on 
cognition. As such, we anticipate finding sex-specific effects; however, it is unclear the 
exact pattern that may emerge regarding if males or females may be at a greater risk for 
deficits. Sex-specific deficits may also be domain specific (Savulich et al., 2021). Prior 
research has been inconsistent regarding how abstinence from cannabis impacts the 
relationship between cannabis use and cognition, and as such, we do not have a specific 
hypothesis regarding the implications of the length of abstinence. As stated above, our 
investigation for effects unique to cannabis users was exploratory, and, as such, we do 






Participants were same-sex twins drawn from the Enrichment Study (ES) of the 
Minnesota Twin Family Study. See Keyes et al. (2009) and Wilson et al. (2019) for a 
detailed overview of inclusion/exclusion criteria and study design. Intake was conducted 
at age 11, and subsequent follow-up assessments were administered at ages 14, 17, and 
24. Assessments at each study wave included a comprehensive, multimodal battery of 
clinical interviews, questionnaires, and cognitive assessments conducted by trained 
assessors. Information was also collected from biological and stepparents across 
assessments.  
Of the original 998 twins recruited at the age-11 intake, 81% (n = 809) 
participated in the most recent age-24 follow-up in some capacity. Twin participation at 
the age-24 assessment was not uniform across all neurocognitive measures due to various 
logistic factors, such as time constraints during interviewing or impractical travel 
distances to participate in-person that necessitated phone interviews (n = 111). Eight 
individuals who reported a history of cannabis exposure on their age-11 intake 
questionnaires were excluded.  
The final sample size consisted of 801 twins, and task-dependent sample sizes 
ranged from 666 to 794. Sample sizes for models will be presented in tables detailing 
initial model statistics. Approximately 60% of participants were monozygotic twins, and 
55% were female, with a mean age of 24.43 (SD: 0.91) at the most recent follow-up 
assessment. Twins were asked to refrain from all substance use for 24-hours before their 




this period. Sixty-four participants reported cannabis use in the 24-hours preceding their 
age-24 follow-up assessment, and recent use was subsequently explored in follow-up 
analyses as a covariate of interest.  
Substance use 
Substance use was assessed at ages 11, 14, and 17 using a Computerized 
Substance Use (CSU; McGue et al., 2014) questionnaire and a revised version of the drug 
supplement from the Diagnostic Interview for Children and Adolescents - Revised 
(DICA-R; Reich, 2000; Welner et al., 1987). A modified version of the Substance Abuse 
Module (SAM; Robins et al., 1987) from the Composite International Diagnostic 
Interview (CIDI; Robins et al., 1988) was used to assess substance use at ages 17 and 24. 
The CSU, DICA, and the expanded version of the SAM assess for information, such as 
the number of intoxications, frequency (past 12 months) and quantity of use (since last 
assessment), heaviest frequency, and age of initiation of substance use.  
Cannabis use  
Six variables were used to capture cannabis use behaviors. Two of these variables 
(frequency of cannabis use (past 12 months) and the number of uses (since last 
assessment)) were integrated across follow-up assessment waves (i.e., 14, 17, and 24) to 
form a single cumulative measure of cannabis exposure across adolescence to young 
adulthood (cannabis index). Combining measures and collapsing across adolescence to 
young adulthood, we encompassed exposure more thoroughly than a single measure that 
narrowly focuses on a brief window of time (e.g., six months to a year). The validity of 
the methods used to derive the cannabis index (described below) were supported by 




(Harper et al., 2021; Malone et al., 2021; Schaefer et al., 2021; Wilson et al., 2017). The 
other three variables (lifetime heaviest frequency, age of initiation, past 24-hour use, time 
since last use) were examined individually. Our primary cannabis variables of interest 
were the cannabis index, lifetime heaviest frequency, and age of initiation. Past 24-hour 
use (recent use) and time since last use (length of abstinence) were used in subsequent 
follow-up analyses as covariates. 
Cannabis index. To obtain our cannabis index, which characterized cumulative 
cannabis exposure from adolescence to young adulthood, separate cannabis indices were 
first calculated for each follow-up wave (i.e., 14, 17, and 24) by averaging two items: (1) 
frequency of use in the past 12 months, and (2) number of times used since last 
assessment. Due to skew and spareness, we transformed responses of frequency and 
number of uses into ordinal measures before averaging these two items, with six 
categories per item. For frequency of use in the past 12 months, categories included: 0 
(no use), 1 (<1x/month), 2 (1-3x/month), 3 (1-4x/week), 4 (every day or nearly every 
day), or 5 (>1x/day). For number of uses since last assessment, categories included: 0 (no 
use), 1 (1-4 uses), 2 (5-30 uses), 3 (31-100 uses), 4 (101-400 uses), or 5 (>400 uses or 
“too many to count”). After we obtained individual indices for each follow-up assessment 
wave, we then computed our cannabis index by averaging each of the separate indices 
into a single composite measure to summarize overall exposure from adolescence to 
young adulthood. We did not include the age-11 intake when computing the cannabis 
index as we had purposefully excluded individuals who had used cannabis before their 




Lifetime heaviest frequency. Participants were asked to think about their period of 
heaviest use either in their lifetime (age 17) or since their last assessment (asked at age 
24) and report the frequency of their cannabis use during that period of heaviest use. To 
obtain a measure of heaviest frequency ever used over a participant’s lifetime (i.e., from 
birth to age 24), we took the max value reported at either their age-17 or age-24 
evaluation. Like procedures used for our cannabis index, we transformed the lifetime 
heaviest frequency variable into an ordinal measure containing six categories to reduce 
skew and spareness of responses. Categories included: 0 (no use), 1 (<1/year), 2 
(>1x/year to 2-3x/month), 3 (1-2x/week to nearly every day), 4 (1-2x/day), 5 (3x/day).  
Age of initiation. For our purposes, age of initiation was defined as the first 
exposure to cannabis regardless of the amount used. To obtain this value, we asked 
participants how old they were when they first tried marijuana at each assessment wave. 
We used the age of initiation reported at the earliest assessment wave as this provided the 
most proximal report of cannabis use behaviors to when use occurred and would likely 
reduce the impact of retrospective recall error. 
Other cannabis covariates. A binary measure was used to evaluate for recent 
cannabis use to characterize if the person had (coded as 1) or had not (coded as 0) used 
cannabis in the 24-hours preceding their age-24 evaluation. To account for the length of 
abstinence, at their age-24 assessment, we assessed for the length of time since the 
participants had last used cannabis. Categories to characterize the length of abstinence 
included: 1 (within the last 2 weeks), 2 (2 weeks to <1 month), 3 (1 month to <6 months), 
4, (6 months to <1 year), 5 (within the last year but don’t know exactly when), and 6 (1 




Other substance use 
As other substance use has been found to influence or attenuate the relationship 
between cannabis use and cognitive outcomes (Gonzalez et al., 2017; Ross et al., 2020), 
indices summarizing alcohol and nicotine use assessed at the age-24 follow-up were also 
computed. Calculations mimicked the above-described procedures for creating the 
cannabis indices and followed the methodology used in previous investigations (Harper 
et al., 2021; Malone et al., 2021; Wilson et al., 2017). Using indices summarizing alcohol 
and nicotine exposure at the age-24 follow-up allowed us to capture proximal use, likely 
during participants' heaviest use period, providing a more substantial control for alcohol 
and nicotine behaviors than if individual variables were used. 
Alcohol index. The alcohol index calculated at the age-24 follow-up consisted of 
four items: (1) number of drinks typically consumed per occasion since the last 
assessment (0 = none to 6 = 30+), (2) frequency of drinking since the last assessment (0 = 
never to 5 = 2+ times per day), (3) maximum drinks consumed in a 24-hour period since 
last assessment (0 = none to 6 = 30+), and (4) number of times intoxicated in lifetime (0 
= never to 6 = 150+ times). Similar to the cannabis indices, we transformed responses 
into ordinal measures, with six to seven categories per item due to skew and sparseness; 
items were averaged to form a single index of alcohol use at age-24.  
Nicotine index. The nicotine index at the age-24 follow-up consisted of two items: 
(1) number of days in a typical month used tobacco in the past 12 months (0 = none to 2 
= 15-30 days per month) and (2) quantity of tobacco used in a typical day in the past 12 
months (0 = none to 3 = 20+). The quantity of tobacco used in a typical day was the sum 




number of chews used. As with the other substance indices, we transformed responses 
into ordinal measures, with three to four categories per item, and items were averaged to 
form a single index of nicotine use at age-24.  
Neurocognitive battery 
Neurocognitive measures included test of (1) verbal learning and memory: Rey 
Auditory Verbal Learning Test (RAVLT; Schmidt, 1996); (2) processing speed: 
Wechsler Adult Intelligence Scale-III Processing Speed Index, Digit Symbol-Coding, 
Symbol Search (WAIS-III; Wechsler, 1997); (3) verbal attention and working memory: 
RAVLT Trial 1 (Schmidt, 1996), WAIS-III Longest Digit Span Forward/Backward 
(Wechsler, 1997); (4) visuospatial attention and working memory: Longest Spatial Span 
Forward/Backward (Wechsler, 1997); (5) decision-making: Iowa Gambling Task (IGT; 
Bechara et al., 1994); (6) cognitive inhibition: Go/No-Go Task (Roche, Garavan, Foxe, & 
O’Mara, 2005); (7) general cognitive ability: Wechsler Adult Intelligence Scale-Revised 
(WAIS-R) Prorated Full Scale IQ (FSIQ), Block Design, Vocabulary (Wechsler, 1981). 
These measures are summarized in Table 3 along with variables obtained from each 
measure. Please see the general study characteristics section for full task descriptions. 
Additional covariates 
Age-11 intelligence quotient (IQ) 
Pre-exposure IQ was assessed at intake (age 11) utilizing the revised Wechsler 
Intelligence Scale for Children-Revised (WISC-R; Wechsler, 1981). Pre-exposure IQ was 
derived from performance on the block design, picture completion, vocabulary, and 
information subtests of the WISC-R and estimated following WISC-R prorated scoring 




Socioeconomic status (SES) 
 A single composite measure of parental socioeconomic status was derived from 
information provided by twins’ parents and stepparents at intake. The parental 
socioeconomic status variable reflected the mean of four standardized scores, including 
highest parent occupational status, mother’s and father’s highest degree, and household 
income.  
Years of education 
 Education for each participant was defined as the number of academic school 
years of formal education successfully completed at the time of their age-24 assessment. 
Statistical Analysis 
Preliminary analyses: attrition and multicollinearity 
 Because ES participants were followed over an extended period, attrition from the 
sample is to be expected. As such, we examined for differences between our sample of 
age-24 participants (n = 801) and age-24 non-participants (n=189) on relevant intake 
variables (sex, age, zygosity, socioeconomic status, pre-exposure IQ). As there was 
minimal to no substance use at intake in either the participant or non-participant group, 
we examined differences in cannabis use between age-24 participants and non-
participants at their first follow-up assessment (age 14) as this provided the closest 
approximation in terms of sample to individuals who participated at the intake assessment 
(participants: n = 772, non-participants: n=158). Cluster robust group comparisons using 
a sandwich estimator for the standard errors were conducted in R using coef_test from the 
“clubSandwich” package with a Satterthwaite approximation (Pustejovsky, 2017). A chi-




(R Core Team, 2020). We ran zero-order correlations between our primary cannabis use 
variables and covariates. We expected that our covariates would be significantly 
correlated with our cannabis use variables as covariates were chosen based on previous 
literature demonstrating a relationship with cannabis use behaviors. Because of this 
correlation, including these covariates in our subsequent analyses could impact standard 
errors through collinearity. Generalized variance-inflation factors, adapted for linear 
mixed models using the corvif function in R (Zuur et al., 2009), were calculated for our 
predictor variables to examine concerns for collinearity. 
Associations between cannabis use and cognitive performance 
Linear mixed models (LMMs) were conducted in R using lmer from the “lme4” 
package (Bates et al., 2015) with denominator degrees of freedom adjusted by Kenward-
Roger approximation from the lmerTest package (Kuznetsova et al., 2017). Random 
intercepts were included at the twin-pair level to account for within-pair correlations. All 
models included participant age, sex, and zygosity as covariates. Initial LMMs evaluated 
the relationship between each of the above-described age-24 cognitive outcomes and our 
primary cannabis use variables of interest: cannabis index, heaviest frequency, and age of 
initiation. Note that the no-go error rate and ambiguous decision-making measures were 
square-root transformed before LMM analyses to correct for positive skew.  
Exploration of relevant covariates 
Subsequent analyses explored for factors influencing the observed associations 
between our cannabis use variables and cognition and rule out other alternative 
explanations for significant effects. These analyses allowed us to examine the robustness 




associated with cannabis use above other confounds. Zero-order correlations were first 
conducted between our primary covariates and cognitive outcomes to demonstrate 
relevance for our covariate analyses. Planned follow-up analyses then investigated 
possible confounding of pre-exposure IQ and parental SES (step 1), then other common 
substance use (i.e., alcohol and nicotine use; step 2), years of education (step 3), and 
finally recent cannabis use (step 4) by including them as covariates in iterative LMMs. 
Given changes in the pattern of findings when including these variables as covariates, 
they were carried forward to all subsequent analyses reported in this study.  
Sex-specific effects of cannabis use on neurocognitive performance 
Males and females may be differentially susceptible to adverse effects associated 
with cannabis exposure for several neurobiological reasons. We first assessed for sex 
differences in neurocognitive performance using cluster-robust group comparisons to 
assess if males and females performed differently on our cognitive outcomes. LMMs 
were then conducted with a cannabis use variable by sex interaction term included. For 
variables that demonstrated significant effects, LMMs were run in males and females 
separately to examine the pattern of effects in each sex. Significant findings in either 
males or females were carried forward through follow-up analyses.  
Isolating impact of age cannabis of initiation from other cannabis use behaviors 
It can be challenging to disentangle the impact of age of cannabis initiation from 
effects related to quantities or frequencies of cannabis use as individuals who begin using 
earlier tend to report larger quantities and higher frequencies of cannabis use. In 
particular, early-onset cannabis users typically escalate to greater cannabis use later in 




relevant than the age at which initial exposure occurred, so we attempted to disentangling 
these variables. Isolating the role of age of initiation was approached in two ways. First, 
significant effects demonstrated in our previous analyses between the age of initiation 
and cognitive performance were re-run with the cannabis index from the most recent 
assessment (age-24 cannabis index) as a covariate, accounting for both quantity and 
frequency of use and more proximal exposure during peak substance use periods. Second, 
if another of our cannabis variables of interest (i.e., cannabis index, lifetime heaviest 
frequency) demonstrated similar findings to our age of initiation variable, LMMs were 
conducted with both variables included to investigate if one variable would rise above the 
other to predict findings.  
The role of abstinence on cannabis use and cognitive outcome associations 
Whether or not deficits associated with cannabis use resolve over time have 
significant functional and policy implications. We assessed the role of abstinence from 
cannabis in two ways. First, LMMs were run exploring the relationship between our 
measure of the length of abstinence from cannabis use and any of our cognitive variables 
that demonstrated significant relationships with our primary cannabis use variables. 
Second, cluster-robust group comparisons were conducted comparing the cognitive 
performance of individuals with less than a month of abstinence from cannabis (n = 173) 
and those with at least one year of abstinence (n = 222) to compare performance at the 
extremes of abstinence length to see if differences emerged.  
Unique relationships within cannabis users   
We focused a set of LMM analyses specifically on lifetime heaviest frequency in 




obscured when including individuals with extremely minimal to no exposure. Analyses 
explored relationships between our lifetime heaviest frequency variable and our cognitive 
outcomes in a subsample excluding individuals that had used less than five times in their 
lifetime, which was consistent with several prior studies definitions for characterizing 
non-users (Epstein et al., 2015; Hanson et al., 2010; Lamers et al., 2006; Medina et al., 
2007; Padula et al., 2007; Solowij et al., 2012; Tapert et al., 2007; Winward et al., 2014).   
Results 
Descriptive statistics for demographic and substance use variables are presented 
in Table 1. Cannabis use across assessments and demographic breakdown broadly 
mimicked national patterns, such that cannabis use increased with age, and males used 
more heavily than females (Johnston et al., 2021). Males also used more alcohol and 
nicotine than females at their age-24 assessment, which is consistent with expectations 
based on national patterns. Cannabis exposure was prevalent in our sample, with 29% of 
participants endorsing some use by their age-17 assessment and 63% endorsing use by 
their age-24 assessment. 
Preliminary analyses  
 Age-24 assessment participants and non-participants did not significantly differ in 
age or zygosity (ps > 0.47). Age-24 non-participants were more likely to be male (2 (1) 
= 11.57, p < 0.01), have a lower parental socioeconomic status (Estimate [SE] = 0.38 
[0.08], t = 4.92, p < 0.01), and lower pre-exposure IQ scores (Estimate [SE] = 6.18 
[1.36], t = 4.56, p < 0.01). However, the overall distribution for pre-exposure IQ for age-
24 participants was still normally distributed, encompassing the lower tail of the 




standard deviation (M = 104.04, SD = 12.75) were similar to a typical distribution for 
standard scores (e.g., mean of 100, standard deviation of 15; see Figure S2 for 
distribution of pre-exposure IQ scores for age-24 participants). Further, we observed no 
significant associations between cannabis use (either cannabis index scores or age of 
initiation) at the age-14 assessment wave and contributing data to the most recent age-24 
follow-up (ps > 0.11). As expected, at least one of our three cannabis use variables was 
significantly correlated with each of our covariates (ps < 0.05; see Table 4 for 
correlations between primary cannabis variable and covariates), except participant age. 
The cannabis index and lifetime heaviest frequency were strongly correlated (r = 0.85, p 
< 0.01) and were not examined in joint models to avoid collinearity. Otherwise, all GVIF 
values were below 2 for our primary cannabis use variables, below conservative cut-offs 
of 2.5 for GVIF values (Kock & Lynn, 2012; Petker et al., 2019).
Associations between cannabis use and cognitive performance 
 We assessed the relationship between our three primary cannabis use measures of 
interest and young adult cognitive outcomes. Performance measure descriptive statistics 
can be found in Table 2, and statistics for initial linear mixed model effects of our 
cannabis variables and cognitive outcomes (discussed in this section) are summarized in 
Table 5.  
 Verbal learning and memory. No significant effects were demonstrated between 
our three cannabis variables and total learning, short-delay recall, and long-delay recall 
scores (ps   0.11). 
 Processing speed. Age of cannabis initiation was significantly associated with all 




(SE) = 0.95 (0.23), t = 4.30, p < 0.01), digit symbol-coding (Estimates (SE) = 0.18 
(0.04), t = 4.09, p < 0.01), and symbol search (Estimates (SE) = 0.17 (0.04), t = 3.74, p < 
0.01), such that an earlier age of initiation predicted worse performance in all cases. 
Higher cannabis index scores were also associated with poorer performance on digit 
symbol-coding (Estimates (SE) = -0.28 (0.11), t = -2.56, p = 0.01) and lower processing 
speed index scores; however, this later finding just missed significance (Estimates (SE) = 
-1.05 (0.55), t = -1.91, p = 0.06). A significant association was not found between our 
cannabis index and symbol search performance (p = 0.34), and lifetime heaviest 
frequency did not predict performance on any of our measures of processing speed (ps  
0.14).    
 Verbal attention and working memory. Consistent with prior research, differences 
in the relationship between our verbal attention measures and cannabis use appeared task 
dependent. Specifically, all three cannabis use variables evidenced a significant 
relationship with our initial list-learning task (RAVLT trial 1), such that higher cannabis 
index scores and lifetime heaviest frequency, and an earlier age of onset were associated 
with recalling fewer words on an the first trial of a list-learning task (cannabis index: 
Estimates (SE) = -0.18 (0.07), t = -2.57, p = 0.01; lifetime heaviest frequency: Estimates 
(SE) = -0.09 (0.04), t = -2.31, p = 0.02; age of initiation: Estimates (SE) = 0.06 (0.03), t 
= 2.08, p = 0.04). In contrast, higher cannabis index scores and lifetime heaviest 
frequency, but not age of initiation (p = 0.40), predicted better performance on longest 
digit span forward (cannabis index: Estimates (SE) = 0.11 (0.05), t = 2.18, p = 0.03; 




significant relationships were demonstrated between our cannabis use variables and 
longest digit span backward (ps   0.34) 
 Visuospatial attention and working memory. Several significant associations were 
demonstrated between our visuospatial attention and working memory variables and 
cannabis use measures. Higher cannabis index scores and lifetime heaviest frequency, 
and an earlier age of initiation all predicted poorer performance on our visuospatial 
attention and working memory measure (longest spatial span forward: [cannabis index: 
Estimates (SE) = -0.09 (0.05), t = -1.97, p = 0.05; age of initiation: Estimates (SE) = 0.07 
(0.02), t = 3.59, p < 0.01]; longest spatial span backwards: [cannabis index: Estimates 
(SE) = -0.13 (0.05), t = -2.43, p = 0.02; lifetime heaviest frequency: Estimates (SE) = -
0.07 (0.03), t = -2.29, p = 0.02; age of initiation: Estimates (SE) = 0.05 (0.02), t = 2.28, p 
= 0.02]). The only exception was that the relationship between lifetime heaviest 
frequency and longest spatial span forward did not reach significance, though it 
demonstrated a similar pattern of findings (Estimates (SE) = -0.03 (0.03), t = -1.26, p = 
0.21). 
 Decision-making. Our cannabis use variables were also highly associated with 
decision-making performance, such that higher cannabis index scores and lifetime 
heaviest frequency, and an earlier age of initiation all significantly predicted poorer 
performance on our three decision-making variables (DM overall: [cannabis index: 
Estimates (SE) = -3.16 (1.47), t = -2.15, p = 0.03; lifetime heaviest frequency: Estimates 
(SE) = -2.60 (0.80), t = -3.27, p < 0.01; age of initiation: Estimates (SE) = 1.58 (0.61), t 
= 2.58, p = 0.01]; DM ambiguity: [lifetime heaviest frequency: Estimates (SE) = -0.05 




0.02]; DM risk: [cannabis index: Estimates (SE) = -2.40 (1.16), t = -2.07, p = 0.04; 
lifetime heaviest frequency: Estimates (SE) = -2.05 (0.63), t = -3.25, p < 0.01; age of 
initiation: Estimates (SE) = 1.07 (0.48), t = 2.23, p = 0.03]). The only relationship that 
did not reach significance was between our cannabis index and decision-making under 
ambiguity, but it showed a similar pattern of effects (Estimates (SE) = -0.07 (0.04), t = -
1.61, p = 0.11). 
 Cognitive inhibition. Only age of initiation was significantly associated with 
performance on our measure of cognitive inhibition (d-prime: Estimates (SE) = 0.05 
(0.02), t = 3.07, p < 0.01; no-go error rate: Estimates (SE) = -0.08 (0.03), t = -3.16, p < 
0.01), with poorer overall ability to inhibit responses and higher error rates occurring 
with an earlier age of initiation. Associations between our cannabis index and lifetime 
heaviest frequency variables and our measures of cognitive inhibition did not reach 
significance (p  0.08).  
 General cognitive ability. Of our cannabis use variables, the strongest predictor of 
general cognitive ability scores was age of cannabis initiation. Cannabis users reporting 
an earlier age of initiation had lower prorated FSIQ scores (Estimates (SE) = 1.45 (0.27), 
t = 5.48, p < 0.01), and poorer performance on block design (Estimates (SE) = 0.22 
(0.05), t = 4.71, p < 0.01) and vocabulary tasks (Estimates (SE) = 0.17 (0.04), t = 4.67, p 
< 0.01). Higher cannabis index scores were also related to poorer performance on block 
design (Estimates (SE) = -0.23 (0.12), t = -1.95, p = 0.05) and the relationship with lower 
prorated FSIQ scores just missed significance (Estimates (SE) = -1.29 (0.68), t = -1.91, p 




0.16) and all associations with lifetime heaviest frequency were not significant (ps  
0.39). 
 Summary. Several significant associations were evidenced in initial LMMs 
between our cannabis use variables and cognition, particularly with age of initiation. 
Specifically, an earlier age of initiation predicted poorer performance across all tasks, 
except for RAVLT (total learning, short- and long-delay recall) and digit span measures. 
Both greater cannabis index scores and higher lifetime heaviest frequencies were 
associated with RAVLT trial 1, longest spatial span backward and overall and risky 
decision-making. Greater cannabis index scores were also significantly related to worse 
digit-symbol coding and block design performance, and higher lifetime heaviest 
frequencies predicted poorer decision-making under ambiguity. Better performance with 
greater cannabis use was demonstrated on only one task (longest digit span forward). No 
other associations suggested better performance in cannabis users.  
Covariate analyses 
 Zero-order correlations are presented in Table 6 to assess relationship between 
our primary covariates and cognitive outcomes. Of note, higher pre-exposure IQ, SES, 
and education significantly predicted better performance on almost all cognitive tasks. 
Four sets of iterative linear mixed models were conducted for each cannabis use variable 
by cognitive measure combination to explore the robustness of associations to covariates. 
Covariates included pre-exposure IQ and SES (step 1), other common substance use 
(alcohol/nicotine; step 2), years of education (step 3), and recent cannabis use (step 4). 
Covariates were carried forward to subsequent models, such that step 4 included all 




following each iterative step (e.g., 1 through 4) and are organized into sections by 
cognitive domain. Each section will be summarized below with references to the 
corresponding section of Table 7. 
Verbal learning and memory (Table 7 section A). There was little evidence of 
deficits on total learning, short-delay recall, or long-delay recall measures with greater 
cannabis index scores, lifetime heaviest frequency, or an earlier age of initiation. Results 
showed a positive relationship between the cannabis index and short-delay recall; 
however, this was only significant after inclusion of recent cannabis use, which 
negatively predicted short-delay recall performance (Estimates (SE) = -0.64 [0.29], t = -
2.23, p = 0.03). No other associations were significant.  
Processing speed (Table 7 section B). An earlier age of initiation continued to 
predict poorer scores on digit symbol-coding, symbol search, and the processing speed 
index after accounting for pre-exposure IQ/SES (step 1) and alcohol/nicotine use (step 2). 
These associations were attenuated after accounting for education (ps  0.06; step 3) with 
little change after covarying for recent cannabis use, although the relationship with 
symbol search performance hovered near significance (Estimates (SE) = 0.09 (0.05), t = 
1.77, p = 0.08). The association between higher cannabis index scores and lower digit-
symbol coding scores followed a similar pattern remaining significant after accounting 
for pre-exposure IQ, SES, alcohol, and nicotine but were significantly diminished after 
accounting for education (p = 0.42) and recent cannabis use (p = 0.83). No significant 
relationships were demonstrated between the cannabis index and symbol search or 
processing speed index scores, except that the cannabis index predicted processing speed 




was not significant in any subsequent steps and was significantly attenuated after the 
inclusion of education and recent cannabis use (ps  ). Lifetime heaviest frequency 
was associated with digit-symbol coding only after accounting for pre-exposure IQ/SES, 
but this association was no longer significant in successive steps (e.g., steps 2, 3, or 4); 
otherwise, consistent with initial models, lifetime heaviest frequency did not significantly 
predict performance on symbol search or lower scores on the processing speed index (ps 
 0.18). 
Verbal attention and working memory (Table 7 section C). Greater cannabis index 
scores and lifetime heaviest frequency continued to be associated with learning fewer 
words on the first trial of the RAVLT after accounting for pre-exposure IQ/SES and 
alcohol and nicotine use (ps < 0.03). However, they were drastically attenuated when 
including education (ps  0.20) and recent cannabis use (ps  0.44). The relationship 
between an earlier age of initiation and trial one on the RAVLT did not survive the 
inclusion of pre-exposure IQ and SES (p = 0.54), which did not change significantly in 
subsequent steps (ps  0.63). 
The relationships between better longest digit span forward scores and greater 
cannabis index scores and higher lifetime heaviest frequency remained after covarying 
for pre-exposure IQ and SES (step 1) but were attenuated after including alcohol and 
nicotine use (ps  0.29) and continued to not be significant in subsequent steps. 
Consistent with initial models, our primary cannabis variables of interest were not 
significantly associated with longest digit span backward scores, nor did age of initiation 
predict longest digit span forward performance throughout any steps of the covariate 




 Visuospatial attention and working memory (Table 7 section D). Regardless of 
covariates, the relationship between an earlier age of initiation and lower spatial span 
forward scores remained significant (Estimates (SE) = 0.05 (0.02), t = 2.19, p = 0.03). 
However, this was the only relationship found to uniquely predict spatial span scores 
independent of covariates. The association between age of initiation and longest spatial 
span backward was drastically diminished with the inclusion of pre-exposure IQ/SES (p 
= 0.35), which was reduced further with our other covariates (ps  0.51). Higher cannabis 
index scores continued to significantly predict longest spatial span forward and backward 
scores until we covaried for education (ps  0.11) and attenuated further with recent 
cannabis use (ps  0.23). The association between lifetime heaviest frequency and longest 
spatial span backward demonstrated a similar pattern, such that the relationship was 
attenuated with the inclusion of education (p = 0.09) and reduced further with the 
addition of recent cannabis use (p = 0.27). The relationship between longest spatial span 
forward and lifetime heaviest frequency remained non-significant and the final model 
was not close to significance (p = ) 
 Decision-making (Table 7 section E). Independent of all covariates, higher 
lifetime heaviest frequencies significantly predicted making fewer advantageous and 
more disadvantageous choices on a gambling task overall (across 100 trials; Estimates 
(SE) = -2.60 (1.05), t = -2.47, p = 0.01), under ambiguity (first 40 trials; Estimates (SE) = 
-0.08 (0.03), t = -2.39, p = 0.02), and under risk (last 60 trials; Estimates (SE) = -1.69 
(0.82), t = -2.05, p = 0.04). Earlier age of initiation was also associated with poorer 
decision-making under ambiguity regardless of covariates (Estimates (SE) = 0.04 (0.02), t 




relationship between age of initiation and overall decision-making (p = 0.15) and 
decision-making under risk (p = 0.35), which were further diminished in subsequent steps 
with the inclusion of our other covariates (ps  0.21). Higher cannabis index scores 
predicted poorer scores for overall decision-making and decision-making under risk until 
alcohol and nicotine use were covaried (ps  0.10), and inclusion of other confounders 
reduced effects further (ps  0.22). Models examining the association between the 
cannabis index and decision-making under ambiguity were significant but only for steps 
2 and 3 and were not significant when all confounders were addressed (step 4, p = 0.22).  
 Cognitive inhibition (Table 7 section F). Age of initiation was associated with 
both d-prime and no-go error rate scores in initial models, but these findings were 
attenuated with the inclusion of alcohol and nicotine use (ps  0.08) and were further 
diminished when covarying for all of our other variables (ps  0.13). All models with our 
cannabis index and lifetime heaviest frequency remained non-significant and were 
drastically reduced by step 4 (ps  0.68). 
 General cognitive ability (Table 7 section G). Independent of covariates, an 
earlier age of initiation was significantly associated with prorated FSIQ scores (Estimates 
(SE) = 0.47 (0.23), t = 2.03, p = 0.04) and block design performance (Estimates (SE) = 
0.09 (0.05), t = 2.10, p = 0.04). The relationship between higher cannabis index scores 
and block design also survived adjustment for confounds (Estimates (SE) = -0.26 (0.13), t 
= -2.00, p = 0.05). The association between the cannabis index and prorated FSIQ 
became larger, reaching significance, after including pre-exposure IQ and SES; however, 
after covarying for education, the association was significantly attenuated (p = 0.27). The 




did not survive the inclusion of alcohol and nicotine use (p = 0.36). Similarly, the 
relationship between age of initiation and vocabulary was diminished after covarying for 
alcohol and nicotine use (p = 0.08) and dropped further when controlling for other 
confounders (ps  0.40). Consistent with initial models, lifetime heaviest frequency did 
not significantly predict performance on block design, vocabulary, or prorated FSIQ 
scores. 
 Summary. Notable alterations occurred in some of the relationships found 
between our cannabis variables and cognitive outcomes following the inclusion of our 
covariates. Typically, the addition of subsequent covariates attenuated estimates of the 
association between cannabis use and cognition. Despite this, our cannabis use variables 
continued to uniquely predict specific cognitive outcomes independent of confounders. 
Higher cannabis index scores were related to worse block design performance. Higher 
lifetime heaviest frequencies continued to predict poorer decision-making performance 
(overall, ambiguous, risky), and an earlier age of cannabis initiation remained associated 
with worse longest spatial span forward performance, poorer decision-making under 
ambiguity, and lower prorated FSIQ and block design scores. Only one association was 
found that suggested cannabis use was related to better performance. Specifically, higher 
cannabis index scores predicted recalling more words after a short delay, but only after 
recent cannabis use was included in the model.  
Sex-specific effects 
 Cluster-robust group comparisons between males and females on neurocognitive 
performance are presented in Table 8. Females demonstrated higher mean scores on total 




d-prime, and lower no-go error rates than males. Group means were significantly higher 
for decision-making under ambiguity, prorated FSIQ, and block design for males 
compared to females. Statistically significant sex differences were not found for short-
delay recall, symbol search, longest digit span forward/backward, longest spatial span 
forward/backward, overall decision-making, decision-making under risk, and vocabulary 
scores. 
Table 9 presents results for all sex-interaction effects with our cannabis variables 
on cognitive outcomes. All analyses included the covariates explored above. Sex 
interaction effects with each of our cannabis variables were significant for symbol search 
(cannabis index: Estimates (SE) = 0.45 (0.13), t = 2.11, p = 0.04; heaviest frequency: 
Estimates (SE) = 0.25 (0.12), t = 2.13, p = 0.03; age of initiation: Estimates (SE) = -0.19 
(0.08), t = -2.19, p = 0.03).  
Both of the sex-specific interaction effects for lifetime heaviest frequency on 
overall decision-making (Estimates (SE) = 3.00 (1.57), t = 1.91, p = 0.06) and decision-
making under risk (Estimates (SE) = 2.29 (1.23), t = 1.85, p = 0.06) just barely missed 
significance thresholds. Given our a priori hypothesis of potential sex-differences and 
that a similar pattern of sex-specific interactions was found for both overall decision-
making and decision-making under risk, we explored the trending sex-specific effect for 
decision-making in males and females separately despite the interactions term not quite 
meeting significance thresholds.   
 Analyses of significant findings conducted separately in males and females are 
presented in Table 10. When exploring the sex-specific interactions on symbol search 




although only the relationship between an earlier age of initiation and poorer symbol 
search performance reached significance in males (Estimates (SE) = -0.15 (0.08), t = 
2.02, p = 0.04). Conversely, females demonstrated no significant effects with symbol 
search performance and, at times, even a slight pattern of better performance with higher 
cannabis index scores and lifetime heaviest frequency, though none of these relationships 
came close to reaching significance (ps > 0.31). For overall decision-making and 
decision-making under risk, males demonstrated significant and negative effects with 
greater lifetime heaviest frequencies (DM overall: Estimates (SE) = -4.07 (1.56), t = -
2.61, p = 0.01; DM risk: Estimates (SE) = -2.73 (1.20), t = -2.27, p = 0.02). Females 
demonstrated a similar pattern of findings as males, but the relationships did not reach 
significance nor were they close to significance (ps > 0.31). Overall, males demonstrated 
significant deficits on a processing speed task with an earlier age of initiation and weaker 
decision-making performance with higher lifetime heaviest frequencies, but females did 
not.  
Isolating the impact of age of cannabis initiation 
 Individuals who demonstrate earlier ages of initiation also tend to report greater 
quantities and frequencies of use, making disentangling the impact of age of onset 
challenging as they are often correlated. Age of initiation linear mixed models that 
demonstrated unique associations, independent of covariates, were re-run with the age-24 
cannabis index included as a covariate. The age-24 cannabis index was chosen as a 
covariate as it is an index of both frequency and quantity of use likely during the period 
of heaviest cannabis use and accounts for more proximal exposure as individuals who 




demonstrated effects remained significant (see Table 11 for age of initiation estimates on 
cognitive outcomes with age-24 cannabis index included as a covariate) and estimates for 
the association with age of initiation remained practically unchanged. Further, the age-24 
cannabis index did not significantly predict performance on prorated FSIQ, block design, 
symbol search, longest spatial span forward, or decision-making under ambiguity. 
 When significant findings for a particular cognitive measure were demonstrated 
with both our age of initiation measure and another of our primary cannabis use measures 
(i.e., cannabis index, lifetime heaviest frequency), we re-ran models including both 
variables (see Table 12 for cannabis effects when both primary cannabis variables were 
included in the same model). This occurred for performance on block design and 
decision-making under ambiguity. When age of initiation and our cannabis index were 
both included in our model to examine the association with block design performance, 
the cannabis index just missed significance (Estimates (SE) = -0.30 (0.15), t = -1.94, p = 
0.05), while the age of initiation effect size was fully attenuated (Estimates (SE) = 0.05 
(0.05), t = 1.10, p = 0.27), suggesting that the cannabis index predominantly is driving the 
relationship with block design. For the relationship between decision-making in 
ambiguous situations and age of initiation and lifetime heaviest frequency, when both 
were entered into the same model, neither variable remained significant. That being said, 
the effect for age of initiation was larger and the model was closer to significance 
(Estimates (SE) = 0.04 (0.02), t = 1.74, p = 0.08) than the effect for lifetime heaviest 
frequency (Estimates (SE) = 0.05 (0.04), t = -1.23, p = 0.22).  
 In summary, these findings suggest that age of initiation was the prevailing 




search performance (in males) above proximal quantity and frequency of use. However, 
cumulative cannabis exposure appears to be a more prominent contributor to performance 
on block design than age of initiation. The relationship with decision-making under 
ambiguity remains somewhat unclear given that neither age of initiation nor lifetime 
heaviest frequency rose above the other as significant predictors. It may be that both 
factors contribute to deficits in this area to varying degrees.  
Length of abstinence 
 Using linear mixed models, the impact of length of abstinence from cannabis use 
was examined for cognitive outcomes that demonstrated previously significant effects 
with at least one of our primary cannabis use variables. Length of abstinence was not 
significantly related to short-delay recall, symbol search, longest spatial span forward, 
decision-making (overall, ambiguous, risky), block design, or prorated FSIQ (see Table 
13 for length of abstinence estimates).  
We also utilized another approach to examine the relationship between length of 
abstinence and cognition to maximize the possibility of seeing significant differences in 
cognitive performance by contrasting extremes in abstinence length. To do this, utilizing 
cluster robust group comparisons, individuals with <1 month of abstinence from cannabis 
(n = 173) were compared with individuals with  1 year of abstinence (n = 222). 
However, even when comparing extremes, these two groups did not perform significantly 
differently on cognitive measures (ps > 0.06; see Table 14 for group comparison models). 
As length of abstinence was not significantly related to our cognitive measure, nor did 
group differences emerge between extremes of abstinence length, it appears findings are 




Relationships unique to cannabis users 
 We explored the relationship between our heaviest frequency ever used variable 
in a sample cannabis users only (see Table 15 for lifetime heaviest frequency effects on 
cognitive outcomes in cannabis users only). Cannabis users demonstrated a significant 
and negative association with longest digit span backward performance (Estimates (SE) = 
-0.13 (0.06), t = -2.31, p = 0.02), even when relevant covariates were accounted for. This 
pattern of findings was not evidenced in the full sample. The slight opposite pattern was 
found in the full sample, such that cannabis users appeared to perform better overall than 
individuals with less or no cannabis use, suggesting that these effects may be unique to 
cannabis users only. No other significant relationships were demonstrated between 




Summary of findings 
   Primary covariate analyses    








4 Isolate Abst. CUs 
Vb. Learning/Memory          
RAVLT Total Learning          
Cannabis index n.s. n.s. n.s. n.s. n.s. n.s.    
Heaviest frequency n.s. n.s. n.s. n.s. n.s. n.s.   n.s. 
Age of initiation n.s. n.s. n.s. n.s. n.s. n.s.    
RAVLT Short-Delay Recall          
Cannabis index n.s. n.s. n.s. n.s. n.s.   N    
Heaviest frequency n.s. n.s. n.s. n.s. n.s. n.s.   n.s. 
Age of initiation n.s. n.s. n.s. n.s. n.s. n.s.    
RAVLT Long-Delay Recall          
Cannabis index n.s. n.s. n.s. n.s. n.s. n.s.    
Heaviest frequency n.s. n.s. n.s. n.s. n.s. n.s.   n.s. 
Age of initiation n.s. n.s. n.s. n.s. n.s. n.s.    
Processing Speed          
Processing Speed Index          
Cannabis index n.s. n.s.  n.s. n.s. n.s.    
Heaviest frequency n.s. n.s. n.s. n.s. n.s. n.s.   n.s. 
Age of initiation n.s.    n.s. n.s.    
Digit Symbol-Coding          
Cannabis index n.s.    n.s. n.s.    
Heaviest frequency n.s. n.s.  n.s. n.s. n.s.   n.s. 
Age of initiation n.s.    n.s. n.s.    




Cannabis index W<M n.s. n.s. n.s. n.s. n.s.    
Heaviest frequency W<M n.s. n.s. n.s. n.s. n.s.   n.s. 
Age of initiation W<M*    n.s. n.s. a N  
Vb. Attention/WM          
RAVLT Trial 1          
Cannabis index n.s.    n.s. n.s.    
Heaviest frequency n.s.    n.s. n.s.   n.s. 
Age of initiation n.s.  n.s. n.s. n.s. n.s.    
Longest DS Forward          
Cannabis index n.s.   n.s. n.s. n.s.    
Heaviest frequency n.s.   n.s. n.s. n.s.   n.s. 
Age of initiation n.s. n.s. n.s. n.s. n.s. n.s.    
Longest DS Backward          
Cannabis index n.s. n.s. n.s. n.s. n.s. n.s.    
Heaviest frequency n.s. n.s. n.s. n.s. n.s. n.s.    
Age of initiation n.s. n.s. n.s. n.s. n.s. n.s.    
Vis. Attention/WM          
Longest SS Forward          
Cannabis index n.s.    n.s. n.s.    
Heaviest frequency n.s. n.s. n.s. n.s. n.s. n.s.   n.s. 
Age of initiation n.s.       N  
Longest SS Backward          
Cannabis index n.s.    n.s. n.s.    
Heaviest frequency n.s.    n.s. n.s.   n.s. 
Age of initiation n.s.  n.s. n.s. n.s. n.s.    
Decision-Making          
DM Overall          
Cannabis index n.s.   n.s. n.s. n.s.    
Heaviest frequency W<M*       N n.s. 




DM Ambiguity          
Cannabis index n.s. n.s. n.s.   n.s.    
Heaviest frequency n.s.      ~ N n.s. 
Age of initiation n.s.      ~ N  
DM Risk          
Cannabis index n.s.   n.s. n.s. n.s.    
Heaviest frequency W<M*       N n.s. 
Age of initiation n.s.  n.s. n.s. n.s. n.s.    
Cognitive Inhibition          
D-prime          
Cannabis index n.s. n.s. n.s. n.s. n.s. n.s.    
Heaviest frequency n.s. n.s. n.s. n.s. n.s. n.s.   n.s. 
Age of initiation n.s.   n.s. n.s. n.s.    
No-go Error Rate          
Cannabis index n.s. n.s. n.s. n.s. n.s. n.s.    
Heaviest frequency n.s. n.s. n.s. n.s. n.s. n.s.   n.s. 
Age of initiation n.s.   n.s. n.s. n.s.    
General Cog. Ability          
Prorated FSIQ          
Cannabis index n.s. n.s.   n.s. n.s.    
Heaviest frequency n.s. n.s. n.s. n.s. n.s. n.s.   n.s. 
Age of initiation n.s.       N  
Block design          
Cannabis index n.s.       N  
Heaviest frequency n.s. n.s. n.s. n.s. n.s. n.s.   n.s. 
Age of initiation n.s.      n.s. N  
Vocabulary          
Cannabis index n.s. n.s.  n.s. n.s. n.s.    
Heaviest frequency n.s. n.s. n.s. n.s. n.s. n.s.   n.s. 




Note:  = negative association; = positive association; n.s. = not significant; W<M = effect size greater 
in males than females; W<M* = significant and larger effect size in males than females. N = no group 
differences between individuals with <1 month abstinence and those with at least a year abstinence. ~ 
Indicates neither lifetime heaviest frequency nor age of initiation rose above the other to predict 
decision-making under ambiguity  
aAnalysis conducted in males only 
Primary covariate analyses: step 1: pre-exposure IQ/SES; step 2: alcohol/nicotine use; step 3: education; 
step 4: recent cannabis use 
Abbreviations: CU*sex, cannabis variable x sex interaction; Initial, initial models without other 
covariates; isolate, isolating age of initiation effect from amount of use; Abst., abstinence group 
comparisons; CUs, analyses conducted in cannabis users only.  
 





 The current study assessed unique associations between nonacute cannabis use 
across adolescence and young adulthood and young adult cognitive outcomes, 
independent of confounding factors. Before discussing findings, there are strengths worth 
highlighting from the current project to provide context for the interpretation of results. 
First, research was conducted in a large population-based sample that recently 
transitioned to young adulthood and demonstrated a range of cannabis use behaviors from 
normative use levels consistent with the US more broadly to more severe use patterns. 
This is notable for a few reasons. First, we increased the likelihood of detecting more 
subtle effects while also making findings more generalizable to a broader population. 
Second, encompassing several types of cannabis use behaviors and documenting those 
behaviors on dimensional scales, as opposed to discrete groups, allowed for a broader 
understanding of the impact of cannabis use, teasing apart what behaviors may be 
associated with the most detrimental outcomes. Dimensional measures have also been 
found to be more reliable and valid than discrete group comparisons (Markon et al., 
2011), which are predominantly used in cannabis research. This sample design also 
included a large proportion of females, allowing us to explore novel sex-specific 
interactions in a longitudinal sample. THC content has increased within recreational 
cannabis products, and, as such, studies conducted in previous decades may no longer be 
as applicable to individuals using today's higher potency cannabis products. The current 
study sample came of age during this period of increased potency and was likely exposed 
to cannabis strains with high THC levels. Thus, the current project results have increased 




primary strength of the current study is its longitudinal design. We were able to assess for 
pre-exposure cognitive ability, better addressing temporal sequencing of findings. 
Further, assessments included extensive interviewing at multiple points that covered 
relevant familial, environmental, and contextual factors and used common, 
psychometrically sound neuropsychological tests to more easily compare findings to 
previous research. Multiple assessments throughout adolescence and young adulthood 
likely reduced error due to retrospective reporting. Additionally, the holistic approach to 
interviewing allowed us to explore alternative explanations that other studies could not 
accommodate. The strengths of this study enabled the current research to replicate 
previous work while also extending and filling gaps in the research base.  
 A general summary of the findings is presented above in Figure 2. Overall, 
consistent with cross-sectional literature (Grant et al., 2003; Lovell et al., 2020; Schreiner 
& Dunn, 2012; Scott et al., 2018), in initial analyses, significant associations were found 
between nonacute cannabis use and impairments in neurocognitive performance, 
including deficits in processing speed, visuospatial attention and working, verbal 
attention, decision-making, cognitive inhibition, and general cognitive abilities, as well as 
some evidence for better performance with cannabis use on a digit span task. As 
expected, our study also highlights the importance of controlling for relevant 
confounding variables as some of these associations did not survive subsequent covariate 
analyses to uniquely predict cognitive performance. However, patterns of significant 
results did emerge independent of confounders with deficits evidenced in decision-
making, general cognitive abilities, processing speed, and visuospatial attention, 




initiation and sex-specific effects suggesting cannabis use conveys greater risk in males 
for specific deficits.  
 One of the most robust findings from this study that emerged was that cannabis 
use uniquely predicted deficits in decision-making above confounders. Higher lifetime 
heaviest frequencies were consistently associated with making fewer advantageous 
choices and more disadvantageous choices overall (over all 100 trials), under ambiguity 
(first 40 trials), and under risk (last 60 trials) on a gambling task. An earlier age of onset 
also predicted poorer decision-making under ambiguity. Of particular interest, our 
measure of overall decision-making and decision-making under risk demonstrated sex-
specific effects, such that heavier lifetime frequency significantly predicted worse 
decision-making in males but not females. Our findings for deficits in decision-making 
converge with several studies in the cross-sectional literature (Becker et al., 2014; Crane, 
Schuster, & Gonzalez, 2013; Gonzalez et al., 2012; Solowij et al., 2012; Verdejo-García 
et al., 2007) and a large meta-analysis (Lovell et al., 2020) along with a longitudinal 
study examining decision-making performance in males (Castellanos-Ryan et al., 2017). 
Our findings contrast with two recent longitudinal studies that did not find an association 
between cannabis and decision-making. However, these studies covered shorter follow-
up periods (e.g., roughly age 14 to 19) than the current project and did not examine sex-
specific effects (Pacheco-Colón et al., 2021, Wendel et al., 2021), which may have 
limited their ability to detect significant effects.  
However, our findings of decision-making deficits with cannabis use across 
adolescence and young adulthood follow logically from other research areas, particularly 




research has demonstrated that adolescence is associated with significant restructuring in 
the brain, particularly in the prefrontal cortex (Gogtay et al., 2004), which subsumes 
functions such as decision-making. Further, males undergo a protracted course of 
neurodevelopment compared to females, such that gray matter volume in the prefrontal 
cortex has been found to peak one to two years earlier in females than males (Giedd et 
al., 1999), and total brain size peaked at 10.5 years in females and 14.5 in males (Lenroot 
et al., 2007). CB1 sites are also densely populated in areas such as the prefrontal cortex 
(Atkinson & Abbott, 2018). Because of males' protracted developmental trajectory 
compared to females, it has been hypothesized that males may be at greater risk for 
developing cannabis-related cognitive deficits for more extended periods during 
adolescence and into young adulthood, especially as they tend to use more heavily and 
earlier (Crane, Schuster, Fusar-Poli, & Gonzalez, 2013), which would be consistent with 
our findings. Sex-specific effects for decision-making have been noted in prior research 
as well (Crane, Schuster, & Gonzalez, 2013). Additionally, our results may converge 
most closely with findings from Castellanos-Ryan and colleagues’ (2017) investigation, 
as their study included males exclusively.  
Maturational differences in males and females may also account for the sex-
specific effects of age of initiation we found on a processing speed task. Specifically, in 
our study, males, but not females, performed poorly on a symbol search task with an 
earlier age of cannabis initiation, and a similar pattern of effects was demonstrated for 
lifetime heaviest frequency and cannabis index; however, the relationship did not reach 
significance for heaviest frequency or our cannabis index when examined in males and 




females reach peak white matter volumes, with females peaking earlier than males 
(Ladouceur et al., 2012). Males also demonstrate ongoing maturation of white matter into 
adulthood, whereas females' maturation ends earlier in adolescence. White matter growth 
is associated with faster and more efficient responding on cognitive tasks (Simmonds et 
al., 2014), as such disruption of growth processes may impact speed. Given this, much 
like with decision-making, adolescence may pose a particularly vulnerable period for 
males for deficits in processing speed due to their protracted neurodevelopmental path 
compared to females. Individual cross-sectional studies have found evidence for similar 
patterns of sex-specific effects to the current projects (King et al., 2011; Lisdahl & Price, 
2012; Pope & Yurgelun-Todd, 1196). The current work partially confers with a large 
meta-analysis conducted on studies of adolescent and young adult cannabis users, which 
found small effect sizes for differences in processing speed between a large sample of 
cannabis users and comparison participants but failed to find a relationship with age of 
onset (Scott et al., 2018). The current project only found significant effects for age of 
onset once sex-specific interactions were accounted for, which was not a focus within the 
meta-analysis conducted by Scott and colleagues (2018) and may account for discrepant 
findings. Longitudinal studies that have noted exploring for sex-specific effects did not 
find patterns to suggest differences in results between males and females (Fried et al., 
2005; Jacobus et al., 2015); however, neither examined sex-specific effects for age of 
initiation. 
 Prior research examining the phenotypic relationship between general cognitive 
abilities and nonacute cannabis use generally find significant associations (Boccio & 




Indeed, a recent meta-analysis of longitudinal studies of IQ found cannabis use predicted 
declines in IQ (Power et al., 2021). The current project results generally cohere with 
these findings in that we found greater cumulative cannabis use across adolescence and 
young adulthood predicted worse block design performance, and an earlier age of 
cannabis initiation was associated with lower prorated FSIQ scores. Age of initiation 
predicted block design performance as well; however, cumulative cannabis use appeared 
to be predominantly driving this relationship as opposed to age of initiation. Our results 
also suggested that the relationship between cannabis use and lower vocabulary scores 
appeared to be due to confounding factors, which converges with prior research 
(Castellanos-Ryan et al., 2017; Jackson et al., 2016; Schaefer et al., 2021). However, our 
significant findings between cumulative cannabis use and block design performance 
contrast with a recent twin study from our group that did not find a significant association 
between cumulative cannabis use and block design performance (Schaefer et al., 2021). 
Methodological differences may account for this discrepancy, as Schaefer et al. (2021) 
examined cumulative cannabis use separately during adolescence and young adulthood. 
Combined cumulative use across adolescence and young adulthood may be more critical 
for predicting block design performance than either developmental period independent of 
the other. Supporting this rationale, in a slightly older sample followed for only three 
years, cannabis users did not perform significantly worse on a block design task than 
controls (Jacobus et al., 2015). In contrast, when adolescents were followed over 14 years 
into young adulthood, Infante and colleagues (2020) found that greater mean levels of 
percent days of cannabis use across time were associated with poorer performance on 




analyses generally did not find evidence for a causal influence of cannabis on general 
cognitive abilities (Jackson et al., 2021; Meier et al., 2018; Ross et al., 2020; Schaefer et 
al., 2021), although only one of these studies explored the role of age of initiation as a 
continuous measure (Ross et al., 2020). Taken together, cumulative use across both 
adolescence and young adulthood and age of initiation warrant additional exploration.  
Our results suggest a persistent relationship between an earlier age of initiation 
and worse visuospatial attention. However, relatively few longitudinal studies have 
assessed for visuospatial attention deficits, and cross-sectional studies are inconsistent 
(Becker et al., 2014; Harvey et al., 2007; Pope et al., 1997; Schuster et al., 2015). That 
being said, similar to current findings, in a large twin study, Meier et al. (2018) found a 
phenotypic relationship between poorer visuospatial attention and both cannabis 
dependence and cannabis frequency, although results from their cotwin analyses suggest 
deficits in visuospatial attention may represent a premorbid liability. Conversely, when 
using discrete group comparisons, both Wendell et al. (2021) and Fried et al. (2005) did 
not find differences. It may be that continuous measures are needed to detect significant 
effects for visuospatial attention.  
Research is also mixed regarding visuospatial working memory deficits. Some 
longitudinal studies have found significant effects (Becker et al., 2018; Meier et al., 
2018), while others have not (Ross et al., 2020; Wendel et al., 2021). It appears that 
several factors may impact or confer risk for visuospatial working memory deficits. In the 
current project, the relationships between lifetime heaviest frequency and cumulative 
cannabis use and visuospatial working memory tended to follow a similar pattern such 




nicotine use, and education into the models but were more fully attenuated after 
accounting for recent cannabis use. Supporting the complexity of the relationship with 
visuospatial working memory, Morin et al. (2019) found evidence to suggest visuospatial 
working memory deficits were a common vulnerability for both later alcohol and 
cannabis use, and cannabis use may impact later spatial working memory performance. 
Additionally, previous literature suggests that visuospatial working memory is impacted 
by acute exposure to THC (D'Souza et al., 2008; Bourque & Potvin, 2021), which would 
be consistent with the drop in effects we saw in our covariate analyses. Taken together, 
while we did not find evidence for a unique nonacute cannabis-related association above 
and beyond covariates, it could be that inconsistencies seen in the literature are related to 
these interactive and shared effects of pre-existing liability, current substance use, and 
nonacute cannabis effects.   
Prior literature suggests an inconsistent relationship between verbal attention and 
cannabis use that at least in part appears to be task-dependent, with studies finding 
significant results when using a list-learning task, whereas studies that use a digit span 
task typically do not (Becker et al., 2014; Hanson et al., 2014; Price et al.,2015; Pujol et 
al., 2014; Schaefer et al., 2021; Takagi et al., 2011). Our results mimicked task-dependent 
results in our initial analyses, such that our cannabis measures predicted learning fewer 
words on the first trial of a list-learning task when confounds were not accounted for, but 
impairments were not seen on a digit span task. Differences in results based on task could 
also be compounded by inconsistent control of confounding variables in the literature. In 
a previous twin study from our group using an overlapping sample to the current project, 




once propensity to use alcohol was covaried, which included factors such as parental 
occupation and participant-specific academic factors. Similarly, in our study, pre-
exposure IQ/SES, education, and other substance use appeared to play significant roles in 
attenuating the relationships between our cannabis variables and trial one performance. 
Indeed, research indicates a strong relationship between education and RAVLT initial 
learning performance (Bolla-Wilson & Bleecker, 1986), and a powerful impact of 
education has been found for tasks with high-attention demand, such as list-learning tasks 
(Le Carret et al., 2003). As such, while cannabis does not appear to uniquely predict trail 
one performance, it may cohere with other factors to confer risk for poorer initial list-
learning performance. For instance, a twin study from our group found evidence that 
cumulative cannabis use during adolescence has potentially deleterious effects on 
adolescent academic functioning and socioeconomic outcomes (Schaefer et al., 2021). It 
may be that cannabis has an indirect impact on RAVLT trial one performance, such that 
cannabis use impacts academic and SES outcomes, which may influence initial learning 
performance on list-learning tasks. Supporting this, prior studies finding significant 
effects with list-learning tasks often did not control for confounds such as SES, 
education, or other substance use (Jacobus et al., 2015; Pope & Yurgelun-Todd, 1996; 
Hanson et al., 2010; Pujol et al., 2011; Takagi et al., 2011) and results no longer reached 
significance when confounders were consistently accounted for (Medina et al., 2007). 
Compared to the complex relationship with verbal attention, even in initial models of the 
full sample, there was little evidence for an association between nonacute cannabis use 
and verbal working memory. This finding coheres fairly closely with much of the 




who also found little evidence for an association with cannabis use (Becker et al., 2018; 
Castellanos-Ryan et al., 2017; Ellingson et al., 2021; Infante et al., 2019; Ross et al., 
2020; Schaefer et al., 2021; Tait et al., 2011).  
Even in initial models without covariates, little evidence was found for a 
relationship between cannabis use and cognitive inhibition. The only significant 
associations demonstrated in initial analyses were between an earlier age of cannabis 
initiation and poorer ability to inhibit responses and an increased error rate; however, 
these relationships were attenuated with the inclusion of pre-exposure IQ/SES and 
alcohol and nicotine use. These findings cohere with a recent meta-analysis of 13 studies 
that did not find evidence for a significant association between cannabis use and 
cognitive inhibition measures, such as the one we used in the present study (e.g., Go/No-
Go tasks; Figueiredo et al., 2020). However, our results contrast partially with two recent 
longitudinal studies. Mahedy et al. (2021) found that early, regular cannabis users 
compared to non-users performed more poorly on a response inhibition task. Similarly, 
Infante et al. (2020) noted that greater mean levels of percent days of cannabis use across 
adolescence to young adulthood were associated with a measure of cognitive inhibition. 
Inconsistencies between these studies and the current project may be due to 
methodological differences in the choice of included covariates as a measure of tobacco 
use was not included in one study (Infante et al., 2020), and alcohol use was 
characterized as a "whole drink" before the age of 13 in the other (Mahedy et al., 2021), 
which may have underestimated the role of alcohol use given their most recent 
assessment was around the age of 24 when alcohol use typically peaks (Johnston et al., 




cross-sectional studies with significant findings for cognitive inhibition often did not 
covary for other substance use and/or socioeconomic status (Clark et al., 2009; Gruber et 
al., 2013; Lamers et al., 2006). Studies that adjusted for these did not find unique 
cannabis-related effects (Gonzalez et al., 2012; Hooper et al., 2014; Tapert et al., 2007). 
Indeed, in a sample of school children, Morin et al. (2019) concluded that common 
vulnerability effects were detected for cognition inhibition and alcohol and cannabis use 
and, in a twin study, Ross and colleagues (2020) found evidence to suggest the 
association between age of initiation and a common executive functioning composite that 
accounted for all variance contributed by inhibition was likely due to premorbid liability. 
Together with our current results, the pattern of findings within the literature suggests 
more support for confounding, particularly from other substance use, than a unique, 
direct cannabis-related association.  
Contrary to expectations, even in initial models, our measures of cannabis use did 
not demonstrate associations with worse verbal learning or memory performance. This 
finding was somewhat confusing given that the relationship between cannabis use and 
poorer verbal learning and memory is one of the more consistent findings established in 
the literature (Grant et al., 2003; Lovell et al., 2020; Pacheco-Colón et al., 2021; Scott et 
al., 2018). However, our findings cohere with a previous project from our group that did 
not find an association between total learning, short-delay recall, or long-delay recall and 
cumulative cannabis use (Malone et al., 2021). Our findings may also converge with 
Scott et al.'s (2018) meta-analysis that reported non-significant effects between 
neurocognitive performance and cannabis use once the analyses were limited to studies 




cannabis and cognition might be better explained by the residual impact of acute cannabis 
intoxication or withdrawal effects. Fried et al. (2005) also found significant group 
differences between current cannabis users and controls in immediate/delayed recall 
performance but not in former cannabis users, suggesting findings may not be attributable 
to nonacute cannabis use. Our results would support this hypothesis as a significant and 
negative relationship emerged between our covariate of recent cannabis use and verbal 
memory scores. A puzzling aspect of our results was that once the relationship with 
recent cannabis use was covaried, a positive association was demonstrated between short-
delay recall and higher cannabis index scores. But a direct benefit of greater cumulative 
cannabis use on verbal learning and memory seems unlikely, particularly given the well-
documented adverse impacts of cannabis intoxication on verbal memory performance 
(Broyd et al., 2016; Cuttler et al., 2021; Ragnathan et al., 2017). This finding could be 
due to chance seeing as a pattern of significant findings did not emerge as the association 
only reached significance with the inclusion of recent cannabis use, nor were 
relationships significant for any of our other cannabis use variables across the steps of our 
analyses. Another explanation could be confounding by an unaccounted for third 
variable. For instance, better memory performance has been linked to more openness to 
experience (Chapman et al., 2017; Simon et al., 2020). Openness to experience has also 
been associated with substance use (Phillips et al., 2017; Terracciano et al., 2008). It may 
be that openness predicts both higher levels of cannabis use and better short-delay recall 
performance. In either case, this association did not appear to be a direct nor robust 




Part of our assessment of nonacute cannabis use and cognition was to examine the 
impact of length of abstinence from cannabis, which has been under-explored in 
longitudinal studies and often demonstrates inconsistent findings across the extant 
literature. Overall, our analyses found little evidence that deficits changed with prolonged 
abstinence of at least a year. Results could reflect cannabis-related alterations occurring 
in the brain that may be carried forward regardless of later cannabis use. Alternatively, 
this may suggest that associations index some pre-existing liability that predates cannabis 
exposure and thus would be present regardless of cannabis initiation. Given that our 
significant associations survived covarying for several common confounders that could 
index risk for cannabis use and cognitive deficits, the latter hypothesis seems less likely 
to fully explain the relationships demonstrated in this study. However, while findings 
appear robust, we cannot account for all confounding factors, such as shared familial and 
environmental liability, and thus cannot speak to the exact etiology of the cognitive 
deficits associated with cannabis use.  
As part of an exploratory analysis, we found an association between verbal 
working memory on a digit span task and lifetime heaviest frequency that was only seen 
in cannabis users but not when comparing across users and non-users. The relationship 
with verbal attention was nearly significant as well. Comparatively in the full sample, a 
slight trend was seen in the opposite direction when examining effects, though this did 
not survive covariate analyses. If these findings are to be taken at face value, the fact that 
significant results do not often emerge in the literature for digit span performance is 




findings were part of an exploratory analysis, it is as of yet unclear what the nature of 
these findings are or if they would be replicated in a separate sample. 
Limitations of the current work 
 The current study is not without limitations. As stated above, this study accounted 
for numerous relevant factors; however, it cannot control for all risk factors, both 
measured and unmeasured, such as familial risk factors. As such, the question of 
causality cannot fully be addressed. Given this, it will be essential to investigate the 
current findings using genetically informative designs, such as the cotwin control 
designs, to better disentangle shared familial and environmental factors from possible 
causal influences of cannabis exposure.  
 Another important consideration for this study is the risk for Type I error. It can 
be challenging to balance the risks of a Type I and Type II error, particularly as one of 
the strengths of this study was how comprehensive it was with its neurocognitive battery 
and its exploration of various measures of cannabis behaviors and alternative 
explanations. The statistical comparisons in this study were not corrected for multiple 
comparisons as many of the findings demonstrated would not be interpreted as significant 
with more rigorous thresholding. This may have increased our risk for Type I error; 
however, given the importance of these findings, we felt this was necessary to provide a 
full view of the data and more easily compare with prior research. To balance this, we 
provided statistics for cannabis effects where relevant in the narrative text and additional 
statistics in our tables so that readers may weigh the various considerations related to 




Additionally, while large and population-based, our study sample is modeled after 
the population in Minnesota at the time of the intake assessment. Due to this, our sample 
is predominantly white, and minority groups are generally under-represented, which is a 
limiting factor in the generalizability of findings, particularly given evidence of 
differences in rates of cannabis use behaviors in various racial/ethnic populations (Wu et 
al., 2016). Attrition in our sample could also be a source of bias that may limit the 
generalizability of findings given that non-participants tended to be male and have lower 
pre-exposure IQ scores and parental socioeconomic status. However, this would seem 
less probable as our cannabis use behaviors did not appear to be significantly impacted by 
attrition. Further, pre-exposure IQ scores for individuals who participated in our most 
recent assessment appeared normally distributed with adequate representation of scores 
from the lower tail of the distribution and a mean/standard deviation close to that of a 
typical standard score distribution. If attrition bias were present, it would seem unlikely 
for our findings to drastically change as to no longer be significant. Rather, given that 
males were more likely to not participate in the most recent assessment and several of our 
findings were specific to males, it would seem more likely that effects may be 
underestimated and some of the effects that just missed significance would have met 
significance thresholds.  
Conclusions 
 The results from this longitudinal study suggest that cannabis use during 
adolescence and young adulthood is associated with deficits in neurocognitive 
performance above and beyond common confounding factors. Findings demonstrated an 




poorer visuospatial attention and decision-making performance under ambiguity. Higher 
lifetime heaviest frequencies of cannabis use predicted lower decision-making scores 
overall, under ambiguity, and under risk; however, sex-specific effects were evidenced 
such that only males demonstrated significantly worse performance on overall decision-
making and decision-making under risk with higher lifetime heaviest frequencies of use. 
A similar pattern was seen for processing speed, such that an earlier age of initiation 
predicted symbol search performance but only in males. Cumulative cannabis use across 
adolescence and young adulthood also predicted lower block design performance. Verbal 
working memory deficits were uniquely evidenced by cannabis users with higher lifetime 
heaviest frequencies and cognitive performance did not differ based on length of 
abstinence from cannabis. When findings are taken together, patterns of earlier onset of 
use and heavier peak frequencies appear to be most relevant for predicting poorer 
cognitive outcomes, suggesting that more diffuse moderate levels of cannabis use, mainly 
occurring later into young adulthood, may be associated with fewer long-term adverse 
outcomes. 
  While we cannot fully speak to whether these associations represent exposure-
related effects of cannabis use, our results demonstrate overall good coherence with 
previous literature, strengthening confidence in our results. Future work could extend 
these findings by exploring effects in larger longitudinal samples with more frequent 
follow-ups, such as those conducted in the Adolescent Brain and Cognitive Development 
(ABCD) project, or in robust casually informative cotwin control designs to speak more 
directly to potential exposure-related effects of cannabis. This information can be used to 




periods, such as adolescence, particularly in males, and assist in informing health 
policies. Future work may also benefit from exploring the clinical and functional 




















Study 2. The Effects of Cannabis Use Behaviors Across Adolescence on Young 
Adult Cognitive Outcomes: A Cotwin Control Study 
Abstract 
Background. Research suggests that there is an association between nonacute 
cannabis use and impaired cognitive performance. However, the etiology of cognitive 
deficits in adolescent and young adult cannabis users remains largely unclear as other 
factors that may increase the risk for cannabis use, such as familial liabilities, may 
confound causal interpretations. We examined casual associations between nonacute 
cannabis use during adolescence and young adulthood and young adult neurocognitive 
outcomes in a sample of twins using a cotwin control design to separate familial liability 
from cannabis exposure-related effects. 
Methods. A large population-based sample of twins (N =801; 55% female) was 
followed from age 11 to 24. Dimensional measures of cannabis and other substance use 
were obtained across four assessments waves (age 11, 14, 17, 24). Cognitive outcomes 
were assessed at the most recent assessment (age 24), with pre-exposure cognitive ability 
assessed at intake (age 11). Linear mixed models assessed individual-level associations 
between cannabis and cognition. Cotwin control analyses were conducted to tease apart 
risk conferred by genetic and environmental factors from potential cannabis exposure-
related effects on cognition.  
Results. Individual-level associations for the full neurocognitive battery were 
presented in our previous report. In the present study, associations that survived multiple 
comparison adjustments indicated deficits in visuospatial attention with greater lifetime 




earlier age of onset. Sex-specific effects in decision-making and processing speed 
performance were observed, such that males demonstrated significant decision-making 
deficits with greater lifetime heaviest frequencies and poorer processing speed scores 
with an earlier age of initiation, but females did not. Cotwin control results suggest that 
deficits in decision-making, estimated intelligence, visuospatial attention, and processing 
speed reflect pre-existing liability toward substance. However, evidence was also 
consistent with a causal influence of an earlier age of cannabis initiation on general 
intelligence in both males and females and an exposure-related effect of greater lifetime 
heaviest frequency on decision-making but only in males. Results suggested that 
differences in length of abstinence did not significantly impact these findings, nor did 
they predict cognitive performance 
Conclusions. Evidence suggests a bidirectional association between cannabis use 
and neurocognition, such that cognitive deficits may represent premorbid characteristics 
of the familial predisposition to use cannabis and may also be adversely impacted by later 
cannabis exposure with specific risk for exposure-related consequences in males. Results 
have potentially important implications for health policy decisions and intervention 












In the last few decades, perceptions regarding the risk of cannabis use have 
decreased, accompanied by an increase in the legalization of use at the state level (Berke 
& Gould, 2020; Johnston et al., 2021). With shifts toward greater acceptance, 
understanding the long-term implications of cannabis use is imperative. This is 
particularly true for cannabis use occurring during adolescence and young adulthood, 
given these are critical periods of neural development (Sturman & Moghaddam, 2011) 
and may be sensitive to exogenous assault from exposure to cannabis (Crane, Schuster, 
Fusar-Poli, & Gonzalez, 2013). Animal research supports this vulnerability hypothesis 
for youth (Atkinson and Abbott, 2018), and cannabis exposure in adolescence, 
particularly high-potency cannabis, has been associated with poorer mental health or 
psychosocial outcomes (Hines et al., 2020).  
Several meta-analytic studies of the cross-sectional research have supported the 
assertion that at the phenotypic level nonacute cannabis use is associated with 
impairments in neurocognitive performance with the most significant evidence for 
learning and memory and more modest evidence for decision-making, attention, 
processing speed, and global cognition (Figeiredo et al., 2020; Grant et al., 2003; Lovell 
et al., 2020; Schreiner & Dunn, 2012; Scott et al., 2018). These associations are often 
assumed to represent neurotoxic effects of exposure. However, the exact nature of the 
relationship between cannabis and cognition has yet to be fully discerned as speaking to 
causality remains a challenge. Cross-sectional research studies are unable to speak to the 




is that lower neurocognitive ability may predispose an individual to later substance use 
(Morin et al., 2019; Ridenour et al., 2009), and controlling for pre-exposure cognitive 
abilities has been found to attenuate relationships between nonacute cannabis use during 
adolescence and later cognitive performance (Meier et al., 2018).  
Longitudinal studies with pre-and post-initiation measures of cognitive ability can 
better speak to the temporal sequencing of the relationship with cannabis. However, 
evidence that cannabis use was associated with declines in neurocognition has been 
characterized as inconsistent (Meier et al., 2018; Power et al., 2020; see Study 1 
summary). Moreover, critics have pointed out that the association between cannabis and 
cognition may arise due to pre-existing vulnerabilities, such as low socioeconomic status, 
rather than cannabis adversely impacting cognition (Daly, 2013; Rogeberg, 2013). 
Indeed, it can be challenging to account for all predisposing familial and environmental 
factors that may confer risk toward substance use and cognitive deficits. Studies that 
disentangle possible causal exposure-related effects from confounding, such as twin 
studies, are needed to better address shared unmeasured confounding factors. 
In response to concerns related to potential confounding, Jackson et al. (2016) 
examined the link between declines in intelligence from ages 9-12 to 17-20 and cannabis 
use in two large samples of twins. Study results showed declines in intelligence scores 
(e.g., vocabulary/information from the Wechsler Abbreviated Scale of Intelligence) of 
cannabis users compared to nonusers; however, differences were not found between 
twins discordant for cannabis use, suggesting the associations were not due to causal 
effects of cannabis. In a twin sample followed to age 18, Meier and colleagues (2018) 




cannabis initiation than non-dependent adolescents but found little evidence that cannabis 
use was associated with declines in IQ. Adolescents who used cannabis also 
demonstrated poorer executive functioning at age 18 than those that did not use cannabis, 
but most of these associations were not evident within twin pairs (i.e., not consistent with 
a causal effect of cannabis); however, they did find that twins who used cannabis more 
frequently in the 12 months before their age 18 assessment performed worse than their 
less frequently using cotwin on a spatial span task of working memory (Meier et al., 
2018). Similarly, Ross et al. (2020) found evidence for a possible causal exposure-related 
effect of frequency of use (past six months) at age 17 on executive functioning 
performance. However, the authors cautioned against over-interpreting this relationship 
as evidence of a causal impact of cannabis on cognition as this was the only significant 
association suggestive of an exposure-related effect out of their analyses. Ross et al. 
(2020) also noted that most associations between cannabis use and intelligence and 
executive functioning were accounted for by other substance use, and associations 
between age of initiation and intelligence and executive functioning appeared to be due 
primarily to familial confounding. In two combined twin cohorts that followed twins into 
their mid-and late-20s, Schaefer et al. (2021), much like the other twin studies, found an 
association between cumulative cannabis use and vocabulary, but this association again 
appeared to be due to shared familial and environmental confounding as opposed to an 
exposure-related effect.  In another twin study focused on a list-learning task from our 
group, propensity to use alcohol was found to account for the relationship between 
cumulative cannabis use and initial and overall learning, and no associations were found 




These studies are informative, but twin studies in adolescents and young adults 
are still rare and relatively narrow in the cognitive domains they address. In this study, a 
longitudinal sample of twins extending from adolescence into young adulthood was 
assessed on a comprehensive battery of neurocognitive assessments. Unique phenotypic 
associations between nonacute cannabis use and cognition, independent of common 
confounders, were described in our previous study (see study 1). Results of that project 
found deficits in general cognitive abilities and visuospatial attention, along with sex-
specific effects for decision-making and processing, such that males demonstrated 
significant impairments with cannabis use, but females did not. These associations rose 
above confounding factors in our previous analyses. Conversely, robust associations, 
independent of confounds, were not demonstrated for verbal learning and memory, 
visuospatial or verbal working memory, or cognitive inhibition. Consistent with the 
literature (Broyd et al., 2016; Scott et al., 2018), associations most typically were found 
with greater heaviest frequencies of use and earlier ages of cannabis initiation, with less 
evidence for more moderate cannabis use behaviors. Deficits did not appear to resolve 
with an abstinence period of at least a year. Within an exploratory analysis, our previous 
project found a negative association between verbal working memory and lifetime 
heaviest frequency that was unique to cannabis users only.  
The current project extends findings from our previous report by exploring the 
etiology of the unique relationships between nonacute cannabis use and cognition by 
capitalizing on our reared-together twins' genetic and environmentally informative nature, 
which more stringently controls for shared familial and environmental influences. To the 




and nonacute cannabis use has not yet been the focus of a twin study in adolescents and 
young adults, nor have sex-specific effects been demonstrated. The prospective design of 
the sample enabled cannabis use to be characterized from multiple time points across 
adolescence and control for cognitive ability measured pre-initiation of cannabis. The 
cotwin control design is unable to account for all confounding factors unshared by twins. 
We were well situated to address potentially nonshared variables such as pre-exposure 
cognitive abilities, years of education, alcohol and nicotine use, recent cannabis use, and 
recency of last cannabis use, as assessment waves included extensive interviewing 
regarding psychosocial and environmental factors.  
Methods 
Sample 
Participants were same-sex twins from the Enrichment Study (ES), a component 
of the Minnesota Twin Family Study (MTFS) at the Minnesota Center for Twin and 
Family Research (MCTFR). Participants were identified from Minnesota birth records. 
The ES sample is a population-based, longitudinal study of reared-together twins 
followed from intake at age 11 and subsequently at age 14, 17, and 24; a detailed 
overview of the ES sample and study design, including inclusion/exclusion criteria, are 
described in Keyes et al. (2009) and Wilson et al., (2019). Assessments at each study 
wave included a comprehensive, multimodal battery of clinical interviews, 
questionnaires, and cognitive assessments conducted by trained assessors. Information 
was also collected from biological and stepparents across assessments.  
Of the original 998 twins recruited for the ES sample at the age-11 intake, 81% (n 




participation at the age-24 assessment was not uniform across all cognitive assessments 
due to logistic factors, such as time constraints during interviewing or impractical travel 
distances to participate in-person that necessitated phone interviews (n = 111). Eight 
individuals were excluded due to reporting cannabis exposure before their age-11 intake 
assessment. See previous report for further description of the sample characteristics and 
attrition across study duration.  
The final sample contained 801 individuals (age: mean [SD] = 24.43 [0.91] years; 
439 women), with 481 monozygotic (233 complete pairs) and 320 dizygotic (153 
complete pairs) twins. Twins were asked to refrain from all substance use for 24-hours 
before their age-24 assessment but were not excluded if they reported recent use. Sixty-
four participants reported cannabis use in the 24-hours preceding their age-24 follow-up 
assessment.  
Substance use 
Substance use was assessed at ages 11, 14, and 17 using a Computerized 
Substance Use (CSU; McGue et al., 2014) questionnaire and a revised version of the drug 
supplement from the Diagnostic Interview for Children and Adolescents-R (DICA-R; 
Reich, 2000; Welner et al., 1987). A modified version of the Substance Abuse Module 
(SAM; Robins et al., 1987) from the Composite International Diagnostic Interview 
(CIDI; Robins et al., 1988) was utilized to assess substance use at ages 17 and 24. The 
CSU, DICA, and the expanded version of the SAM assess for information, such as the 
number of intoxications, frequency and quantity of use, heaviest periods of use, and age 





Cannabis was measured with six variables, including frequency of use (past 12 
months), number of uses (since last assessment), heaviest frequency (lifetime), age of 
initiation, recent use (past-24 hours), and length of abstinence (time since last use). 
Frequency of use (12 months) and number of uses (since the last assessment) were 
combined across follow-up waves to form a cumulative measure of cannabis (cannabis 
index). Description of the cannabis index computation is presented below; the validity of 
the methods used to derive the cannabis index was supported by comparable studies that 
explored implications of common substance use behaviors (Harper et al., 2018; Malone et 
al., 2021; Schaefer et al., 2021; Wilson et al., 2018). Our primary cannabis variables of 
interest were the cannabis index, lifetime heaviest frequency, and age of initiation.  
Cannabis index.  The cannabis index characterized cumulative cannabis exposure 
from adolescence to young adulthood. To compute this measure, separate indices were 
first calculated for each follow-up wave (i.e., 14, 17, and 24) by averaging two items: (1) 
frequency of use (past 12 months), and (2) number of times used (since last assessment). 
For frequency of use in the past 12 months, categories included: 0 (no use), 1 
(<1x/month), 2 (1-3x/month), 3 (1-4x/week), 4 (every day or nearly every day), or 5 
(>1x/day). For number of uses since last assessment, categories included: 0 (no use), 1 
(1-4 uses), 2 (5-30 uses), 3 (31-100 uses), 4 (101-400 uses), or 5 (>400 uses or “too many 
to count”). Because responses to these questions tended to be sparse and positively 
skewed, they were transformed into 6-point ordinal scales using methods developed at 
the MCTFR before averaging them. We derived a single index by averaging these scores 
across follow-up assessment waves (i.e., age 14, 17, and 24). We did not include age-11 




intake assessment were excluded and, as such, age-11 cannabis use was zero for all 
participants.  
Lifetime heaviest frequency. Participants were asked to think about the period 
when they were using cannabis the most, either in their lifetime (asked at age 17) or since 
their last assessment (asked at age 24), heaviest frequency was not assessed at the earlier 
assessment waves. Participants were then asked to report the frequency of their cannabis 
use during the time of their heaviest use. We used the max value reported at either their 
age-17 or age-24 evaluation to assess for heaviest frequency ever used in the participant’s 
lifetime. Mimicking procedures for the cannabis index, we transformed lifetime heaviest 
frequency into an ordinal measure containing six categories to reduce skew and spareness 
of responses. Categories included: 0 (no use), 1 (<1/year), 2 (>1x/year to 2 to 3x/month), 
3 (1 to 2x/week to nearly every day), 4 (1 to 2x/day), 5 (3x/day).  
Age of initiation. Age of initiation was defined as the first exposure to cannabis 
regardless of the amount used. To obtain this value, we asked participants how old they 
were when they first tried cannabis at each assessment wave. The age reported at the 
earliest assessment was used, as this was the report most proximal to when use occurred, 
likely reducing measurement error due to retrospective reporting over more extended 
periods.  
Other cannabis covariates. At the age-24 follow-up, participants were asked if 
they had used cannabis in the 24 hours before their assessment. Responses were coded as 
either a yes (1) or no (0) answer. Participants were also asked when they had last used 




weeks), 2 (2 weeks to <1 month), 3 (1 month to <6 months), 4, (6 months to <1 year), 5 
(within the last year but don’t know exactly when), and 6 (1 year or more ago). 
Other substance use 
Two composite measures were calculated to approximate alcohol (age-24 alcohol 
index) and nicotine (age-24 nicotine index) exposure during emerging adulthood (17-25 
years), likely during peak substance use (Johnston et al., 2021). Computation was similar 
to those used to calculate the cannabis indices and followed methods used in several other 
studies from our group that have examined implications of common substance use 
behaviors (Harper et al., 2018; Malone et al., 2021; Schaefer et al., 2021; Wilson et al., 
2018). 
The alcohol index was calculated by taking the average of four dimensional 
alcohol use items assessed at the age-24 follow-up: (1) number of drinks typically 
consumed per occasion since the last assessment (0 = none to 6 = 30+), (2) frequency of 
drinking since the last assessment (0 = never to 5 = two+ times per day), (3) maximum 
drinks consumed in a 24-hour period since last assessment (0 = none to 6 = 30+), and (4) 
number of times intoxicated in lifetime (0 = never to 6 = 150+ times). The nicotine index 
was derived by taking the average of two items: (1) number of days in a typical month 
used tobacco in the past 12 months (0 = none to 2 = 15 to 30 days per month), and (2) 
number times used tobacco in a typical day in the past 12 months (0 = none to 3 = 20+). 
The number of times used tobacco in a typical day was the sum of four individual items 
on the number of cigarettes, cigars, and pipes smoked, and the number of chews used.  




 This report focused on a subset of the neurocognitive battery used in our previous 
report that demonstrated robust, unique effects with our cannabis measures (see study 1 
for complete list). Neurocognitive measures included test of (1) processing speed: 
Wechsler Adult Intelligence Scale-III (WAIS-III) Symbol Search (Wechsler, 1997); (2) 
verbal working memory: WAIS-III Longest Digit Span Backward (Wechsler, 1997); (3) 
visuospatial attention: Longest Spatial Span Forward (Wechsler, 1997); (4) decision-
making: Iowa Gambling Task (IGT; Bechara et al., 1994); (5) general cognitive ability: 
Wechsler Adult Intelligence Scale-Revised (WAIS-R) Prorated Full Scale IQ (FSIQ), 
Block Design (Wechsler, 1981). Measures for the full neurocognitive battery examined in 
our previous study and the subset focused on in the current project are summarized in 
Table 3 along with variables obtained from each measure. See general study 
characteristics section for full task descriptions. 
Additional covariates 
Age-11 intelligence quotient (IQ) 
Pre-exposure IQ, assessed at intake, was derived from performance on the block 
design, picture completion, vocabulary, and information subtests of the Wechsler 
Intelligence Scale for Children-Revised (WISC-R) and estimated following WISC-R 
prorated scoring procedures for IQ (Wechsler, 1981).  
Years of education 
 Education for each participant was defined as the number of academic school 





Cotwin control (CTC) analyses rely both on the similarities and differences 
between twins. The degree to which our cannabis measures of interest are similar or 
dissimilar can impact our ability to detect either a causal exposure-related effect of 
cannabis or a pre-existing liability toward use. To illustrate similarities, correlations were 
conducted between twins in a twin pair for our measures of cannabis use using intra-class 
correlations for MZ and DZ twins separately. Additionally, we examined the distribution 
of absolute twin difference scores (|TwinA – TwinB|), providing descriptive statistics of 
within-pair differences to characterize twin differences in cannabis use behaviors in our 
sample.   
Both individual-level and CTC analyses used linear mixed models (LMMs) to 
examine effects. LMMs were conducted in R using lmer from the lme4 package (Bates et 
al., 2015) with denominator degrees of freedom adjusted by Kenward-Roger 
approximation from the lmerTest package (Kuznetsova et al., 2017). Random intercepts 
were included at the twin-pair level to account for within-pair correlations. All analyses 
included covariates for age, sex, and zygosity as appropriate. 
Unique, robust associations between our cannabis use and cognitive variables 
demonstrated in our previous report were carried forward to this project to assess for 
evidence of causal effects of exposure (see study 1 for detailed exploration of phenotypic 
associations). While our previous study reported the phenotypic associations between our 
cannabis and cognitive variables, individual-level associations were assessed in this 
project and summarized below for baseline comparison to subsequent CTC analyses. 
Given sex-specific effects evidenced in our previous project for decision-making and 




females. A false discovery rate (FDR) procedure adjusting for multiple comparisons was 
applied (Storey, 2003; Storey & Tibshirani, 2003) at q < 0.05 (Storey et al., 2018). 
Associations that survived FDR adjustment were assessed in the CTC analyses. For 
investigations of sex-specific effects, non-significant findings in females were also 
carried forward to CTC analyses for exploratory purposes and a better understanding of 
sex-related influences.  
CTC analyses assessed for possible causal exposure and shared familial and 
environmental risk effects by using reared-together twins to control for both measured 
and unmeasured familial confounding more stringently. For CTC analyses, cognitive 
outcomes are compared between members of a twin pair. For example, if a twin used 
cannabis more than their cotwin, the cognitive outcome of the lesser-using twin provides 
a close approximation of the expected outcome for their heavier-or earlier-using cotwin 
had they used cannabis less or began using at a later age (unobserved counterfactual; 
Rutter, 2007).  
Our cannabis use variables (e.g., cannabis index, lifetime heaviest frequency, age 
of initiation) were each split into two orthogonal components: (1) the between-pair effect, 
or twin-pair mean score, and (2) the within-pair effect, or each twin's deviation from their 
respective twin-pair mean (Begg & Parides, 2003). The between-pair effect, or what is 
shared within a twin-pair, primarily reflects both measured and unmeasured pre-existing 
genetic and shared environmental vulnerability influencing both cannabis use and 
cognitive performance. The within-pair effect, or what differs within a twin pair, reflects 
nonshared environmental effects of cannabis exposure unconfounded by familial risk 




Given this parameterization, a significant between-pair effect in the CTC model 
would suggest that the association between cannabis use and a neuropsychological 
outcome is most consistent with shared genetic or environmental confounding. On the 
other hand, a significant within-pair effect would be more compatible with a causal 
cannabis exposure-related effect on cognitive performance. As the CTC relies on the 
similarity between twins, only complete twin pairs were be used for this method. We 
compared the magnitude of within-pair effects between MZ and DZ twin pairs with a 
within-pair by zygosity interaction term in our CTC models. Statistically commensurate 
MZ and DZ within-pair effects would be consistent with an exposure-related effect of 
cannabis (McGue et al., 2010) 
While the CTC can control for measured and unmeasured shared genetic and 
environmental factors, it cannot fully control for factors unshared by twins. As such, for 
associations that demonstrated significant within-pair effects, CTC models were 
conducted to include pre-exposure IQ, years of education, alcohol use, nicotine use, and 
recent cannabis use. These are variables that may differ between twins and are relevant 
for cannabis use and cognitive outcomes. These variables were represented as each twin's 
deviation from their twin-pair mean. Cannabis users who begin using earlier often use 
more heavily, and relationships with age of onset may be better accounted for by 
frequency of use (Castellanos-Ryan et al., 2017). Thus, for any within-pair effects found 
for age of onset, models exploring unshared confounds also included a covariate for twin 
differences in the age-24 cannabis index to account for both proximal quantity and 




Length of time since last use may mediate the relationship between cannabis and 
cognition (Scott et al., 2018; Schreiner & Dunn, 2012). Twin differences in length of 
abstinence from cannabis were included as a covariate in a final set of cotwin models to 
assess if recency of last use predicted neurocognitive performance or attenuated 
previously demonstrated significant within-pair effects. 
Results  
Preliminary analyses 
Twin correlations for our exposure variables are presented in Table 16. 
Descriptive statistics for demographic and substance use variables are presented in Table 
1 and neurocognitive descriptive statistics are in Table 2. All within-pair twin 
correlations were higher in MZ relative to DZ twins, consistent with influences of 
additive genetic factors. All correlations were less than 1, which also suggests influences 
from environmental factors not shared by twins. For complete twin pairs, absolute twin 
differences (|TwinA – TwinB|) in our cannabis index ranged from 0 to 3.25 (M = 0.45, 
SD = 0.56). Thirty-three percent of twins were concordant (e.g., had the same index 
score) for the cannabis index (n = 254, 160 MZ/94 DZ), and the rest were discordant (n = 
518, 306 MZ/212 DZ). Our cannabis index collapses ordinal measures of the number of 
uses and frequency of use (past 12 months), so a difference of 1 between twins would be 
equivalent with one twin using <1x/month and the other using 1-3x/month, or one twin 
using 1-4x/week and the other using every day or nearly every day. Another possibility is 
that one twin reported 1-4 uses since their last assessment and the other reported 5-30, or 
one reported 31-100 uses and the other reported 101 to 400 uses. Absolute twin 




Forty-two percent of twins were concordant for lifetime heaviest frequency (n = 322, 226 
MZ/96 DZ) and the rest were discordant (n = 450, 240 MZ/210 DZ). Absolute twin 
differences in age of initiation ranged from 0 to 8 years (M = 1.75, SD = 1.68). Twenty-
three percent of twins were concordant for age of initiation (n = 98, 68 MZ/ 30 DZ) with 
the remaining discordant (n = 314, 184 MZ/ 130 DZ).  
Individual-level associations 
 Table 17 presents individual-level associations, including sex-specific effects. 
Associations demonstrated with decision-making under ambiguity, block design, and 
digit span did not survive FDR adjustment (q > 0.05). All other significant associations 
survived multiple comparison adjustments. A summary is provided below. 
 Diminished longest spatial span forward and prorated FSIQ scores were 
associated with an earlier age of cannabis initiation (p < 0.01). Sex-specific effects were 
demonstrated for overall decision-making (p < 0.01; the total number of advantageous 
minus disadvantageous choices across 100 trials) and decision-making under risk (p < 
0.01; last 60 trials), such that males, but not females (p  0.12) demonstrated significant 
impairments with greater lifetime heaviest frequencies of use. Males also demonstrated 
lower symbol search scores with an earlier age of cannabis initiation (p < 0.01), but the 
relationship was not significant in females (p  0.15).  
Cotwin control analyses 
 CTC models, including within-and between-pair estimates are presented in Table 
18. Lifetime heaviest frequency within-pair estimates were significant for both measures 
of decision-making in males (overall decision-making: Estimate (SE): -4.87 (2.11),  t = -




0.01), which are consistent with a causal effect of cannabis; however, the between-pair 
effect was also significant for overall decision-making (Estimate (SE): -3.50 (1.50), t = -
2.34, p = 0.02) and was nearly significant for decision-making under risk (Estimate (SE): 
-2.27 (1.18), t = -1.93, p = 0.06). Similar findings were demonstrated in the full sample 
(e.g., males and females) for the association between age of initiation and prorated FSIQ, 
such that both the between- and within-pair effects for age of initiation were significant 
(between-pair: Estimate (SE): -2.52 (0.45), t = 5.59, p < 0.01); within-pair: Estimate 
(SE): 1.00 (0.41), t = 2.45, p = 0.02). These findings suggest that the associations seen 
with decision-making (in males) and prorated FSIQ may, at least in part, reflect pre-
existing liability, in addition to adverse consequences of greater lifetime heaviest 
frequencies of cannabis use. Consistent with expectations for a within-pair effect (McGue 
et al., 2010), within-pair by zygosity interaction terms were not significant (ps  0.32).  
 In contrast to their male counterparts, females demonstrated a significant negative 
between-pair effect of lifetime heaviest frequency, but not a within-pair effect, on 
decision-making. Females demonstrated a slight positive lifetime heaviest frequency 
within-pair effect for overall decision-making and decision-making under risk; however, 
these did not come close to significance (p  0.30). Contrasting signs of the between- and 
within-pair effects in females likely contribute to the lack of a significant association seen 
at the phenotypic level. Overall, this pattern suggests that decision-making deficits may 
index some pre-existing liability toward cannabis use in females.    
The age of onset between-pair effects, but not within-pair effects (ps  0.38), were 
significant for both processing speed in males and visuospatial attention in the full 




cannabis use. Neither the between- nor within-pair effect were significant for the 
relationship between age of initiation and symbol search performance in females; 
however, the between-pair effect was larger. A larger sample may be necessary to tease 
apart findings given previous literature's overall small effect sizes (Scott et al., 2018). 
Unshared confounding 
 The CTC models can control for both measured and unmeasured genetic and 
familial factors shared by twins that may confound the relationship between cannabis and 
cognition; however, CTC analyses cannot account for possible confounding by factors 
not shared by twins that might influence cannabis use and cognition. We attempted to 
account for primary factors that may confound within-pair effects of cannabis on 
cognition, such as differences in pre-exposure IQ, education, alcohol and nicotine use, 
and recent cannabis use. For significant age of onset within-pair effects, we also covaried 
for the age-24 cannabis index to better isolate the impact of age of initiation from heavy 
frequencies and quantities of cannabis use.  
 Independent of unshared confounding factors, the significant within-pair effect of 
lifetime heaviest frequency held for decision-making under risk in males (see right-hand 
column of Table 19 for adjusted within-pair estimates for decision-making variables), 
which is not consistent with unshared confounding.  Conversely, unshared confounding 
appeared to attenuate somewhat the within-pair effect of lifetime heaviest frequency on 
overall decision-making performance in males, though it remained close to significance 
(Estimate [SE] = -4.60 (2.61), t = -1.76, p = 0.08). The age of onset within-pair effect on 
prorated FSIQ in the full sample remained significant and thus does not appear to reflect 




differences in proximal frequency and quantity of cannabis use (see right-hand column of 
Table 20 for adjusted within-pair estimates for FSIQ). 
 The impact of differences in length of abstinence was also explored for significant 
within-pair effects that remained after covarying for other confounders. Within-pair 
estimates for length of abstinence were not significantly related to scores for either 
decision-making under risk or prorated FSIQ (ps  0.68; see Table 21 for decision-
making within-pair estimate and Table 22 for FSIQ within-pair estimates after covarying 
for abstinence length). Additionally, cannabis use within-pair estimates remained 
significant. This pattern suggests that differences in length of abstinence did not mediate 
the relationship between exposure-related effects of cannabis, nor did it predict 
neurocognitive performance.  
Discussion 
 As a follow-up to our previous study, we assessed the causal association between 
cannabis use and neurocognitive performance in a large sample of twins assessed from 
adolescence to young adulthood. Our prior investigation examined the robustness of the 
association between cannabis use and cognition, independent of potential confounds. 
Results of that report that survived adjustment for multiple comparisons in the present 
study indicated persistent deficits in estimated intelligence and visuospatial attention. 
Sex-specific effects were found, such that males performed significantly worse on overall 
and risky decision-making and processing speed measures with higher lifetime heaviest 
frequencies, but females did not. Consistent with previous research, impairments were 
seen with heavier patterns of use (Fried et al., 2005; Meier et al., 2012; Scott et al., 2018) 




control design, the present study expands on these results providing important and novel 
information regarding the nature of the association between cannabis use and cognition in 
adolescence and young adulthood. 
 Associations found between lifetime heaviest frequency ever used and decision-
making concurs with previous literature (Becker et al., 2014; Castellanos-Ryan et al., 
2017; Gonzalez et al., 2012; Grant et al., 2012; Lovell et al., 2019; Solowij et al., 2002), 
as do our sex-specific effects suggesting significant deficits in males, but not females 
(Crane, Schuster, & Gonzalez, 2013). Within the current study, cotwin control analyses 
demonstrated a significant within-pair effect of cannabis on decision-making under risk, 
with a between-pair effect that approached but just missed significance in males. The 
reverse pattern was demonstrated for the relationship with overall decision-making. 
While individual-level effects were not significant, females did demonstrate a significant 
between-pair effect for both overall decision-making and decision-making under risk, 
with no evidence of a negative within-pair effect. Taken together, these suggest a 
complex relationship between greater lifetime heaviest frequency of use and decision-
making such that deficits may index both a pre-existing liability toward cannabis use in 
both males and females but only a causal exposure-related effect of cannabis in males. 
Brain regions that subsume functioning related to decision-making, such as the 
prefrontal cortex (Funahashi, 2017), are known to be rich in cannabinoid receptor type 1 
(CB1) binding sites, where cannabis’ main psychoactive ingredient Δ-9-
tetrahydrocannabinol (THC) binds in the brain. Prefrontal cortical regions undergo 
critical maturational processes during adolescence and young adulthood (Tau & Peterson, 




poor cognitive outcomes related to cannabis exposure (Atkinson and Abbott, 2018). Our 
findings, that suggest a possible causal influence of cannabis on decision-making, would 
support this hypothesis. Imaging studies converge on this as well. Cousijin et al. (2012) 
found brain activation differences in core brain regions associated with decision-making 
in young adult heavy cannabis users compared to controls. Additionally, brain activation 
differences in prefrontal cortex regions between cannabis users and controls were linked 
to poorer performance on a decision-making task in cannabis users (Vaidya et al., 2012). 
Consistent with the present study findings, a prior functional magnetic resonance imaging 
study found that chronic young adult cannabis users performed more poorly at the end of 
a gambling task compared to controls, but differences were not seen between groups 
during the initial strategy development phase (Wesley et al., 2011). In that same study, 
brain activation differences were found alongside performance differences in brain 
regions such as the frontal cortex. The authors posit that cannabis users are less sensitive 
to negative feedback during strategy development than controls (Wesley et al., 2011). 
Taken a step further, our study demonstrated evidence consistent with an adverse impact 
of cannabis exposure in males but not females. As reviewed in our previous report, 
research has posited that protracted neurodevelopmental trajectories in prefrontal brain 
regions may make adolescent and young adult males more vulnerable to cannabis-related 
neural disruptions than females, particularly given that males tend to use more heavily 
and earlier than females (Crane, Schuster, Fusar-Poli, & Gonzalez, 2013). The findings in 
the current study support the theory that sex-specific differences in neurodevelopmental 
trajectories may place adolescent and young adult males at heightened risk for cognitive 




important for future studies to explore this sex-specific effect in cannabis users who did 
not use in adolescence or young adulthood to further explore this hypothesis.  
Associations between an earlier age of onset and estimated intelligence are 
consistent with longitudinal studies that found associations with or declines in IQ with 
cannabis use (Boccio & Beaver, 2017; Infante et al., 2019; Meier et al., 2012; Powers et 
al., 2020) and phenotypic analyses within other twin studies (Jackson et al., 2016; Meier 
et al., 2018; Ross et al., 2020; Schaefer et al., 2021). Our findings from the cotwin control 
analyses are in partial accordance with other twin studies, such that we found evidence 
for potential shared familial and environmental confounding (e.g., significant between-
pair effect) and the relationship between cumulative cannabis use and block design did 
not appear to be robust, which was also demonstrated in other twin analyses (Jackson et 
al., 2016; Meier et al., 2018; Ross et al., 2020; Schaefer et al., 2021). However, our 
findings contrast in that we also found evidence to suggest a possible adverse causal 
influence of an earlier age of cannabis on prorated FSIQ (e.g., significant within-pair 
effect), independent of shared familial risk, measured unshared confounding, and severity 
of cannabis use. This discordance may be for several reasons. First, most of the other 
twin analyses did not explore the implications of age of initiation as a continuous 
measure, instead focusing on measures of cumulative cannabis use, frequency of use, or 
cannabis dependence/cannabis use disorder (Jackson et al., 2016; Meier et al., 2018; 
Schaefer et al., 2021). Ross et al. (2020) assessed the causal impact of age of initiation 
but only found evidence for significant between-pair effects with measures of 
intelligence. Discrepancies with this study may be attributable to methodological 




(2020) used the youngest age of initiation reported across all assessments as well as 
assigned non-cannabis users an age a year above the highest age reported in the sample 
(i.e., age 30). Conversely, in the present study, we took an individual's first report of age 
of initiation as it was the most proximal report to when cannabis use occurred to reduce 
measurement error from retrospective report, and we focused on individuals who had 
previous cannabis exposure. It will be necessary for future research to examine this 
relationship further; however, if an exposure-related effect of an earlier age of onset is 
replicated in future research, this finding has public health ramifications as it may 
represent a widespread disruption in neurodevelopmental processes (e.g., synaptic 
pruning, dendritic plasticity) and influences on the endocannabinoid systems subserving 
neurotransmitter processes for ongoing maturational rearrangement in the brain.  
Literature on whether neurocognitive deficits related to cannabis persist despite 
abstinence has been mixed (Castellanos-Ryan et al., 2017; Lovell et al., 2020; Scott et al., 
2018). For both our lifetime heaviest frequency and age of onset within-pair effects on 
decision-making (in males) and general estimated intelligence scores, evidence did not 
suggest that results were impacted by differences in the recency of last cannabis use. Nor 
did we find evidence that differences in length of time since last cannabis use was 
associated with improvements in neurocognitive performance. Some of the 
inconsistencies in prior literature may, at least in part, be due to methodological 
differences. For instance, a recent 14-year longitudinal study did not find evidence that 
recency of last cannabis use predicted neuropsychological performance, nor did it 
mediate the association between block design performance over time and cannabis use 




(2005), current, heavy cannabis users had lower mean IQ scores compared to controls, 
but no differences were found in former cannabis users (at least three months abstinence); 
however, this investigation covered a shorter period (8 years), ended earlier in young 
adulthood, and relied on groups comparisons as opposed to dimensional measures of use, 
all of which may have limited ability to detect significant group differences. Our results 
converge with a recent meta-analysis of imaging studies that found alterations in 
prefrontal regions involved with executive functioning in adolescent cannabis users 
compared to controls, and group differences were also noted between an abstinent group 
of cannabis users (~25 days) and nonusers (Blest-Hopley et al., 2019). Taken together, 
these suggest that possible adverse consequences related to cannabis use may not resolve 
even with prolonged abstinence; however, longitudinal studies are needed that extend 
beyond the developmental period of young adulthood to assess if deficits are enduring 
once neuromaturation stabilizes.  
Meta-analyses of the relationship between nonacute cannabis use and 
neurocognition have repeatedly demonstrated small to, at best, moderate effect sizes 
(Grant et al., 2003; Schreiner & Dunn, 2012; Scott et al., 2018; Lovell et al., 2020). Our 
results are generally in line with these findings. It is worthwhile to consider the clinical 
significance of such effects given their magnitude. Given the complexity of the 
relationships demonstrated (e.g., evidence for causal relationships in addition to pre-
existing liability), it is challenging to say how the unique impact specific to cannabis 
exposure affects functional outcomes, which we did not speak to here. Additionally, 
cannabis use does not occur in a vacuum. Many of the factors that we controlled for as 




variance and co-occur with cannabis use, the combination of which may compound 
adverse effects. Understanding how these effects play out in an individual's day-to-day 
life will be necessary to better grasp the implications of cannabis use during adolescence 
and young adulthood. The landmark Adolescent Brain Cognitive Development study will 
hopefully help address some of these questions with a longitudinal dataset of 10,0000 
children that includes more frequent and intensive interviewing, assessment, and 
neuroimaging (https://abcdstudy.org).  
As noted above, in addition to within-pair effects, we also observed cannabis 
effects in the cotwin control analysis that are likely not due directly to cannabis exposure 
but rather index vulnerability to use cannabis (between-pair effect). This was found for 
both decision-making and estimated intelligence for both males and females. Evidence 
was also demonstrated for a pre-existing liability for visuospatial attention and processing 
speed, though the between-pair effect was weaker and did not reach significance for 
processing speed in females. While decision-making and processing speed have not 
previously been a focus of twin studies in adolescents and young adults, our other 
findings generally cohere with twin studies on visuospatial attention and intelligence 
(Jackson et al., 2016; Meier et al., 2018; Ross et al., 2020; Schaefer et al., 2021). Shared 
familial and environmental risk factors that influence cannabis use also appear to impact 
all of the neurocognitive measures related to cannabis use. Thus, neurocognitive deficits 
would likely be observed before cannabis exposure and may subsequently contribute to 
risky actions, such as cannabis use. Indeed, studies have found that deficits in 
neurocognitive performance predict later increases in cannabis use in adolescents (Morin 




2008), individuals with these predispositions are at risk for other adverse outcomes, such 
as cannabis use disorders or dependence (Butterworth et al., 2014). Meier et al. (2018) 
found that lower IQ scores in childhood predicted later cannabis dependence at age 18. In 
conjunction with previous research, this study demonstrates the complexity of the 
relationship between nonacute cannabis use and cognition, particularly in adolescence to 
young adulthood when maturational processes are ongoing, which likely contributes to 
the inconsistencies found in the overall extant literature. But this also highlights the 
importance of continued focus on the implications of cannabis exposure on the adolescent 
and young adult brain.   
While the relationship between verbal working memory and lifetime heaviest 
frequency did not survive statistical adjustment, it does highlight the possibility that 
unique relationships could be demonstrated within cannabis users that are potentially 
masked by nonusers or those who use very minimally. Indeed, there is some evidence to 
suggest that individuals who use only minimally may demonstrate an unexpected 
relationship between cannabis and cognition, such that they perform better than 
individuals with no exposure to cannabis (Wendel et al., 2021). It may be worthwhile to 
explore this avenue further as the relationship between cannabis use and cognition 
appears to be nuanced.  
Strengths 
A primary strength of the present investigation is the twin sample, which 
increases our ability to draw inferences regarding the etiology of cannabis-related 
cognitive deficits beyond what is possible in cross-sectional studies or studies with 




population-based sample of males and females that more recently transitioned to young 
adulthood. Follow-up assessments covered both critical maturational periods of brain 
development and captured a spectrum of cannabis use behaviors ranging from normative 
to more severe use behaviors, which is essential for generalizing findings to broader 
populations. Their transition to young adulthood also coincided with increases in 
cannabis potency in the medicinal and recreational market (Chandra et al., 2019), making 
the current findings more relevant to users who now use products with higher THC 
content. Additionally, by using detailed gold-standard interviewing measures, we were 
able to avoid relying solely upon discrete group comparisons and instead used 
dimensional measures of cannabis, which have been suggested as a better representation 
of substance use (Iacono et al., 2008; Krueger et al., 2002; Infante et al., 2019) and have 
been shown to have greater validity and reliability than discrete measures (Markon et al., 
2011). Participants also completed extensive neuropsychological testing covering a wide 
array of cognitive domains, some of which had yet to be explored using a CTC design. 
The strengths of this study enabled the current research to replicate previous work while 
also extending and filling gaps in the research base.    
Limitations 
While the CTC design allows for greater confidence in interpretations regarding 
the etiology of cognitive deficits, it is not without its limitations. First, the CTC model 
cannot entirely rule out the possibility of confounding and establish that an association 
represents a direct causal effect of cannabis on cognition. We attempted to control for 
several common confounding factors that may differ between twins and that have been 




measured. This leaves open the possibility that there may be other unshared confounders 
that we have not explored, and thus results do not necessarily imply a direct neurotoxic 
effect of cannabis. Another limitation is that measurement error in our exposure variables 
is more likely to attenuate estimates of within-pair effects compared to individual-level 
estimates. This could lead to underestimates of effects and misattribution of findings. 
However, we employed robust interviewing processes with well-validated assessment 
measures across multiple time points, which likely reduced bias related to error that is 
introduced when individuals are required to recall information over long periods 
retrospectively, sometimes over decades.   
Additionally, while large and population-based, our study sample is modeled after 
the population in Minnesota at the time of the intake assessment. Due to this, our sample 
is predominantly white, and minority groups are generally under-represented, which is a 
limiting factor in terms of the generalizability of findings. Lack of attention to cultural 
variation risks potentially incomplete or inaccurate conclusions when applied to a broader 
context of individuals (Apicella & Barrett, 2016). Future work would benefit from 
recruiting more diverse samples with appropriate representation of minority groups to 
improve generalizability.  
A final consideration for the current study is that we could not ascertain fine-
grained details regarding cannabis use behaviors, such as the potency of products used, 
route of consumption, or cannabis metabolite levels. A recent investigation comparing 
methods of characterizing cannabis use (e.g., self-report vs. urinary metabolite 
measurements) found that 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THCCOOH), a 




adolescent and young adults, but self-report measures did not (Wade et al., 2021). It may 
be more informative moving forward to obtain objective measures of cannabis use, such 
as measuring metabolites, to better index cannabis exposure and patterns of use that may 
be influenced by person-specific factors.  
Conclusions 
Results of the current project suggest pre-existing deficits in neurocognitive 
performance may index risk toward both greater lifetime heavier frequencies and earlier 
initiation of cannabis use during adolescence and young adulthood, which may in turn 
adversely impact estimated intelligence scores and, in males specifically, decision-
making performance. These findings have important implications for prevention efforts. 
Prevention campaigns may focus on delaying and reducing cannabis use and targeting 
efforts toward individuals with a predisposition toward cannabis use, particularly those 
who may be at high risk for exposure-related neurocognitive insults (e.g., males). The 
information documented here could be used to inform health policies surrounding 
legalization, given the push at the state level for access both medicinally and 
recreationally to cannabis. Clinical correlation of these findings to functional outcomes 
may also help inform treatment planning. 
General Conclusion 
Adolescence and young adulthood are critical periods for neuromaturation and 
neuronal restructuring and are often periods of peak substance use (Johnston et al., 2021). 
Exposure to substances, such as cannabis, during these time frames, may disrupt brain 
developmental processes and produce harmful and potentially lasting effects that would 




found relationships between nonacute cannabis use and neurocognitive performance in 
adolescents and young adults across cognitive domains (Scott et al., 2018); however, the 
exact nature of these relationships remains elusive. Cross-sectional studies tended to rely 
on small sample sizes and were unable to determine the temporal sequencing or causality 
of associations. Meta-analytic and longitudinal studies have attempted to address some of 
these issues, but the extant literature has produced inconsistent findings and has 
highlighted questions regarding the robustness of unique cannabis-related impacts on 
cognition above confounding factors along with other limitations in the literature (Grant 
et al., 2003; Power et al., 2020; Scott et al., 2018). Longitudinal studies with pre-and 
post-cannabis initiation measures of cognitive ability can better speak to temporal 
sequencing of associations. However, they cannot stringently control unmeasured 
confounds, such as shared familial and environmental liability toward cannabis use. As 
such, longitudinal studies could not fully disentangle possible causal influences of 
cannabis exposure from the effects of pre-existing liability factors on cognitive 
performance. Twin studies are well suited to address questions of causality; however, 
twin studies on nonacute cannabis use and cognition in adolescents and young adults are 
still rare and tend to focus on a narrow set of cognitive domains.  
To address limitations and gaps in the literature, this dissertation was designed to 
assess the nature of associations found between nonacute cannabis use and 
neurocognitive performance and understand the implications of cannabis exposure on the 
developing brain. To do this, we used a large longitudinal sample of male and female 
twins followed at multiple time points across adolescence and into young adulthood with 




using this type of design conferred several strengths to the current project, including 1) 
use of several dimensional measures characterizing cannabis use across adolescence and 
young adulthood from multiple time points, 2) assessment of pre-cannabis exposure 
general cognitive ability, 3) roughly equal number of males and females allowed for the 
exploration of sex-specific effects, and 4) extensive interviewing allowed us to control 
for several relevant confounding factors and neurocognitive assessments covered a wide 
variety of cognitive domains.  
Across the two studies, consistent with previous literature, nonacute cannabis use 
was associated with deficits in neurocognitive functioning. Evidence suggested that many 
of these relationships were not robust or unique to nonacute cannabis use, independent of 
confounding variables. Study 1 also highlighted that many of the inconsistencies seen in 
the literature might be due to methodological differences, such as suboptimal control of 
confounding variables or differences in neurocognitive task selection. However, beyond 
other factors, heavier and early cannabis use was related to persistent deficits in decision-
making, processing speed, visuospatial attention, and general cognitive abilities. We also 
found evidence for sex-specific effects, such that males performed more poorly than 
females on decision-making and processing speed tasks with cannabis use. Converging 
on conclusions from Study 1 to explore the etiology of the most robust relationships, 
Study 2 found evidence that deficits in neurocognitive performance both indexed pre-
existing familial or environmental liability toward cannabis use but may in turn also be 
adversely impacted by heavy and early cannabis use, specifically for estimated IQ and, in 
males, decision-making performance. Taken together, these findings have significant 




given an uptick in the acceptance of use and desire to explore the potential medicinal 
effects of cannabis. It will be necessary for findings such as these to be considered when 
informing specific policy guidelines.  
The overall study focus of these projects should be considered when interpreting 
findings and considered in the context of relevant factors. For instance, the purpose of 
this dissertation was to examine associations unique to cannabis use above and beyond 
other potential confounding factors, such as other substance use. However, it is important 
to note that psychoactive substances are associated with some level of risk, and cannabis 
use does not occur in a vacuum. It would seem plausible that even when nonacute 
cannabis use is not a unique predictor of a cognitive outcome, that use may contribute to 
or compound deleterious outcomes. This project does not address factors such as co-
occurring substance use beyond statistically controlling for differences in common 
substance use (alcohol/nicotine). Co-occurrence of cannabis with other substances, such 
as alcohol or nicotine, is common (Richter, 2019), and co-occurrence of these substances 
may have an additive effect on adverse outcomes. For instance, the use of alcohol, 
nicotine, or cannabis substantially increases the risk of becoming dependent on one of the 
other substances and can interfere with attempts to quit or reduce the use of the other 
substance (Kristman-Valente et al., 2017; Rabin & George, 2015). It will be necessary for 
future research to consider the potential interaction effects of co-occurring substance use 
on cognitive outcomes moving forward. Another important direction for future research 
will be the consideration of the measurement of cannabis. One of the biggest challenges 
when comparing across studies is that cannabis metrics are often defined differently, such 




on frequency or quantity of use units of measurement may vary. Additionally, the 
potency of THC ratio to other cannabinoids, such as cannabidiol (CBD), can significantly 
impact the pharmacokinetic implications of a particular cannabis plant (Hložek et al., 
2017), and may also lead to differences in outcomes. Understanding how these factors 
interact to either reduce or exacerbate adverse outcomes associated with cannabis use will 
be essential. 
The results of this dissertation provide important and novel contributions to the 
field regarding the nature of the association between nonacute cannabis use and cognitive 
functioning during periods of key neuromaturation. Findings collectively suggest a 
complex relationship such that deficits in neurocognition represent a combination of pre-
existing shared familial and environmental risk, unshared confounding contributions, and 
causal exposure-related effects of cannabis. These results could guide decisions regarding 
cannabis legalization policies and intervention efforts aimed at reducing and delaying 



















































Table 2. Descriptive performance statistics for neurocognitive measures. 
 Male (N = 362) Female (N = 439) Total (N = 801) 
Cognitive Measure Mean (SD) Range Mean (SD) Range Mean (SD) Range 
Age-11 Cognitive Measure       
Pre-exposure IQa 105.77 (12.96) 64.00 – 146.00 102.69 (12.45) 69.00 – 150.00 104.09 (12.77) 64.00 – 150.00 
Age-24 Cognitive Measures       
Vb. Learning/Memory       
Total Learningb 44.81 (9.10) 15.00 – 71.00 48.93 (8.52) 27.00 – 69.00 47.12 (9.01) 15.00 – 71.00 
Short-delay Recallb -1.72 (1.75) -9.00 – 2.00 -1.67 (1.86) -9.00 – 6.00 -1.69 (1.81) -9.00 – 6.00 
Long-delay Recallb -2.26 (1.95) -8.00 – 2.00 -1.91 (1.73) -7.00 – 4.00 -2.06 (1.83) -8.00 – 4.00 
Processing Speed       
PSIa 103.75 (13.20) 76.00 – 145.00 109.09 (12.78) 71.00 – 143.00 106.74 (13.23) 71.00 – 145.00 
Digit Sym-Codc 9.84 (2.52) 4.00 – 17.00 11.33 (2.57) 4.00 – 18.00 10.67 (2.65) 4.00 – 18.00 
Symbol Searchc 11.61 (2.65) 6.00 – 19.00 12.00 (2.60) 5.00 – 19.00 11.83 (2.62) 5.00 – 19.00 
Vb. Attention/WM       
RAVLT Trial 1b 5.67 (1.69) 0.00 – 13.00 6.25 (1.66) 2.00 – 11.00 6.00 (1.70) 0.00 – 13.00 
Longest DSFb 6.93 (1.18) 4.00 – 9.00 6.76 (1.22) 4.00 – 9.00 6.83 (1.12) 4.00 – 9.00 
Longest DSBb 4.91 (1.26) 2.00 – 8.00 4.93 (1.23) 2.00 – 8.00 4.92 (1.24) 2.00 – 8.00 
Vis. Attention/WM       
Longest SSFb 6.48 (1.20) 2.00 – 9.00 6.42 (1.01) 3.00 – 9.00 6.45 (1.10) 2.00 – 9.00 
Longest SSBb 6.33 (1.21) 2.00 – 9.00 6.27 (1.26) 2.00 – 9.00 6.30 (1.24) 2.00 – 9.00 
Decision-Making       
DM Overallb 6.18 (35.22) -80.00 – 100.00 2.30 (33.70) -96.00 – 100.00 4.00 (34.40) -96.00 – 100.00 
DM Ambiguityd 6.09 (1.12) 3.00 – 9.00 5.95 (0.92) 2.24 – 9.00 6.00 (1.02) 2.24 – 9.00 
DM Riskb 8.80 (27.26) -50.00 – 60.00 7.42 (26.98) -60.00 – 60.00 8.02 (27.09) -60.00 – 60.00 
Cognitive Inhibition       
D-primeb 3.41 (0.90) 0.24 – 5.57 3.63 (0.80) 0.54 – 5.57 3.53 (0.85) 0.24 – 5.57 
No-go Error Rated,e 3.63 (1.61) 0.00 – 8.66 3.28 (1.36) 0.00 – 8.55 3.43 (1.49) 0.00 – 8.66 














Prorated FSIQa 109.04 (15.73) 76.00 – 151.00 104.66 (16.75)  70.00 – 151.00 106.59 (16.44) 70.00 – 151.00 
Block Designc 12.91 (2.71) 6.00 – 19.00 12.14 (2.77) 5.00 – 19.00 12.48 (2.77) 5.00 – 19.00 
Vocabularyc 9.72 (2.13) 5.00 – 19.00 12.14 (2.77) 5.00 – 19.00 12.48 (2.77) 5.00 – 19.00 
Abbreviations:  IQ, intelligence quotient; Vb., verbal; PSI, processing speed index, Digit Symb-Cod, digit symbol-coding; WM, working memory; RAVLT, 
Rey Auditory Verbal Learning Test; DSF, digit span forward; DSB, digit span backwards; Vis., visuospatial; SSF, spatial span forward; SSB, spatial span 
backwards; DM, decision-making; FSIQ, full scale intelligence quotient. 
aStandard score: mean of 100, standard deviation of 15  
bRaw score 
cScaled score: mean of 10, standard deviation of 3 
dSquare-root transformed 







Table 3. Neurocognitive battery. 
Domain Measure Variables References 
Verbal learning & 
memory 
Rey Auditory Learning Test (RAVLT): learn a list of 15 
words across 5 trials and recall list after short- and long-
delay recall 
Total learning: total # of words repeated back 
across 5 learning trials 
 
Short-delay recall: # of words recalled after short 
delay minus # of words learned on last learning 
trial 
 
Long-delay recall: # of words recalled after 30-
minute delay minus # of words learned on last 
learning trial 
Schmidt, 1996 
   
   
    
Processing speed Digit Symbol-Coding: match symbols to numbers using 
reference key as quickly as possible 
Derived scaled score following standard 
administration and scoring procedures; reflects # 
of correctly paired symbols completed in 120 sec  
Wechsler, 1999 
 Symbol Search: visually scan row of symbols, mark 
matching symbol to target symbol or “no” box if no 
match is found 
Derived scaled score following standard 
administration and scoring procedures; reflects # 
of accurately marked symbols/”no” boxes less 
any errors completed in 120 secs 
 
 Processing Speed Index (PSI) Derived standard score following standard 
scoring procedures based on digit symbol-coding 
and symbol search scores 
 
   Wechsler, 1999 
Verbal attention & 
working memory 
Digit Span: repeat back a string of digits either in the 
forward or backwards order 
Longest digit span forward: max # of digits 
correctly repeated in the original presentation 
order 
 
Longest digit span backward: max # of digits 
correctly repeated in the backwards order 
 
 
   
   
 RAVLT Trial 1: learn a list of 15 words  Total # of accurately repeated words after initial 
presentation of word list 
Schmidt, 1996 







Spatial Span: click on irregularly spaced blocks in the 
same or backwards order that they initially lit up on the 
screen 
Longest spatial span forward: max # correctly 
identified squares in the original presentation 
order 
 
Longest spatial span backward: max # correctly 
identified squares selected in the backwards order 
Wechsler, 1997; E-Prime 
version 2.0, Schneider et 
al., 2002 
   
   
    
Decision-making Iowa Gambling Task (IGT): select cards from 4 decks of 
cards to maximize winnings using feedback about 
winning/losing money 
Overall decision-making: # of advantageous deck 
selections minus # of disadvantageous deck 
selections across all 5 blocks (100 trials) 
Decision-making under ambiguity: # of 
advantageous deck selections minus # of 
disadvantageous deck selections across the first 2 
blocks (40 trials) 
 
Decision-making under risk: # of advantageous 
deck selections minus # of disadvantageous deck 
selections across the last 3 blocks (60 trials) 
Bechara et al., 1994; Almy 
et al., 2019; E-Prime 
version 2.0, Schneider et 
al., 2002 
   
   
    
Cognitive 
inhibition 
Go/No-Go Task: press button when the stimulus 
presented (e.g., letters) followed a different stimulus 
(“go” trial) and withhold response when stimulus was 
preceded by an identical stimulus (“no-go” trials) 
D-prime: z-transformed hit rate minus the z-
transformed false-alarm rate 
 
No-go error rate: frequency of responding to no-
go trials 
Garavan et al., 2005; 
Wickens, 2002 
   
    
General cognitive 
ability 
Block Design: duplicate a presented patten using 2, 4, or 
9 identical red/white blocks 
Derived scaled score reflects # correct based on 
standard administration and scoring procedures 
Wechsler, 1981 
 Vocabulary: define a word that is presented both orally 
and visually 
Derived scaled score reflects # correct based on 
standard administration and scoring procedures 
 
 Prorated Full Scale IQ (FSIQ)  Derived standard score following standard 
prorating scoring procedures based on block 
design and vocabulary scores 
 










Table 4. Zero order correlations between cannabis variables and covariates. 
  1 2 3 4 5 6 7 8 9 10 11 12 13 14 
1. Cannabis index 1 
             
2. Lifetime heaviest frequency 0.85** 1 
            
3. Age of initiation -0.53** -0.42** 1 
           
4. Sexa -0.17** -0.20** 0.11* 1 
          
5. Age 0.02 0.00 0.07 0.08* 1 
         
6. Zygosity -0.05 -0.03 0.12** 0.02 0.03 1 
        
7. Pre-exposure IQ 0.04 0.04 0.23** -0.12** 0.05 0.00 1 
       
8. Socioeconomic status -0.01 0.04 0.18** -0.08* -0.03 -0.03 0.28** 1 
      
9. Age-24 Alcohol index 0.46** 0.54** -0.22** -0.30** -0.01 0.01 0.08* 0.01 1 
     
10. Age-24 Nicotine index 0.49** 0.52** -0.36** -0.36** -0.01 -0.04 -0.03 -0.06 0.52** 1 
    
11. Education -0.30** -0.25** 0.37** 0.15** 0.09* 0.00 0.27** 0.39** -0.13** -0.31** 1 
   
12. Recent cannabis useb 0.49** 0.46** -0.18** -0.10**c 0.04 -0.02 0.03 -0.01 0.22** 0.25** -0.17** 1 
  
13. Length of abstinence -0.51** -0.57** 0.16** 0.15** 0.06 -0.02 0.00 -0.06 -0.20** -0.22** 0.14** -0.44** 1 
 
14. Age-24 Cannabis index 0.87** 0.92** -0.29** -0.22** -0.01 -0.02 0.09* 0.07* 0.50** 0.47** -0.23** 0.58** -0.69** 1 
Notes. Correlations between our primary cannabis use variables and covariate variables.  
*significant at the 0.05 level; **significant at the 0.01 level 







Table 5. Linear mixed models of the association between cannabis use and cognitive outcomes. 
 Cannabis index Lifetime heaviest frequency Age of initiation 













Vb. Learning/Memory             
Total Learning 690 -0.50 (0.37) -1.34 0.18 690 -0.11 (0.20) -0.53 0.60 459 0.26 (0.16) 1.62 0.11 
Short-delay Recall 690 0.03 (0.07) 0.39 0.69 690 0.00 (0.04) 0.12 0.91 459 0.00 (0.03) 0.06 0.95 
Long-delay Recall 689 0.02 (0.08) 0.21 0.84 689 0.01 (0.04) 0.24 0.81 459 0.02 (0.03) 0.66 0.51 
Processing Speed             
PSI 688 -1.05 (0.55) -1.91 0.06 688 -0.24 (0.29) -0.81 0.42 458 0.95 (0.22) 4.30 <0.01 
Digit Sym-Cod 688 -0.28 (0.11) -2.56 0.01 688 -0.09 (0.06) -1.48 0.14 458 0.18 (0.04) 4.09 <0.01 
Symbol Search 688 -0.11 (0.11) -0.96 0.34 688 0.00 (0.06) -0.05 0.96 458 0.17 (0.04) 3.74 <0.01 
Vb. Attention/WM             
RAVLT Trial 1 690 -0.18 (0.07) -2.57 0.01 690 -0.09 (0.04) -2.31 0.02 459 0.06 (0.03) 2.08 0.04 
Longest DSF 689 0.11 (0.05) 2.18 0.03 689 0.06 (0.03) 2.32 0.02 458 0.02 (0.02) 0.84 0.40 
Longest DSB 683 0.05 (0.05) 0.95 0.34 683 0.02 (0.03) 0.85 0.39 454 0.01 (0.02) 0.63 0.53 
Vis. Attention/WM             
Longest SSF 667 -0.09 (0.05) -1.97 0.05 667 -0.03 (0.03) -1.26 0.21 442 0.07 (0.02) 3.59 <0.01 
Longest SSB 666 -0.13 (0.05) -2.43 0.02 666 -0.07 (0.03) -2.29 0.02 441 0.05 (0.02) 2.28 0.02 
Decision-Making             
DM Overall 672 -3.16 (1.47) -2.15 0.03 672 -2.60 (0.80) -3.27 <0.01 445 1.58 (0.61) 2.58 0.01 
DM Ambiguitya 672 -0.07 (0.04) -1.61 0.11 672 -0.05 (0.02) -2.23 0.03 445 0.05 (0.02) 2.37 0.02 
DM Risk 672 -2.40 (1.16) -2.07 0.04 672 -2.05 (0.63) -3.25 <0.01 445 1.07 (0.48) 2.23 0.03 
Cognitive Inhibition             
D-prime 679 -0.06 (0.04) -1.74 0.08 679 -0.03 (0.02) -1.54 0.12 453 0.05 (0.02) 3.07 <0.01 
No-go Error Ratea,b 679 0.04 (0.06) 0.60 0.55 679 0.02 (0.03) 0.58 0.57 453 -0.08 (0.03) -3.16 <0.01 
General Cognitive 
Ability 
            
Prorated FSIQ 685 -1.29 (0.68) -1.91 0.06 685 -0.09 (0.35) -0.25 0.80 454 1.45 (0.27) 5.48 <0.01 
Block Design 686 -0.23 (0.12) -1.95 0.05 686 -0.05 (0.06) -0.87 0.39 455 0.22 (0.05) 4.71 <0.01 
Vocabulary 794 -0.13 (0.09) -1.42 0.16 794 0.00 (0.05) -0.01 0.99 510 0.17 (0.04) 4.67 <0.01 




























Abbreviations: Vb., verbal; PSI, processing speed index, Digit Symb-Cod, digit symbol-coding; WM, working memory; RAVLT, Rey Auditory Verbal 
Learning Test; SS, scaled score; DSF, digit span forward; DSB, digit span backwards; Vis., visuospatial; SSF, spatial span forward; SSB, spatial span 
backwards; DM, decision-making; FSIQ, full scale intelligence quotient 
aValues were square-root transformed prior to analyses 










Table 6. Zero order correlations between primary covariates and cognitive outcomes. 
 1 2 3 4 5 6 7 8 9 10 
1.Pre-exposure IQ 1 
         
2.SES 0.28** 1 
        
3.Age-24 Alcohol index 0.08* 0.01 1 
       
4.Age-24 Nicotine index -0.03 -0.06 0.52** 1 
      
5.Education 0.27** 0.39** -0.13** -0.31** 1 
     
6.Recent usea 0.03 -0.01 0.22** 0.25** -0.17** 1 
    
7. Total learning 0.27** 0.16** -0.07 -0.16** 0.27** -0.09* 1 
   
8.Short-delay recall 0.10** 0.03 -0.05 -0.04 0.04 -0.05 0.12** 1 
  
9.Long-delay recall 0.06 -0.01 -0.08* -0.10** 0.04 0.00 0.19** 0.70** 1 
 
10.Processing speed index 0.28** 0.13** -0.03 -0.22** 0.27** -0.09* 0.34** 0.11** 0.10* 1 
11.Digit symbol-coding 0.20** 0.15** -0.08* -0.27** 0.32** -0.09* 0.32** 0.09* 0.07 0.88** 
12.Symbol Search 0.29** 0.09* 0.03 -0.12** 0.16** -0.07 0.27** 0.10* 0.09* 0.88** 
13.RAVLT Trial 1 0.27** 0.16** -0.06 -0.14** 0.27** -0.09* 0.72** 0.09* 0.17** 0.26** 
14.Longest DS forward 0.19** 0.22** 0.14** 0.07 0.14** 0.03 0.15** -0.04 -0.12** 0.15** 
15.Longest DS backward 0.23** 0.18** 0.03 -0.04 0.13** 0.03 0.29** 0.05 0.05 0.21** 
16.Longest SS forward 0.19** 0.12** 0.04 -0.04 0.17** -0.05 0.23** 0.09* 0.06 0.31** 
17.Longest SS backward 0.19** 0.11** 0.01 -0.07 0.22** -0.09* 0.26** 0.03 0.03 0.30** 
18.DM overall 0.20** 0.17** -0.02 -0.06 0.18** -0.09* 0.18** 0.05 0.03 0.07 
19.DM risk 0.23** 0.18** -0.06 -0.10** 0.21** -0.07 0.22** 0.07 0.06 0.08* 
20.DM ambiguityb 0.04 0.07 0.05 0.04 0.04 -0.10* 0.01 -0.02 -0.05 0.02 
21.D_prime 0.12** 0.13** -0.04 -0.20** 0.26** -0.04 0.24** 0.05 0.07 0.43** 
22.No-go error rateb,c -0.16** -0.15** 0.03 0.16** -0.25** 0.00 -0.22** -0.06 -0.05 -0.41** 
23.Prorated FSIQ 0.68** 0.35** -0.02 -0.08* 0.34** -0.00 0.34** 0.13** 0.10** 0.36** 
24.Block design 0.53** 0.19** 0.01 -0.05 0.18** -0.01 0.20** 0.11** 0.08* 0.40** 
25.Vocabulary 0.60** 0.37** -0.04 -0.11** 0.40** -0.02 0.37** 0.11** 0.09* 0.21** 
Notes. Correlations between our primary covariates and cognitive outcomes. Correlation Table continued on next page.  
*significant at the 0.05 level; **significant at the 0.01 level 
aRecent cannabis use (past 24-hours) = Yes (1), No (0); b Square-root transformed;  cHigher scores = more errors 
Abbreviations: IQ, intelligence quotient; SES, socioeconomic status; RAVLT, Rey Auditory Learning Task; DS, digit span; SS, spatial span; DM, decision-








Table 6. Zero order correlations between primary covariates and cognitive outcomes (continued) 




              
12.Symbol Search 0.54** 1 
             
13.RAVLT Trial 1 0.26** 0.19** 1 
            
14.Longest DS 
forward 
0.13** 0.14** 0.16** 1 
           
15.Longest DS 
backward 
0.21** 0.16** 0.26** 0.38** 1 
          
16.Longest SS 
forward 
0.26** 0.28** 0.17** 0.10** 0.18** 1 
         
17.Longest SS 
backward 
0.27** 0.26** 0.17** 0.12** 0.20** 0.26** 1 
        
18.DM overall 0.04 0.09* 0.13** 0.10* 0.17** 0.10* 0.04 1 
       
19.DM risk 0.06 0.08* 0.15** 0.12** 0.19** 0.11** 0.08* 0.95** 1 
      
20.DM ambiguityb -0.02 0.05 0.02 0.02 0.04 0.04 -0.05 0.71** 0.45** 1 
     
21.D-prime 0.44** 0.33** 0.16** 0.15** 0.23** 0.18** 0.24** 0.15** 0.17** 0.04 1 
    
22.No-go error rateb,c -0.42** -0.30** -0.15** -0.18** -0.27** -0.17** -0.21** -0.15** -0.18** -0.03 -0.88** 1 
   
23.Prorated FSIQ 0.28** 0.36** 0.29** 0.21** 0.32** 0.25** 0.29** 0.26** 0.29** 0.07 0.21** -0.23** 1 
  
24.Block design 0.30** 0.40** 0.16** 0.12** 0.24** 0.29** 0.33** 0.16** 0.18** 0.04 0.16** -0.15** 0.81** 1 
 
25.Vocabulary 0.17** 0.20** 0.33** 0.23** 0.29** 0.15** 0.16** 0.26** 0.29** 0.09* 0.19** -0.22** 0.81** 0.34** 1 
Notes. Correlations between our primary covariates and cognitive outcomes  
*significant at the 0.05 level; **significant at the 0.01 level 
aRecent cannabis use (past 24-hours) = Yes (1), No (0); b Square-root transformed;  cHigher scores = more errors 
Abbreviations: IQ, intelligence quotient; SES, socioeconomic status; RAVLT, Rey Auditory Learning Task; DS, digit span; SS, spatial span; DM, decision-











Table 7. Associations between cannabis use and cognitive outcomes adjusted for covariates. 
 Cannabis index Lifetime heaviest frequency Age of initiation 
  Estimates (SE) t p  Estimates (SE) t p  Estimates (SE) t p 
Section A Step    Step    Step    
RAVLT Total 
Learning 1 -0.49 (0.35) -1.37 0.17 1 -0.16 (0.19) -0.82 0.42 1 0.05 (0.16) 0.30 0.77 
 2 -0.43 (0.41) -1.06 0.29 2 -0.10 (0.23) -0.42 0.67 2 0.05 (0.16) 0.33 0.74 
 3 0.02 (0.42) 0.04 0.97 3 0.13 (0.24) 0.56 0.58 3 -0.06 (0.17) -0.36 0.72 
 4 0.30 (0.46) 0.65 0.52 4 0.28 (0.25) 1.10 0.27 4 -0.08 (0.17) -0.50 0.62 
RAVLT Short-Delay 
Recall 1 0.03 (0.07) 0.43 0.67 1 0.00 (0.04) 0.04 0.97 1 -0.01 (0.03) -0.29 0.77 
 2 0.12 (0.09) 1.37 0.17 2 0.06 (0.05) 1.10 0.27 2 -0.03 (0.03) -0.94 0.35 
 3 0.15 (0.09) 1.59 0.11 3 0.06 (0.05) 1.18 0.24 3 -0.04 (0.04) -1.13 0.26 
 4 0.24 (0.10) 2.36 0.02 4 0.10 (0.06) 1.80 0.07 4 -0.05 (0.04) -1.30 0.20 
RAVLT Long-Delay 
Recall 1 0.02 (0.08) 0.23 0.82 1 0.01 (0.04) 0.20 0.84 1 0.01 (0.03) 0.34 0.74 
 2 0.14 (0.09) 1.54 0.13 2 0.09 (0.05) 1.71 0.09 2 -0.01 (0.04) -0.42 0.67 
 3 0.17 (0.09) 1.87 0.06 3 0.10 (0.05) 1.88 0.06 3 0.03 (0.04) -0.79 0.43 
 4 0.18 (0.10) 1.82 0.07 4 0.10 (0.06) 1.81 0.07 4 -0.03 (0.04) -0.77 0.44 
Section B Step    Step    Step    
Processing Speed 
Index 1 -1.15 (0.52) -2.21 0.03 1 -0.37 (0.28) -1.33 0.18 1 0.64 (0.22) 2.94 <0.01 
 2 -1.11 (0.59) -1.90 0.06 2 -0.35 (0.33) -1.07 0.28 2 0.55 (0.23) 2.43 0.02 
 3 -0.49 (0.61) -0.81 0.42 3 -0.06 (0.34) -0.19 0.85 3 0.42 (0.23) 1.79 0.07 
 4 -0.11 (0.65) -0.17 0.87 4 0.14 (0.35) 0.38 0.70 4 0.39 (0.23) 1.66 0.10 
Digit Symbol-Coding 1 -0.29 (0.10) -2.76 0.01 1 -0.11 (0.06) -2.01 0.05 1 0.12 (0.04) 2.81 0.01 
 2 -0.24 (0.12) -2.03 0.04 2 -0.09 (0.07) -1.27 0.20 2 0.09 (0.04) 2.05 0.04 
 3 -0.10 (0.12) -0.80 0.42 3 -0.02 (0.07) -0.32 0.75 3 0.06 (0.05) 1.37 0.17 




Symbol Search 1 -0.13 (0.11) -1.21 0.23 1 -0.02 (0.06) -0.40 0.69 1 0.11 (0.04) 2.46 0.01 
 2 -0.16 (0.12) -1.31 0.19 2 -0.04 (0.07) -0.57 0.57 2 0.11 (0.05) 2.24 0.03 
 3 -0.10 (0.13) -0.75 0.45 3 0.00 (0.07) -0.07 0.95 3 0.09 (0.05) 1.88 0.06 
 4 -0.04 (0.14) -0.28 0.78 4 0.03 (0.07) 0.38 0.70 4 0.09 (0.05) 1.77 0.08 
Section C Step    Step    Step    
RAVLT Trial 1 1 -0.18 (0.07) -2.70 0.01 1 -0.09 (0.04) -2.59 0.01 1 0.02 (0.03) 0.61 0.54 
 2 -0.18 (0.08) -2.29 0.02 2 -0.10 (0.04) -2.21 0.03 2 0.01 (0.03) 0.35 0.73 
 3 -0.09 (0.08) -1.18 0.24 3 -0.06 (0.05) -1.29 0.20 3 -0.01 (0.03) -0.32 0.75 
 4 -0.05 (0.09) -0.59 0.56 4 -0.04 (0.05) -0.78 0.44 4 -0.02 (0.03) -0.48 0.63 
Longest DS Forward 1 0.11 (0.05) 2.16 0.03 1 0.06 (0.03) 2.11 0.04 1 -0.01 (0.02) -0.33 0.74 
 2 0.06 (0.06) 1.07 0.29 2 0.03 (0.03) 0.80 0.43 2 0.00 (0.02) -0.05 0.96 
 3 0.10 (0.06) 1.70 0.09 3 0.04 (0.03) 1.34 0.18 3 -0.01 (0.02) -0.37 0.71 
 4 0.10 (0.06) 1.49 0.14 4 0.04 (0.04) 1.13 0.26 4 -0.01 (0.02) -0.33 0.74 
Longest DS 
Backward 1 0.05 (0.05) 0.97 0.33 1 0.02 (0.03) 0.55 0.58 1 -0.02 (0.02) -0.84 0.40 
 2 0.07 (0.06) 1.13 0.26 2 0.02 (0.03) 0.64 0.53 2 -0.01 (0.02) -0.62 0.54 
 3 0.09 (0.06) 1.46 0.14 3 0.03 (0.04) 0.86 0.39 3 -0.02 (0.02) -1.00 0.32 
 4 0.08 (0.07) 1.13 0.26 4 0.02 (0.04) 0.52 0.61 4 -0.02 (0.02) -0.94 0.35 
Section D Step    Step    Step    
Longest SS Forward 1 -0.09 (0.05) -2.06 0.04 1 -0.04 (0.02) -1.52 0.13 1 0.05 (0.02) 2.52 0.01 
 2 -0.12 (0.05) -2.35 0.02 2 -0.06 (0.03) -1.89 0.06 2 0.06 (0.02) 2.78 0.01 
 3 -0.09 (0.06) -1.62 0.11 3 -0.04 (0.03) -1.30 0.20 3 0.05 (0.02) 2.31 0.02 
 4 -0.07 (0.06) -1.20 0.23 4 -0.03 (0.03) -0.89 0.37 4 0.05 (0.02) 2.19 0.03 
Longest SS 
Backward 1 -0.13 (0.05) -2.48 0.01 1 -0.07 (0.03) -2.57 0.01 1 0.02 (0.02) 0.94 0.35 
 2 -0.14 (0.06) -2.28 0.02 2 -0.09 (0.03) -2.50 0.01 2 0.02 (0.02) 0.67 0.51 
 3 -0.08 (0.06) -1.31 0.19 3 -0.06 (0.04) -1.72 0.09 3 0.00 (0.03) -0.05 0.96 
 4 -0.04 (0.07) -0.58 0.56 4 -0.04 (0.04) -1.11 0.27 4 -0.01 (0.03) -0.21 0.83 
Section E Step    Step    Step    
DM Overall 1 -3.15 (1.43) -2.20 0.03 1 -2.75 (0.78) -3.54 <0.01 1 0.91 (0.63) 1.46 0.15 
 2 -2.77 (1.66) -1.67 0.10 2 -3.14 (0.96) -3.29 <0.01 2 0.83 (0.66) 1.25 0.21 
 3 -2.12 (1.74) -1.22 0.22 3 -2.83 (0.98) -2.87 <0.01 3 0.59 (0.69) 0.85 0.40 
 4 -1.21 (1.90) -0.63 0.53 4 -2.60 (1.05) -2.47 0.01 4 0.50 (0.69) 0.73 0.47 
DM Ambiguity 1 -0.07 (0.04) -1.60 0.11 1 -0.05 (0.02) -2.30 0.02 1 0.04 (0.02) 2.07 0.04 
 2 -0.11 (0.05) -2.28 0.02 2 -0.10 (0.03) -3.34 <0.01 2 0.05 (0.02) 2.48 0.01 




 4 -0.07 (0.06) -1.23 0.22 4 -0.08 (0.03) -2.39 0.02 4 0.04 (0.02) 1.96 0.05 
DM Risk 1 -2.39 (1.12) -2.13 0.03 1 -2.16 (0.61) -3.56 <0.01 1 0.46 (0.49) 0.94 0.35 
 2 -1.42 (1.30) -1.09 0.28 2 -2.02 (0.75) -2.70 0.01 2 0.23 (0.51) 0.46 0.65 
 3 -0.75 (1.36) -0.55 0.58 3 -1.73 (0.77) -2.24 0.03 3 -0.01 (0.53) -0.02 0.98 
 4 -0.31 (1.49) -0.21 0.84 4 -1.69 (0.82) -2.05 0.04 4 -0.05 (0.54) -0.10 0.92 
Section F Step    Step    Step    
D-prime 1 -0.07 (0.04) -1.88 0.06 1 -0.03 (0.02) -1.75 0.08 1 0.04 (0.02) 2.23 0.03 
 2 -0.04 (0.04) -1.00 0.32 2 -0.02 (0.02) -0.94 0.35 2 0.02 (0.02) 1.45 0.15 
 3 -0.01 (0.04) -0.19 0.85 3 -0.01 (0.02) -0.25 0.80 3 0.02 (0.02) 1.10 0.27 
 4 -0.02 (0.05) -0.38 0.71 4 -0.01 (0.03) -0.41 0.68 4 0.02 (0.02) 1.31 0.26 
No-go Error Ratea,b 1 0.04 (0.06) 0.71 0.48 1 0.02 (0.03) 0.73 0.46 1 -0.06 (0.03) -2.33 0.02 
 2 0.01 (0.07) 0.19 0.85 2 0.01 (0.04) 0.29 0.78 2 -0.05 (0.03) -1.78 0.08 
 3 -0.05 (0.07) -0.66 0.51 3 -0.02 (0.04) -0.40 0.69 3 -0.04 (0.03) -1.47 0.14 
 4 -0.03 (0.08) -0.38 0.70 4 -0.01 (0.04) -0.14 0.89 4 -0.05 (0.03) -1.53 0.13 
Section G Step    Step    Step    
Prorated FSIQ 1 -1.60 (0.50) -3.21 <0.01 1 -0.45 (0.27) -1.64 0.10 1 0.70 (0.21) 3.29 <0.01 
 2 -1.33 (0.58) -2.30 0.02 2 -0.11 (0.33) -0.34 0.73 2 0.64 (0.23) 2.83 <0.01 
 3 -0.65 (0.59) -1.10 0.27 3 0.23 (0.33) 0.68 0.50 3 0.46 (0.23) 2.00 0.05 
 4 -0.83 (0.64) -1.30 0.19 4 0.22 (0.36) 0.62 0.54 4 0.47 (0.23) 2.03 0.04 
Block Design 1 -0.27 (0.10) -2.73 0.01 1 -0.08 (0.05) -1.53 0.13 1 0.11 (0.04) 2.65 0.01 
 2 -0.27 (0.12) -2.31 0.02 2 -0.6 (0.07) -0.89 0.37 2 0.10 (0.04) 2.33 0.02 
 3 -0.24 (0.12) -2.03 0.04 3 -0.05 (0.07) -0.68 0.50 3 0.10 (0.05) 2.13 0.03 
 4 -0.26 (0.13) -2.00 0.05 4 -0.04 (0.07) -0.56 0.58 4 0.09 (0.05) 2.10 0.04 
Vocabulary 1 -0.16 (0.07) -2.19 0.03 1 -0.04 (0.04) -1.11 0.27 1 0.08 (0.03) 2.37 0.02 
 2 -0.07 (0.08) -0.91 0.36 2 0.03 (0.05) 0.55 0.58 2 0.06 (0.03) 1.74 0.08 
 3 0.04 (0.08) 0.49 0.62 3 0.08 (0.05) 1.78 0.08 3 0.03 (0.03) 0.80 0.42 
 4 0.02 (0.09) 0.27 0.78 4 0.08 (0.05) 1.67 0.10 4 0.03 (0.03) 0.84 0.40 
Notes.  All linear mixed models include covariates for age, sex, and zygosity and a random intercept at the twin-pair level. Significant effects (alpha = 0.05) 
are bolded. Step 1 = Pre-exposure IQ/SES, Step 2 = alcohol/nicotine age-24 indices, Step 3 = education, Step 4 = recent cannabis use. Each step includes 
covariates from each of the preceding steps.   
Abbreviations: RAVLT, Rey Auditory Verbal Learning Test; DS, digit span; SS, spatial span; DM, decision-making; FSIQ, full scale intelligence quotient 
aValues were square-root transformed prior to analyses 














Table 8. Group comparisons between males and females for cognitive outcomes. 
 
Male (N = 
362) 
Female (N = 
439) Cluster-robust group comparisons 
Cognitive measures Mean (SD) Mean (SD) Estimate (SE) t-statistic p-value 
Vb. Learning/Memory      
Total Learninga 44.81 (9.10) 48.93 (8.52) 3.97 (0.81) 4.92 <0.01 
Short-delay Recalla -1.72 (1.75) -1.67 (1.86) 0.05 (0.15) 0.35 0.72 
Long-delay Recalla -2.26 (1.95) -1.91 (1.73) 0.35 (0.15) 2.28 0.02 
Processing Speed      
PSIb 
103.75 
(13.20) 109.09 (12.78) 5.26 (1,24) 4.24 <0.01 
Digit Sym-Codc 9.84 (2.52) 11.33 (2.57) 1.46 (0.24) 6.19 <0.01 
Symbol Searchc 11.61 (2.65) 12.00 (2.60) 0.39 (0.25) 1.58 0.11 
Vb. Attention/WM      
RAVLT Trial 1a 5.67 (1.69) 6.25 (1.66) 0.55 (0.14) 3.81 <0.01 
Longest DSFa 6.93 (1.18) 6.76 (1.22) -0.19 (0.11) -1.76 0.08 
Longest DSBa 4.91 (1.26) 4.93 (1.23) 0.01 (0.11) 0.11 0.92 
Vis. Attention/WM      
Longest SSFa 6.48 (1.20) 6.42 (1.01) -0.06 (0.09) -0.62 0.53 
Longest SSBa 6.33 (1.21) 6.27 (1.26) -0.07 (0.11) -0.61 0.54 
Decision-Making      
DM Overalla 6.18 (35.22) 2.30 (33.70) -3.94 (2.97) -1.33 0.19 
DM Ambiguitya,d 6.09 (1.12) 5.92 (0.92) -0.18 (0.08) -2.10 0.04 
DM Riska 8.80 (27.26) 7.42 (26.98) -1.41 (2.34) -0.61 0.55 
Cognitive Inhibition      
D-primea 3.41 (0.90) 3.63 (0.80) 0.21 (0.08) 2.68 0.01 
No-go Error Ratea,d,e 3.63 (1.61) 3.28 (1.36) -0.33 (0.14) -2.37 0.02 
General Cognitive Ability      
Prorated FSIQb 
109.04 
(15.73) 104.66 (16.75) -4.42 (1.58) -2.80 0.01 
Block Designc 12.91 (2.71) 12.14 (2.77) -0.77 (0.25) -3.02 <0.01 
Vocabularyc 9.72 (2.13) 9.42 (2.34) -0.33 (0.20) -1.70 0.09 
Notes. Cluster-robust sandwich estimator provided standard errors of parameter estimates, given that 
individual twins are nested within pairs (families). All models control for age and zygosity. Significant 
effects (alpha = 0.05) are bolded. 
Abbreviations: Vb., verbal; PSI, processing speed index, Digit Symb-Cod, digit symbol-coding; WM, 
working memory; RAVLT, Rey Auditory Verbal Learning Test; SS, scaled score; DSF, digit span 
forward; DSB, digit span backwards; Vis., visuospatial; SSF, spatial span forward; SSB, spatial span 
backwards; DM, decision-making; FSIQ, full scale intelligence quotient 
aRaw score; bStandard score: mean of 100, standard deviation of 15; cScaled score: mean of 10, standard 







Table 9. Sex-specific interaction effects of primary cannabis variables on cognitive outcomes. 
 Cannabis index Lifetime heaviest frequency Age of initiation 











Vb. Learning/Memory             
Total Learning 676 0.43 (0.72) 0.61 0.55 676 0.54 (0.39) 1.40 0.16 451 0.15 (0.31) 0.49 0.63 
Short-delay Recall 676 0.00 (0.15) -0.02 0.98 676 0.06 (0.08) 0.71 0.48 451 -0.06 (0.07) -0.96 0.33 
Long-delay Recall 675 0.09 (0.16) 0.58 0.57 675 0.05 (0.09) 0.64 0.52 451 -0.03 (0.07) -0.47 0.64 
Processing Speed             
PSI 675 1.74 (1.04) 1.67 0.10 675 0.65 (0.55) 1.19 0.24 451 -0.71 (0.43) -1.66 0.10 
Digit Sym-Cod 675 0.16 (0.21) 0.76 0.45 675 -0.02 (0.11) -0.15 0.88 451 -0.05 (0.08) -0.59 0.56 
Symbol Search 675 0.45 (0.22) 2.11 0.04 675 0.25 (0.12) 2.13 0.03 451 -0.19 (0.08) -2.19 0.03 
Vb. Attention/WM             
RAVLT Trial 1 676 0.05 (0.14) 0.40 0.69 676 0.04 (0.07) 0.55 0.58 451 -0.02 (0.06) -0.25 0.80 
Longest DSF 676 0.07 (0.10) 0.66 0.51 676 0.07 (0.05) 1.30 0.19 451 -0.03 (0.04) -0.62 0.54 
Longest DSB 670 0.20 (0.11) 1.87 0.07 670 0.06 (0.06) 1.08 0.28 447 -0.01 (0.04) -0.32 0.75 
Vis. Attention/WM             
Longest SSF 653 0.03 (0.09) 0.29 0.78 653 0.05 (0.05) 0.93 0.36 433 -0.01 (0.04) -0.33 0.74 
Longest SSB 652 -0.01 (0.11) -0.09 0.93 652 0.02 (0.06) 0.30 0.76 433 -0.03 (0.05) -0.67 0.50 
Decision-Making             
DM Overall 658 3.30 (2.93) 1.13 0.26 658 3.00 (1.57) 1.91 0.06 437 -1.07 (1.23) -0.87 0.38 
DM Ambiguitya 658 0.08 (0.09) 0.93 0.35 658 0.06 (0.05) 1.37 0.17 437 -0.03 (0.04) -0.81 0.42 
DM Risk 658 2.40 (2.29) 1.05 0.30 658 2.29 (1.23) 1.85 0.06 437 -0.52 (0.95) -0.54 0.59 
Cognitive Inhibition             
D-prime 665 0.05 (0.07) 0.75 0.45 665 0.00 (0.04) -0.06 0.96 445 -0.04 (0.03) -1.25 0.21 
No-go Error Ratea,b 665 0.01 (0.13) 0.08 0.93 665 0.05 (0.07) 0.77 0.44 445 0.07 (0.05) 1.40 0.16 
General Cognitive 
Ability             
Prorated FSIQ 673 -0.08 (1.00) -0.08 0.93 673 0.47 (0.54) 0.87 0.39 448 0.22 (0.42) 0.54 0.59 
Block Design 674 0.05 (0.20) 0.24 0.81 674 0.14 (0.11) 1.24 0.22 449 -0.04 (0.08) -0.54 0.59 
Vocabulary 782 -0.12 (0.14) -0.89 0.37 782 -0.02 (0.07) -0.28 0.78 504 0.08 (0.06) 1.31 0.19 
Notes. Females were coded as 1 and males were coded as 0 in analyses of sex-interaction effects.  All models included covariates for age, sex, zygosity, pre-
















Abbreviations: Vb., verbal; PSI, processing speed index, Digit Symb-Cod, digit symbol-coding; WM, working memory; RAVLT, Rey Auditory Verbal 
Learning Test; SS, scaled score; DSF, digit span forward; DSB, digit span backwards; Vis., visuospatial; SSF, spatial span forward; SSB, spatial span 
backwards; DM, decision-making; FSIQ, full scale intelligence quotient.  
aValues were square-root transformed prior to analyses; bHigher values = more errors. 
 
Table 10. Associations between cannabis variables and neurocognitive outcomes separated by sex. 
 Females Males 
Cognitive measures N Estimates (SE) t-statistics p-value N Estimates (SE) t-statistics p-value 
Symbol Search         
Cannabis index 375 0.14 (0.20) 0.70 0.48 300 -0.25 (0.19) -1.32 0.19 
Lifetime heaviest frequency 375 0.11 (0.11) 1.02 0.31 300 -0.09 (0.10) -0.84 0.40 
Age of initiation 230 0.03 (0.07) 0.51 0.60 221 0.15 (0.08) 2.02 0.04 
DM Overall         
Lifetime heaviest frequency 367 -1.48 (1.45) -1.02 0.31 291 -4.07 (1.56) -2.61 0.01 
DM Risk         
Lifetime heaviest frequency 367 -1.09 (1.15) -0.95 0.35 291 -2.73 (1.20) -2.27 0.02 
Notes.  All models included covariates for age, zygosity, pre-exposure IQ, SES, education, alcohol/nicotine use, recent cannabis use and a random intercept at 
the twin-pair level. Significant effects (alpha = 0.05) are bolded. 











Table 11. Associations between age of initiation and neurocognitive outcomes covarying for age-24 cannabis index (frequency/quantity). 
 Age of initiation Age-24 Cannabis index 
Cognitive measures Estimates (SE) t p Estimates (SE) t p 
Prorated FSIQ 0.48 (0.23) 2.07 0.04 0.23 (0.49) 0.47 0.64 
Block Design 0.09 (0.05) 2.00 0.05 -0.04 (0.10) -0.47 0.64 
Symbol Searcha 0.15 (0.08) 1.96 0.05 -0.04 (0.14) -0.27 0.79 
Longest SS Forward 0.05 (0.02) 2.02 0.04 -0.04 (0.05) -0.84 0.40 
DM Ambiguityb 0.04 (0.02) 1.96 0.05 -0.07 (0.02) -1.41 0.16 
Notes.  All models included covariates for age, sex, zygosity, pre-exposure IQ, SES, education, alcohol/nicotine use, recent cannabis use and a random 
intercept at the twin-pair level. Significant effects (alpha = 0.05) are bolded.   
Abbreviations: FSIQ, full scale intelligence quotient; SS, spatial span; DM, decision-making.  





Table 12. Associations between age of initiation and neurocognitive outcomes covarying for the cannabis index or lifetime heaviest frequency. 
 Age of initiation Cannabis index Lifetime heaviest frequency 
Cognitive measures Estimates (SE) t p Estimates (SE) t p Estimates (SE) t p 
Block Design 0.05 (0.05) 1.10 0.27 -0.30 (0.15) -1.94 0.05    
DM Ambiguitya 0.04 (0.02) 1.74 0.08    -0.05 (0.04) -1.23 0.22 
Notes.  All models included covariates for age, sex, zygosity, pre-exposure IQ, SES, education, alcohol/nicotine use, recent cannabis use and a random 
intercept at the twin-pair level. Significant effects (alpha = 0.05) are bolded. The p-value for the effect of cannabis index on block design appears significant, 
but this is due to rounding. 
Abbreviations: DM, decision-making  






























Table 13. Associations between length of abstinence and neurocognitive outcomes. 
 Length of abstinence 
Cognitive measures Estimates (SE) t p 
Prorated FSIQ 0.03 (0.26) 0.10 0.92 
Block Design 0.06 (0.05) 1.10 0.27 
Symbol Search 0.07 (0.06) 1.35 0.18 
Longest SS Forward 0.02 (0.03) 0.92 0.36 
Short-Delay Recall 0.04 (0.04) 1.05 0.30 
DM Overall 0.90 (0.78) 1.15 0.25 
DM Ambiguitya 0.04 (0.02) 1.48 0.14 
DM Risk 0.39 (0.61) 0.64 0.53 
Notes: All models included covariates for age, sex, zygosity, pre-exposure IQ, SES, education, and alcohol/nicotine use and 
a random intercept at the twin-pair level. Significant effects (alpha = 0.05) are bolded. 
Abbreviations: FSIQ, full scale intelligence quotient; SS, spatial span; DM, decision-making 






Table 14. Group differences between individuals with less than a month of abstinence compared to those with at least a year of abstinence from cannabis. 
 
< 1 month abstinence 
(n = 173) 
 1 year abstinence 
(n = 222) 
Cluster-robust group comparisons 
 
Cognitive measures Mean (SD) Mean (SD) Estimates (SE) t p 
Prorated FSIQa 106.63 (15.19) 107.39 (16.80) -1.78 (1.87) -0.95 0.34 
Block Designb 12.32 (2.60) 12.75 (2.84) -0.60 (0.31) -1.91 0.06 
Symbol Searchb 11.59 (2.48) 12.11 (2.78) -0.43 (0.29) -1.47 0.14 
Longest SS Forwardc 6.42 (1.21) 6.53 (1.13) -0.12 (0.14) -0.89 0.37 
Short-Delay Recallc -1.75 (1.66) -1.46 (1.93) -0.25 (0.21) -1.21 0.23 
DM Overallc -0.92 (32.08) 4.89 (35.91) -6.17 (4.07) -1.52 0.13 
DM Ambiguityc,d 5.93 (1.05) 6.06 (1.08) -0.17 (0.12) -1.43 0.16 
DM Riskc 3.85 (24.52) 7.98 (27.45) -4.00 (3.15) -1.27 0.21 
Notes:  Cluster-robust sandwich estimator provided standard errors of parameter estimates, given that individual twins are nested within pairs (families). All 
models control for age, sex, and zygosity. Individuals with less than a month of abstinence from cannabis were coded as 1 and individuals with at least a 
year of abstinence were coded as 0. 
Abbreviations: FSIQ, full scale intelligence quotient; SS, spatial span; DM, decision-making 
 aStandard score: mean of 100, standard deviation of 15; bScaled score: mean of 10, standard deviation of 3; cRaw score; dValues were square-root 


















Table 15. Associations between lifetime heaviest frequency and cognitive measures in cannabis users 
only. 
 Lifetime heaviest frequency 
Cognitive measures N Estimates (SE) t-statistics p-value 
Vb. Learning/Memory     
Total Learning 325 -0.21 (0.37) -0.57 0.57 
Short-delay Recall 325 0.05 (0.08) 0.65 0.52 
Long-delay Recall 325 0.03 (0.08) 0.42 0.68 
Processing Speed     
PSI 325 -0.18 (0.52) -0.34 0.73 
Digit Sym-Cod 325 -0.05 (0.11) -0.51 0.61 
Symbol Search 325 -0.01 (0.11) -0.14 0.89 
Vb. Attention/WM     
RAVLT Trial 1 325 -0.08 (0.08) -0.99 0.32 
Longest DSF 325 -0.10 (0.05) -1.83 0.07 
Longest DSB 322 -0.13 (0.06) -2.31 0.02 
Vis. Attention/WM     
Longest SSF 313 -0.01 (0.05) -0.16 0.88 
Longest SSB 313 -0.01 (0.06) -0.18 0.86 
Decision-Making     
DM Overall 316 -0.41 (1.54) -0.27 0.79 
DM Ambiguitya 316 0.05 (0.05) 0.94 0.35 
DM Risk 316 -1.10 (1.22) -0.90 0.37 
Cognitive Inhibition     
D-prime 321 -0.01 (0.04) -0.38 0.70 
No-go Error Ratea,b 321 0.00 (0.06) 0.07 0.95 
General Cog Ability     
Prorated FSIQ 324 -0.17 (0.53) -0.33 0.74 
Block Design 324 -0.09 (0.10) -0.85 0.40 
Vocabulary 359 0.04 (0.07) 0.56 0.58 
Notes.  All models included covariates for age, sex, zygosity, pre-exposure IQ, SES, education, 
alcohol/nicotine use, recent cannabis use and a random intercept at the twin-pair level. Significant effects 
(alpha = 0.05) are bolded.  
Abbreviations: Vb., verbal; PSI, processing speed index, Digit Symb-Cod, digit symbol-coding; WM, 
working memory; RAVLT, Rey Auditory Verbal Learning Test; SS, scaled score; DSF, digit span 
forward; DSB, digit span backwards; Vis., visuospatial; SSF, spatial span forward; SSB, spatial span 
backwards; DM, decision-making; FSIQ, full scale intelligence quotient. 
aValues were square-root transformed prior to analyses; bHigher values = more errors. 
 
Table 16. Twin correlations for cannabis variables 
  
Twin correlations by 
zygosity 
 Full MZ DZ 
Cannabis index 0.72 0.81 0.62 
Lifetime heaviest frequency 0.58 0.72 0.38 
Age of initiation 0.55 0.60 0.45 
Notes. Correlations between twin pairs for the full sample and then split by 







Table 17. Individual-level analyses between cannabis use and cognition. 
  Individual-level analyses 
 N Estimates (SE) t-statistics p-value 
Cannabis index     
General Cognitive Ability     
Block Design 686 -0.23 (0.12) -1.95 0.05 
Lifetime heaviest frequency     
Decision-Making     
DM Overall 672 -2.60 (0.80) -3.27 <0.01 
Females 378 -1.67 (1.10) -1.47 0.14 
Males 294 -3.84 (1.67) -3.29 <0.01 
DM Ambiguitya 672 -0.05 (0.02) -2.23 0.03 
DM Risk 672 -2.05 (0.63) -3.25 <0.01 
Females 378 -1.38 (0.88) -1.58 0.12 
Males 294 -2.95 (0.91) -3.25 <0.01 
Age of initiation     
Processing Speed     
Symbol Search 458 0.17 (0.04) 3.74 <0.01 
Females 234 0.09 (0.06) 1.45 0.15 
Males 224 0.28 (0.07) 4.02 <0.01 
Visuospatial Attention     
Longest SS Forward 442 0.07 (0.02) 3.59 <0.01 
Decision-Making     
DM Ambiguitya 445 0.05 (0.02) 2.37 0.02 
General Cognitive Ability     
Prorated FSIQ 454 1.45 (0.27) 5.48 <0.01 
Lifetime heaviest frequency (CU only)     
Verbal Attention/WM     
Longest DS Backward 326 -0.12 (0.05) -2.44 0.02 
Notes. All models included covariates for age, sex, zygosity and a random intercept at the twin-pair 
level. Bold denotes tests significant at the false discovery rate (FDR) of q < 0.05. 
Abbreviations: DM, decision-making; SS, spatial span; FSIQ, full scale intelligence quotient; WM, 
working memory; DS, digit span. 









Table 18. Associations between cannabis use and neurocognitive outcomes using cotwin control analyses. 
     Cotwin control analyses 
 Individual-level models Between-pair estimate Within-pair estimate 
 N 
Estimates 
(SE) t-statistics p-value N 
Estimates 
(SE) t-statistics p-value 
Estimates 
(SE) t-statistics p-value 
Lifetime heaviest 
frequency            
Decision-Making            
DM Overall 672 -2.60 (0.80) -3.27 <0.01 652 -3.18 (0.97) -3.28 <0.01 -1.38 (1.52) -0.91 0.36 
Females 378 -1.67 (1.10) -1.47 0.14 373 -3.10 (1.28) -2.43 0.02 2.25 (2.17) 1.04 0.30 
Males 294 -3.84 (1.17) -3.29 <0.01 279 -3.50 (1.50) -2.34 0.02 -4.87 (2.11) -2.31 0.02 
DM Risk 672 -2.05 (0.63) -3.25 <0.01 652 -2.39 (0.77) -3.10 <0.01 -1.36 (1.19) -1.15 0.25 
Females 378 -1.38 (0.88) -1.58 0.12 373 -2.61 (1.03) -2.54 0.01 1.77 (1.73) 1.02 0.31 
Males 294 -2.95 (0.91) -3.25 <0.01 279 -2.27 (1.18) -1.93 0.06 -4.35 (1.58) -2.75 0.01 
            
Age of initiation            
Processing Speed            
Symbol Search 458 0.17 (0.04) 3.74 <0.01 371 0.23 (0.07) 3.34 <0.01 0.03 (0.09) 0.40 0.69 
Females 234 0.09 (0.06) 1.45 0.15 183 0.12 (0.09) 1.29 0.20 -0.04 (0.13) -0.28 0.78 
Males 224 0.28 (0.07) 4.02 <0.01 188 0.34 (0.10) 3.50 <0.01 0.11 (0.12) 0.88 0.38 
Visuospatial Attention            
Longest SS Forward 442 0.07 (0.02) 3.59 <0.01 357 0.10 (0.03) 3.83 <0.01 0.00 (0.05) 0.05 0.96 
General Cognitive 
Ability            
Prorated FSIQ 454 1.45 (0.27) 5.48 <0.01 366 2.52 (0.45) 5.59 <0.01 1.00 (0.41) 2.45 0.02 
Notes.  Significant effects are in bold.  All models included covariates for age, sex, zygosity and a random intercept at the twin-pair level. All individual-level 
models survived multiple comparison adjustment at the false discovery rate (FDR) of q < 0.05. 


















Table 19. Within-pair associations between lifetime heaviest frequency and decision-making with and without covariate adjustment. 
Lifetime heaviest frequency (males) Cotwin control analyses 
 Unadjusted Covariates, adjusted 
Cognitive measures Estimates (SE) t-statistics p-value Estimates (SE) t-statistics p-value 
Decision-Making       
DM Overall -4.87 (2.11) -2.31 0.02 -4.60 (2.61) -1.76 0.08 
DM Risky -4.35 (1.58) -2.75 0.01 -4.99 (2.49) -2.00 0.05 
Notes.  Significant effects are in bold.  Adjusted models included twin difference scores for pre-exposure IQ, education, age-24 alcohol and nicotine indices, 
and recent cannabis use.  All models included covariates for age, sex, zygosity and a random intercept at the twin-pair level. 
Abbreviations: DM, decision-making. 
Table 20. Within-pair associations between age of initiation and decision-making with and without covariate adjustment. 
Age of initiation Cotwin control analyses 
 Unadjusted Covariates, adjusted 
Cognitive measures Estimates (SE) t-statistics p-value Estimates (SE) t-statistics p-value 
General Cognitive Ability       
Prorated FSIQ 1.00 (0.41) 2.45 0.02 0.83 (0.39) 2.11 0.04 
Notes. Significant effects are in bold.  Adjusted models included twin difference scores for pre-exposure IQ, education, age-24 alcohol and nicotine indices, 
and recent cannabis use.  All models included covariates for age, sex, zygosity and a random intercept at the twin-pair level. 










Table 21. Within-pair associations for lifetime heaviest frequency and length of abstinence on decision-making under risk. 
  Cotwin control analyses 
  Lifetime heaviest frequency within-pair effect Length of abstinence within-pair effect 
  Estimates (SE) t-statistics p-value Estimates (SE) t-statistics p-value 
Decision-Making        
DM Risk  -5.83 (2.53) -2.31 0.02 -0.05 (1.45) -0.04 0.97 
Notes. Significant effects are in bold.  All models included covariates for age, sex, zygosity and twin difference scores for pre-exposure IQ, education, age-24 
alcohol and nicotine indices, and recent cannabis use. Models also included a random intercept at the twin-pair level 
Abbreviations: DM, decision-making. 
Table 22. Within-pair associations for age of initiation and length of abstinence on prorated FSIQ. 
  Cotwin control analyses 
  Age of initiation within-pair effect Length of abstinence within-pair effect 
  Estimates (SE) t-statistics p-value Estimates (SE) t-statistics p-value 
General Cognitive Ability        
Prorated FSIQ  0.79 (0.40) 1.98 0.05 -0.20 (0.48) -0.41 0.68 
Notes. Significant effects are in bold.  All models included covariates for age, sex, zygosity and twin difference scores for pre-exposure IQ, education, age-24 
alcohol and nicotine indices, and recent cannabis use. Models also included a random intercept at the twin-pair level 
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Figure S1. Histogram depicting pre-exposure IQ distribution for individuals who participated in the 
age-24 assessment and were included in the current study sample. 
